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Kindler syndrome (KS) is an autosomal recessive genodermatosis resulting from 
pathogenic mutations in the FERMT1 (KIND) gene. This gene encodes kindlin-1 
(also known as fermitin family homologue 1), a focal adhesion protein involved in 
activation of the integrin family of extracellular matrix receptors. Most cases of KS 
show a marked reduction or complete absence of the kindlin-1 protein in 
keratinocytes, resulting in defective integrin activation and abnormal cell adhesion 
and migration. However, currently very little is known about the way in which 
different FERMT1 mutations found in patients impact upon keratinocyte behaviour. 
The aim of this thesis is to screen for novel binding partners of kindlin-1 to elucidate 
possible new functions for this protein in epidermal cells. The main approaches 
taken were to assess differentially expressed proteins in normal vs. KS patient 
keratinocytes and also to use recombinant wild type and mutant kindlin-1 for 
pulldown assays to identify novel binding partners. Mass spectrometry analysis 
revealed a number of downregulated proteins in KS keratinocytes including 
epidermal growth factor receptor (EGFR) and thrombospondin-1 (TSP-1). 
Immunoblotting confirmed a significant reduction in both of these proteins. Further 
investigation showed changes in localisation of both TSP-1 and EGFR, and also 
defective signalling and response following EGF stimulation in KS keratinocytes. 
Moreover, EGFR levels in KS keratinocytes were partially restored following 
treatment with lysosomal inhibitors, suggesting that kindlin-1 can regulate the 
recycling of this receptor. Mass spectrometry analysis also identified the potential 
interaction partners of kindlin-1 to be talin and integrin linked kinase (ILK). 
Biochemical analysis revealed that kindlin-1 interacts specifically with the talin head 
domain. This interaction was significantly reduced with a mutant form of kindlin-1 
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identified in a KS patient that lacks part of the F3 subdomain. Taken together, these 
studies have identified novel proteins that are regulated by kindlin-1 and may be 
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1.1 Structure of the skin  
1.1.1 Epidermis and epidermal keratinocytes 
The skin is the largest organ of the human body. It consists of a multi-layered 
stratified epidermis, a dermis containing collagen and elastic fibres, and underlying 
subcutaneous fat. The epidermis is a stratified squamous epithelium. It forms a 
protective barrier against the environment and has several important functions 
including; prevention of water loss, excluding toxins, resisting mechanical stress and 
involvement in immune responses. The epidermis is divided into 4 main layers 
which are the basal layer (stratum basale), spinous layer (stratum spinosum), 
granular layer (stratum granulosum) and cornified layer (stratum corneum) (Simpson 
et al., 2011). The basal layer consists of a single layer of specialised skin epidermal 
cells known as keratinocytes, which are attached to an underlying matrix. The cells 
proliferate and some of their daughter keratinocytes enter the spinous layer, where 
they exit the cell cycle, grow larger and establish intercellular connections. Cells in 
the granular layer flatten and assemble a water-impermeable cornified envelope 
underlying the plasma membrane. And lastly the corneal layer keratinocytes release 
lysosomal enzymes to degrade major organelles; the cells become completely 
squamous and are tightly crosslinked together to form the cutaneous barrier 
(Simpson et al., 2011). The structure and composition of the stratum corneum and 
upper epidermis form a physical barrier against the external environment and 






1.1.2 The dermis 
The dermis is the layer that lies between the epidermis and subcutaneous tissues; it 
consists of connective tissue and buffers the body from stress and strain. It is 
subdivided into two layers, the papillary region and a deep thicker area known as the 
reticular dermis. The dermis is tightly connected to the epidermis through a 
basement membrane and contains structural components including collagen, elastic 
fibres, and ground substance (extrafibrillar matrix). Of the twenty seven types of 
collagen found in vertebrates, eight of these are expressed in the skin. Collagen not 
only maintains structure but also has important functions such as cell adhesion, 
chemotaxis and migration (Myllyharju and Kivirikko, 2004). Elastic fibres are 
composed of elastin and fibrillin proteins, and are less tough than collagen but 
provide extensible properties to the skin. This allows the skin to stretch and recoil 
without damage (Midwood and Schwarzbauer, 2002). The ground substance is the 
intercellular material in which the cells and fibres are embedded and is mostly 
composed of proteoglycans and glycoproteins. The proteoglycans are made up of 
multiple core proteins which have large molecules, glycoaminoglycans, such as 
hyaluronic acid. These molecules play an essential role in water retention 
(Heinegård, 2009). The fibroblast is the predominant cell type in the dermis and 
secretes collagens, elastic fibres and ground substance. Other cells in the dermis 
include mast cells, plasma cells, lymphocytes, dermal dendritic cells and histiocytes. 
The dermis also contains mechanoreceptors that provide the sense of touch and heat, 
hair follicles, sweat glands, sebaceous glands, apocrine glands, lymphatic vessels and 
blood vessels. These blood vessels provide nourishment and waste removal for both 




1.1.3 The subcutis 
The subcutis is the innermost layer of the skin, and is composed of adipose tissue. 
The adipose tissue is compartmentalised by fibrous septae. Bundles of fibres from 
the dermis extend into the subcutis to strengthen the connection between these two 
compartments. This layer functions as an insulator, conserving the body's heat, and 
as a shock-absorber, protecting the inner organs. It also stores fat as an energy 
reserve for the body. The blood vessels, nerves, lymph vessels, and hair follicles also 
cross through this layer. It also has an endocrine function, communicating with the 
hypothalamus via secreted molecules such as leptin to alter energy expenditure and 
appetite.  
 
1.1.4 Structure of the dermal-epidermal junction 
The junction between the dermis and the epidermis is composed of a specialised 
layer of extracellular matrix (ECM) called the basement membrane, and is referred 
to as the dermal-epidermal junction (DEJ) in the skin. The DEJ restricts molecules 
based on their size and charge and also mediates cells to migrate under normal or 
pathological conditions (Burgeson and Christiano, 1997). The DEJ has two main 
classes of extracellular macromolecules including polysaccharide chains of the class 
called glycosaminoglycans (GAGs), which are usually found covalently linked to 
protein in the form of proteoglycans, and fibrous proteins, including collagen, 
elastin, fibronectin, and laminin, which have both structural and adhesive functions. 
These proteins can bind to each other to make a highly crosslinked extracellular 
matrix (LeBleu et al., 2007). Ultrastructurally, the DEJ can be divided into four 
zones and this includes the cell membranes of the basal keratinocytes, which 
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contains the hemidesmosomes and integrin based adhesions (Burgeson and 
Christiano, 1997). The second zone is the lamina lucida, through which the 
anchoring filaments traverse, is rich in laminin. The lamina densa is the third zone 
and is mainly composed of collagen IV but also consists of laminins and 
proteoglycans. The final zone is the sub-basal lamina, which contains anchoring 
fibrils, mostly collagen VII (Burgeson and Christiano, 1997).  
The basal keratinocytes of the epidermis assemble hemidesmosomes and integrin 
based adhesions at the basal surface to maintain cell attachment to the underlying 
basement membrane (BM) (McMillan et al., 2003). Hemidesmosomes link the 
keratin intermediate filaments of basal keratinocytes with the ECM while integrins 
provide transmembrane connections from the ECM to the intracellular actin network. 
Hemidesmosomal structures are composed of α6β4, plectin, bullous pemphigoid 
antigen 1e (BP230) and BP180, which mediate linkage between keratin filaments 
such as keratin 5 and 14 to collagen fibres and laminin in the BM (McMillan et al., 
2003; Fassihi et al., 2006). The adhesion sites are complex molecular structures that 
connect ECM proteins such as fibronectin, collagen and laminin to the actin 
cytoskeleton via integrin receptors. Integrins do not bind to actin directly but are 
connected through various actin-binding proteins such as talin, paxillin, vinculin and 
actinin. The only focal adhesion protein that is associated with a disease is kindlin-1, 
whose pathogenesis results in Kindler syndrome (Siegel et al., 2003; Tsuruta et al., 
2011). Loss of function mutations in any of the components of the hemidesmosome 
including the keratin filaments and ECM proteins result in dysadhesion of the 
epidermis and development of blisters between the keratinocyte layers of the skin 
and dermis (McMillan et al., 2003; Fassihi et al., 2006). These phenotypes have 
been identified as pathogenic in a family of skin fragility and blistering disorders 
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know as epidermolysis bullosa (EB). There are several subtypes of this disorder, 
which includes EB simplex, junctional EB and dystrophic EB, and are defined by the 
gene that is mutated and the severity of the condition (Fassihi et al., 2006; Tsuruta et 
al., 2011). Molecules at the BM are also involved in cell signalling between the 
dermis and the epidermis. In addition to its role in maintaining dermal-epidermal 
adhesion, the BM prevents the epidermal keratinocytes from invading the dermis 
(Amano, 2009). It also determines polarity for the epidermis so that once the BM is 
assembled, the basal keratinocytes recognise the surface adjacent to the BM as its 
basal surface (Amano, 2009). 
 
1.1.4.1 Components of the ECM 
Among the structural components of the ECM, many transiently secreted proteins 
also exist including members of the matricellular family. Thrombospondin-1 (TSP-
1) is a member of the matricellular family and was originally discovered as a major 
component in platelet α-granules. It is secreted into the matrix, binds to matrix 
components and to cell surface receptors, but does not play a structural role. TSP-1 is 
a protein with many functions, which it achieves through its multiple domain 
structure (Adams and Lawler, 2004).  TSP1 binds to extracellular matrix ligands 
including fibrinogen, fibronectin, some collagens, latent and active transforming 
growth factor-beta-1, MMPs, and heparan sulphate proteoglycans. TSP1 also binds 
to cell surface receptors including CD36, CD47, and the integrins alpha-V/beta-3, 
alpha-3/beta-1, alpha-4/beta-1, and alpha-6/beta-1 (Chen et al., 2000). TSP1 in a 
context-dependent and cell-specific manner stimulates or inhibits cell adhesion, 
proliferation, motility, and survival (Chen et al., 2000). TSP-1 has been shown to be 
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involved in thrombus formation (Murphy-Ullrich and Mosher, 1985) and plays a 
significant role in wound healing with increased expression seen at the wound edge 
(Reed et al., 1993). It is also a potent inhibitor of angiogenesis, demonstrated by its 
ability to inhibit endothelial cell migration (Short et al., 2005) and in addition has 
been shown to modulate tumour biology through cell adhesion, migration and 
invasion. However, it appears to have roles in both tumour growth and inhibition 
(Esemuede et al., 2004). The ability of TSP-1 to bind different matrix proteins and 
cell surface receptors may account for its multi-functional and sometimes opposing 
nature.   
 
1.1.5 Epidermal stem cells  
There are three differentiating epithelial compartments in the skin, which includes 
the epidermis, hair follicles and associated glands such as the sebaceous gland. The 
growth of both the epidermis and sebaceous gland is continuous. In the epidermis, 
proliferation occurs in the basal layer and the terminally differentiated progeny move 
through the suprabasal layer to the cell surface (Blanpain and Fuchs, 2009). 
Cutaneous stem cells are slow-cycling cells and are found in the bulge of the hair 
follicles and also in the sebaceous glands. Stem cells niches contribute to 
regeneration of the skin and lineage-specific differentiation. (Ghazizadeh and 
Taichman, 2001). The stem cells are involved in the regeneration of the hair follicles, 
sebaceous glands and also the interfollicular epidermis during wound healing 
processes. The stem cells within the basal layer of keratinocytes are responsible for 
the production of the majority of the interfollicular epidermis. The stem cells in the 
bulge of the hair follicles are characterised by high levels of β integrin, keratin 15 
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and keratin 19 expression (Jones and Simons, 2008). Stem cells divide 
asymmetrically to give rise to one daughter cell committed to terminal differentiation 
and another daughter stem cell (Lechler and Fuchs, 2005). There are, however, 
several modes of asymmetrical division, for example one that positions the mitotic 
spindle parallel to the BM and another that places the division perpendicular to the 
BM. β1 integrin mediated adhesions are known to regulate differentiation of 
epidermal keratinocytes, while Notch signalling has been implicated as a key factor 
that regulates the basal to spinous switch (Blanpain and Fuchs, 2009). A highly 
proliferative population of cells can be generated by some stem cells and are known 
as transient amplifying cells. These cells are found within clusters of stem cells and 
are characterised by positive expression of  β1 integrin, Notch ligand delta, cell 
surface proteoglycan MSPG, desmosomal protein desmoglein 3 (DSG3) and 
transcription factor LRIG1 (Jones and Simons, 2008). 
 
1.2 Kindler syndrome 
1.2.1 History of Kindler syndrome 
Kindler syndrome (KS; OMIM 173650) is caused by an abnormality in the actin 
cytoskeleton and its association with the ECM due to a deficiency or defect in the 
focal adhesion protein, kindlin-1 (also known as fermitin family homologue 1 and 
previously kindlerin) (Jobard et al., 2003; Siegel et al., 2003). KS was first described 
by Theresa Kindler in 1954. The patient, a 14 year old girl, presented with congenital 
blistering on the arms, legs and feet and also developed pigmentary changes after 
suffering from photosensitivity  (Kindler, 1954). The clinical features of KS 
overlapped with those seen in other diseases such as the inherited skin blistering 
disease EB. Similarities to hereditary acrokeratotic poikilodema, an autosomal 
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dominant disorder described by Weary et al. resulted in the term Weary-Kindler 
syndrome being introduced (Weary et al., 1971). This led to confusion in providing a 
clear diagnosis but subsequent reports tended to separate autosomal recessive KS 
from autosomal dominant Weary syndrome. Further molecular characterisation of 
the overlapping clinical disorders allowed KS to be classified as a distinct and 
separate genodermatosis. 
 
1.2.2 Clinical features of Kindler syndrome  
The initial feature of KS is trauma-induced blistering which reduces or ultimately 
stops in later childhood. Patients also develop progressive poikiloderma and skin 
atrophy which is more acute on the dorsal aspects of the hands and feet. In addition, 
KS patients may show marked photosensitivity (Ashton, 2004). Other features 
include early onset destructive periodontal disease and severe desquamative 
gingivitis causing bleeding gums and loss of teeth. Mucosal involvement including 
anal, vaginal, urethral and oesophageal stenoses is frequently seen in individuals 
with KS. Patients can also develop gastrointestinal symptoms such as severe colitis. 
Finger webbing, squamous cell carcinoma and nail dystrophy are other reported 
features (Ashton, 2004; Lai-Cheong et al., 2007; Lai-Cheong et al., 2010). Some of 




Figure 1.1: Clinical features of Kindler syndrome. 
a) Significant poikiloderma on dorsa of the hands. b) Atrophy and erythema on the 
dorsae of the hands. c) Trauma-induced scars and post-inflammatory 
hyperpigmentation on the lower limbs. d) Facial erythema. e) Marked poikiloderma 
on the face and neck. f) Telangiectasiae on lower lip mucosa and mild oral 
inflammation. g) Skin wrinkling and atrophy on the elbow.        
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1.2.3 Histological abnormalities in Kindler syndrome skin  
Histologically, characterisation of KS skin shows that the epidermis is flattened and 
atrophic with hyperkeratosis as well as a loss of rete ridges. There is vacuolisation of 
the basal layer of the epidermis, telangiectatic vessels as well as pigmentary 
incontinence in the superficial dermis (Hovnanian et al., 1989; Shimizu et al., 1997). 
Electron microscopy reveals multiple planes of cleavage, marked reduplication of 
the lamina densa and cleft formation in the lamina lucida. Abnormal cleavage may 
be within or just above the basal layer of epidermis, within the lamina lucida or 
below the lamina densa. Hemidesmosomes and anchoring fibrils, however, appear 
grossly normal (Shimizu et al., 1997). Figure 1.2 highlights some of the structural 






Figure 1.2: Structure of Kindler syndrome skin  
Light microscopy (LM) of a) normal skin and b) KS skin. E = epidermis; D = dermis   
Scale bar = 50 μm. c) Ultrastructural appearances of the DEJ in NHS: HD = 
hemidesmosome; LD = lamina densa; AF = anchoring fibrils. d) in KS, there is a 
blister (asterisk). In addition, the LD is fragmented with some present in the roof and 
base. In some parts of the section AF are seen below the LD in the blister roof, while 
in others parts of the section the AF are below the LD in the floor of the blister. 
Fragmentation of the LD and duplication of the LD (shown within the dermis) are 
characteristic ultrastructural hallmarks of KS. The plane of blistering is variable in 
KS: here the cleavage is both sub-LD and also within the lamina lucida, while other 
cases may reveal some blistering within basal keratinocytes (not shown here). 
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1.2.4 Identification of the Kindler syndrome gene 
The gene implicated in KS was identified in 2003 by two independent groups 
(Jobard et al., 2003; Siegel et al., 2003). Genome-wide linkage analysis was 
performed and showed the gene responsible for KS to be on chromosome 20p12.3. 
Six predicted genes were identified within this region, but only one contained a 
mutation; FLJ20116, which is also known as c20orf42 and subsequently renamed 
KIND1 (Siegel et al., 2003). Other nomenclatures associated with this gene include 
unc-related protein 1 (URP1), UNC112A and fermitin family homologue 1 
(FERMT1), however, for the purposes of the present work it will be referred to as 
KIND1.  
The KIND1 gene spans 48.5 kb of genomic DNA and contains 14 coding (exons 2 to 
15) and one non-coding exon (exon 1). The KIND1 gene is the human homologue of 
the Caenorhabditis elegans gene, unc-112, which encodes a protein that mediates 
actin cytoskeleton anchorage with the ECM (Rogalski et al., 2000). The human 
KIND1 mRNA transcript is ∼4.9 kb and gene expression was shown in cultured 
keratinocytes, colon, kidney and placenta and at lower expression levels in heart, 
skeletal muscle, liver, and small intestine (Siegel et al., 2003). The colon contains an 
additional transcript that is ∼5.8 kb. Since identifying the KIND1 gene, 150 patients 
and 46 mutations have been reported. These mutations include nonsense, frameshift, 
splice site and internal deletion changes (Has et al., 2011b). The KIND1 gene 
encodes the protein kindlin-1 which consists of 677 amino acid residues and has a 
molecular weight of 77 kDa (Siegel et al., 2003). The kindlin-1 protein possesses a 
bipartite FERM (4.1 protein, ezrin, radixin, moesin) domain at the C-terminal region. 
The FERM domain consists of three subdomains, F1, F2 and F3 as shown in Figure 
1.3. The F2 subdomain is disrupted by a pleckstrin homology (PH) domain. Both the 
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FERM and PH domain are present in many proteins that are involved in anchorage 
of the cytoskeleton to the ECM and the PH domain is found in several cell signalling 
molecules that associate with cell membranes by binding to specific lipid molecules 
(Meves et al., 2009). 
 
 
Figure 1.3: Domain organisation of kindlin-1 protein 
The kindlin-1 protein consists of a bipartite FERM (Four point one protein, Ezrin, 
Radixin and Moesin) domain, which contains three subdomains, denoted F1, F2 and 
F3. There is a PH (Pleckstrrin homology) sandwiched within the F2 subdomain.    
 
1.3 Kindlin-1 
1.3.1 Kindlin-1 homologues   
The kindlin-1 protein has closely related homologues in fish (Onchrhynchus), fruit 
flies (Drosophila melanogaster) and worms (Caenorhabditis elegans) (Rogalski et 
al., 2000; Schaller, 2000; Siegel et al., 2003). In C.elegans the homologue of 
kindlin-1 is the unc-112 protein and loss of this protein results in a paralysed lethal 
phenotype (pat – paralysed arrested elongation at twofold). This is characterised by a 
loss of adhesion between muscle and the ECM during embryo unfolding (Rogalski et 
al., 2000). Embyros with a loss of perlecan (unc-52, α integrin (pat-2) or β integrin 
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(pat-3) subunits also exhibit a similar PAT phenotype, indicating that UNC-112 may 
be involved in cell-ECM interactions at sites of integrin adhesions (Rogalski et al., 
2000). 
 
1.3.2 Kindlin-1 localisation in skin and keratinocytes 
An anti-kindlin-1 antibody has been used to determine the localisation of kindlin-1 
in normal human and KS patient skin as well as in keratinocytes. In normal skin, 
kindlin-1 localises mostly in the epidermis, more specifically in keratinocytes and 
also along the DEJ. However in KS skin, the signal was markedly reduced and 
almost completely absent from the basal keratinocytes (Siegel et al., 2003). In 
keratinocytes, kindlin-1 colocalised with filamentous actin as well as with vinculin, a 
marker for focal adhesions (Siegel et al., 2003). The localisation of kindlin-1 in these 
cells is supportive of a role in anchorage of the actin cytoskeleton to the ECM. 
 
1.3.3 Kindlin-1 and keratinocyte behaviour 
In vitro studies have demonstrated that kindlin-1-deficient keratinocytes display a 
number of abnormal phenotypes. Initial studies using siRNA to deplete kindlin-1 
expression in HaCaT cells showed a notable decrease in cell spreading (Kloeker et 
al., 2004). In addition to this, Herz et al. reported that keratinocytes derived from KS 
patients had multiple narrow leading edges with multipolar shapes (Herz et al., 
2006). This was in contrast to the polygonal shapes and polarised lamelipodia of 
NHKs. Furthermore, KS keratinocytes had smaller cell areas, showed reduced 
proliferation, and demonstrated reduced adhesion on fibronectin and laminin-332. 
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Wound closure assays also showed that these keratinocytes had reduced migration 
with reduced persistence. However, KS keratinocytes did not show any defects in 
apoptosis (Herz et al., 2006). These results were substantiated by a later report 
showing similar findings (Has et al., 2008). Taken together, these findings provide 
some insight into the atrophic and blistering skin phenotype seen in KS but the 
physiological functions of kindlin-1 and the molecular disease mechanisms in KS 
still remain unclear. 
 
1.3.4 Kindlin-1 and intestinal disease  
Patients with KS also present with gastrointestinal problems such as bowel 
inflammation and diarrhoea. Kindlin-1 localises to the plasma membrane of 
epithelial cells in the colon and rectum (Kern et al., 2007). Loss of kindlin-1 leads to 
multiple focal detachments of the epithelium from the underlying tissue in intestinal 
mucosa, which results in breach of the epithelial barrier and to an inflammatory 
intestinal phenotype (Kern et al., 2007). Studies using kindlin-1 knockout mice 
showed severe epithelial atrophy, as seen in KS patients, however the mice died 
shortly after birth. This was a result of detachment of intestinal epithelial cells 
induced by shear force, significant inflammation as well as organ destruction (Ussar 
et al., 2008). Furthermore, in vitro studies have shown a considerable reduction in 
integrin activation which caused a defect in adhesion of cells to the ECM resulting in 
detachment (Ussar et al., 2008). Collectively, these findings suggest that the 
intestinal phenotypes seen in KS patients are not a secondary effect, but rather occur 
as a direct result of kindlin-1 deficiency.    
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1.3.5 Kindlin-1 and cancer 
Kindlin-1 may potentially play a role in cancer development as reports have 
discovered a significant increase in kindlin-1 expression levels in particular tumours. 
Kindlin-1 was shown to be overexpressed in 60% of lung cancers and 70% of colon 
cancers, indicating a close association (Weinstein et al., 2003). Subsequent 
microarray studies performed on human mammary epithelial cells (HMEC) treated 
with TGF-β show an increase in kindlin-1 expression level. TGF-β is found to be 
overexpressed in many colon cancers and the increase in kindlin-1 levels may play a 
role in epithelial to mesencymal transition (EMT) a crucial aspect of cancer 
formation as a result of its effect on cell migration and spreading (Kloeker et al., 
2004). Kindlin-1 may also be involved in breast cancer progression as it has been 
found to be differentially expressed in breast tumours and it is significantly increased 
in tumours metastasising to the lung (Sin et al., 2011). By contrast, a recent report 
suggests that kindlin-1 has an opposing role by inhibiting tumour growth and 
invasion in lung cancer (Zhan et al., 2012). In addition, several clinical case reports 
have shown an increased incidence of squamous cell carcinoma in KS patients, 
however the mechanism underlying this has yet to be elucidated (Lai-Cheong et al., 
2009b). 
 
1.4 Kindlin-1 and integrins 
1.4.1 Regulation of integrin activation 
Integrins are a major class of cell adhesion receptor family. They are hereterodimeric 
transmembrane proteins consisting of α and β subunits, which consist of a large 
extracellular domain, a transmembrane domain and a short cytoplamic domain 
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(Hynes, 2002; Humphries et al., 2006). Integrins mediate the attachment of cells to 
the ECM, providing a link between the ECM ligands and the cytoskeleton. Integrins 
also transduce a variety of signalling pathways that regulate various cellular 
processes, including proliferation, survival, shape, polarity, motility, gene expression 
and differentiation. These processes are important in development, haemostasis, 
immune responses and also cancer formation (Hynes, 2002). As integrins have no 
inherent kinase activity and cannot associate with the cytoskeleton directly, they 
require adaptor proteins to enable the receptor to connect to F-actin and mediate 
transduction of vital signals into the cell (Harburger and Calderwood, 2009). 
Integrins convey important information regarding the local environment, location, 
adhesive state and surrounding matrix, in this way the cell can respond accordingly 
with responses such as migration, survival and differentiation. Binding of integrins 
to ECM ligands can trigger their clustering and formation of multi-protein 
complexes, which involve an array of different scaffold and signalling proteins 
(Harburger and Calderwood, 2009).  
Both talin and kindlins have been shown to bind directly to the cytosplasmic domain 
of β integrin subunits and regulate integrin activation, as shown in Figure 1.4. 
Kindlin-1 was implicated in integrin regulation as a result of studies performed on 
KS keratinocytes which showed defects in migration, spreading and adhesion 
(Kloeker et al., 2004; Herz et al., 2006; Has et al., 2008). These factors were 
indicative of a potential disruption to integrin signalling. Moreover, there is a 
significant reduction in integrin activation although total expression levels are 
normal in KS keratinocytes (Lai-Cheong et al., 2009a). Kloeker et al. then showed 
evidence that kindlin-1 in fact is a constituent of integrin focal adhesions and is able 
to form complexes with both β1 and β3 integrin cytoplasmic tails (Kloeker et al., 
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2004). Kindlin-1 FERM (4.1 protein, ezrin, radixin, moesin) domain has been shown 
to bind directly to β1 and β3 subunits. Kindlin-1 has been shown to bind to the β 
integrin cytoplasmic tail (Harburger et al., 2009). More specifically the F3 
subdomain of kindlin-1 is required for this interaction as mutants generated in this 
region including the tryptophan to alanine (Trp612Ala) disrupted direct interaction 
with integrins (Harburger et al., 2009).  
Overexpression of a GFP-tagged kindlin-1 in KS keratinocytes was shown to restore 
integrin activation and rescue the KS cellular phenotype (Lai-Cheong et al., 2009a). 
Using GST pull down assays, kindlin-1 has been shown to bind directly to the 
cytoplasmic tails of β1 and β3 integrins (Ussar et al., 2006; Harburger et al., 2009). 
This interaction occurs between the second conserved NxxY motif (795 Tyr), a 
preceding threonine-containing region (788 Thr and 789 Thr) of the integrin β1A 
tail, and a conserved tryptophan in the F3 subdomain of the kindlin-1 FERM domain 
(612 Trp) (Harburger et al., 2009). Furthermore, kindlin-1 can also interact with 
migﬁlin and kindlin-2 (Lai-Cheong et al., 2008) as well as with α-actinin and focal 
adhesion kinase (Has et al., 2009). It has recently been shown, using ﬂuorescence-
activated cell sorting, that transient expression of kindlin-1 (and also of kindlin-2) in 
Chinese hamster ovary (CHO) cells is able to inhibit the activation of endogenous 
α5β1 or stably expressed αIIbβ3 integrins in these cells (Harburger et al., 2009). This 
occurs independently of direct kindlin–integrin interaction since mutant kindlin with 
impaired integrin binding ability also inhibits integrin activation (Harburger et al., 
2009). However, co-expression of kindlin-1 (or kindlin-2) with the talin head domain 
results in activation of αIIbβ3 but not β1 integrin, suggesting that kindlin-1 and -2 
may exert integrin-speciﬁc effects (Harburger et al., 2009). The mechanisms by 
40 
 

















Figure 1.4:  Integrin activation 
Model showing bi-directional signalling of integrin. Outside-in signalling occurs as a 
result of ligand binding to the extracellular domain of integrin leading to 
conformational change and activation. While inside-out signalling occurs when 










Talin is a major structural protein and was the first protein to be found to activate 
integrins. There are two talins in humans, talin 1 and talin 2. Talin 1 is ubiquitously 
expressed while talin-2 is more restricted in its expression, and is found primarily in 
striated muscle and in the brain (Senetar et al., 2007). Similarly to kindlins, talin 
belongs to the FERM domain family of proteins, a domain that is conserved in many 
cytoskeletal-associated proteins involved in localising proteins to the plasma 
membrane. The FERM domain is further divided into subdomains of F1, F2 and F3. 
The talin protein consists of a N-terminus head domain of ~50 kDa which contains 
the FERM arranged in a linear form, in contrast to other FERM proteins 
(Calderwood, 2004; Elliott et al., 2010); it also has a rod domain of ~ 220 kDa at the 
C-terminus. The talin head has been shown to directly interact with the β integrin 
subunit cytoplasmic tail (Calderwood et al., 1999). The F3 subdomain has the 
highest affinity for the β tail and resembles a phosphotyrosine binding (PTB) domain 
which binds to the membrane proximal NPxY motif (Calderwood et al., 1999; 
Calderwood et al., 2002) and a membrane proximal helix of the β integrin subunit 
tail (Wegener et al., 2007). The expression of the head domain alone results in 
activation of the integrin β3 six times higher than that of full length talin due to 
masking of the binding site (Yan et al., 2001). The rod domain of talin consists of an 
actin binding site which allows it to link integrins to the actin cytoskeleton. Talin 
also has a number of vinculin binding sites in the rod domain which is important for 
recruiting vinculin to adhesion sites (Critchley, 2009). Talin is autoinhibited by 
binding of the α-helical component of the rod domain to the F3 subdomain. This is 
released by calpain cleavage which increases binding of the talin head domain to the 
β3 integrin subunit (Yan et al., 2001). Martel et al also reported that interaction with 
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phosphatidylinositol 4, 5-bisphosphate (PIP2) can significantly increase binding of 
talin to β1 integrins (Martel et al., 2001). Additionally, talin activation of integrin is 
enhanced is through the Ras-related protein 1 (Rap1)-Rap1–GTP-interacting adapter 
molecule (RIAM) pathway (Anthis and Campbell, 2011). The proposed model of 
activation of integrins by talin is dependent on the interaction between the talin F3 
subdomain and the membrane proximal β tail which results in the disruption of the α 
and β tails association (Calderwood, 2004). Talin forms a salt bridge with the β tail 
and for full activation induces the reorientation of the β subunits transmembrane 
domain (Anthis et al., 2009). The contribution of kindlins to integrin activation, 
however, is still unclear. Although considerable evidence suggests that kindlins 
enhance integrin activity, there is conflicting data which shows that it can also inhibit 
activation (Harburger et al., 2009); thus further investigation is needed to resolve 
these issues.    
 
1.4.2 Integrin ligands and function  
The human genome contains 8 β and 18 α integrin subunits, which combine to give 
24 different combination of integrin receptors, that provide specificity to ligands and 
have nonredundant roles (Hynes, 2002) . Integrins are expressed abundantly in all 
nucleated cells and they are also expressed simultaneously in the cells. Knockout of 
integrins in mice show a wide range of phenotypes including a block in 
perimplantation, embryonic or perinatal lethality and major developmental defects 
(Hynes, 2002; Gahmberg et al., 2009). Leukocyte adhesion deficiency syndrome 
(LAD-1) is a good example of mutations in integrins effects on humans. In this 
particular case the disease occurs due to mutation in the β2 integrin gene leading to 
impaired functions of leukocytes resulting in microbial infections, impaired wound 
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healing, defects in phagocytosis and chemotaxis (Gahmberg et al., 2009). There are 
two main types of integrins expressed in the basal epidermis in skin and these are 
α6β4 and α3β1. The integrin α6β4 is critical for the assembly of hemidesmosomes 
and mutations in either subunit results in junctional EB with skin blistering (Hashmi 
and Marinkovich, 2011). Furthermore, the integrin α3β1 is important for cell-ECM 
adhesion as well as cell-cell adhesion, and mutations in the α3 subunit has been 
shown to also cause EB, albeit a new form of EB that has not previously been 
characterised (Has et al., 2012). The development of these skin fragility disorders 
highlight the importance of integrins in skin homeostasis. 
Integrins bind to a number of ligands and can be divided into four main classes 
dependent on the integrin-ligand combination which considers the structural basis of 
the molecular interaction. The four classes include the arginine-glycine-aspartic acid 
(RGD)-binding integrins, the leucine-aspartic acid-valine (LDV)-binding integrins, 
the A-domain β1 integrins and the non-αA domain-containing laminin-binding 
proteins (Humphries et al., 2006). The RGD motif is a tripeptide sequence that binds 
the interface between the α and β subunit. The integrins that bind this motif are 
especially promiscuous, in particular β3 integrin which binds to a large number of 
ECM and soluble vascular ligands (Humphries et al., 2006). The LDV-binding 
integrins bind to ligands containing the acidic motif LDV including fibronectin. The 
A-domain β1 integrins form a distinct collagen/laminin binding subfamily. The α 
subunits of this family contain the A (Willebrand factor or inserted (I)) domain, 
which is the principal domain required for ligand binding in the class (Humphries et 
al., 2006; Gahmberg et al., 2009). Finally, the non-αA domain-containing laminin-
binding proteins include α3β1, α6β1, α7β1 as well as α6β4, which are all highly 
specific laminin receptors. Other integrin ligands identified are the ADAM family of 
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metalloproteases, E-cadherin, fibrillin, vitronectin, ICAM, MMPs, TSP and VEGF 
(Humphries et al., 2006). The connection between integrins and ligands in the 
underlying matrix helps the cells to endure pulling forces, thus providing a 
mechanical role in anchorage. It also provides structural stability to the epithelium, 
and connects the ECM to the cell cytoskeleton, which allows force-transmission.   
 
1.5 Kindlin-2 and -3 
1.5.1 Kindlin-2  
The kindlin protein family consists of three members; kindlin-1, kindlin-2 and 
kindlin-3 (Siegel et al., 2003). All of the kindlin proteins have similar protein 
architecture comprising a FERM domain at the C-terminus with a PH domain 
inserted in the F2 subdomain, as shown in figure 1.3. Kindlin-2 was the first of the 
family members to be discovered when Wick et al. in 1994 performed a differential 
cDNA library screen to try and identify proteins involved in G0/1 to S phase 
progression (Wick et al., 1994). This approach revealed a number of proteins, one of 
which they termed as mitogen inducible gene-2 (Mig-2) (Wick et al., 1994). Siegel 
et al. subsequently identified Mig-2 as having close homology to kindlin-1 (~62%) 
and renamed the protein kindlin-2 (also known as fermitin family homologue 2) 
(Siegel et al., 2003). Kindlin-2 was found to be ubiquitously expressed and is the 
only member of its family found to be expressed in embryonic stem cells. Similar to 
kindlin-1, kindlin-2 localises to focal adhesions and is additionally also located at 
cell-cell junctions (Ussar et al., 2006). It localises in the nuclei of certain cell types, 
including smooth muscle cells (Kato et al., 2004), and is the only family member to 
possess a nuclear localisation signal (NLS) (Ussar et al., 2006). Kindlin-2 has many 
similar features to kindlin-1 including its ability to bind the membrane distal motif 
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integrins β1 and β3 cytoplasmic tails and cause activation via its F3 subdomain 
(Montanez et al., 2008; Harburger et al., 2009). Furthermore, it interacts with 
migfilin, which mediates its localisation to focal adhesion sites. This also serves as a 
link to the actin cytoskeleton as migfilin interacts with filamin, an actin binding 
protein (Tu et al., 2003). Kindlin-2 also binds to ILK which was initially 
demonstrated with unc-112 in C.elegans and later shown for the human homologue 
kindlin-2 (Mackinnon et al., 2002; Montanez et al., 2008). This demonstrates that 
kindlin-2 is a bi-directional signalling molecule as it contributes to both outside-in 
signalling and inside-out signalling of integrins.  
 
1.5.1.1 Kindlin-2 and embryonic lethality 
To analyse the functional relevance of kindlin-2, the impact of kindlin-2 deficiency 
was reported in mice by two independent groups. They both showed that kindlin-2 
knock-out mice died during embryogenesis before or at embryonic age 7.5 as a result 
of severe detachment of the epiblast and endoderm causing peri-implantation 
lethality (Dowling et al., 2008a; Montanez et al., 2008). The age of lethality was 
similar to that reported for β1 integrin and ILK knockout mice (Dowling et al., 
2008a; Montanez et al., 2008). Furthermore, embryonic stem cells with kindlin-2 
deficiency displayed reduced compactness of stem cell colonies as well as reduced 
adhesion to ECM substrates including laminin-111, laminin-332 and fibronectin. The 
cells also had a marked absence of active β1 integrin, measured by loss of 9EG7 
staining, an antibody that recognises the active state of this protein (Montanez et al., 
2008). Downregulation of kindlin-2 in zebrafish also caused premature lethality, 
further highlighting the functional importance of the protein (Dowling et al., 2008a). 
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The lack of a disease model of kindlin-2 in humans, however, may be explained by 
the fact that it is vitally important during early development.    
 
1.5.1.2 Kindlin-2 and cancer 
Kindlin-2 has been implicated in carcinogenesis, showing increased expression 
levels in the aggressive breast cancer cell line TMX2-28. Silencing of kindlin-2 in 
this cell line led to a significant reduction in cell invasion (Gozgit et al., 2006). A 
recent study also showed overexpression of kindlin-2 in a number of breast cancer 
cell lines, including Hs578T and MDA-MB-231. In these cell lines, kindlin-2 was 
shown to regulate breast cancer proliferation, apoptosis and survival to induce 
tumour formation (Zhao et al., 2013). Kindlin-2 is suggested to cause genome 
instability as there was an increase in mitotic abnormalities including an increased 
number of chromosomal break fragments, chromatid breaks and gaps (Zhao et al., 
2013). Furthermore, kindlin-2 overexpression has been associated with a number of 
other highly invasive cancers, including malignant mesothelioma (MM) tumour (An 
et al., 2010), a small subset of high grade invasive bladder cancer (Talaat et al., 
2011) and in gastric cancer tissues (Shen et al., 2012). In contrast to these findings, 
kindlin-2 has also shown to play an important role in the suppression of 
mesenchymal cancer cell invasion (Shi and Wu, 2008). Moreover, kindlin-2 levels 
were found to be lower in the invasive uterine leiomyosarcoma cells compared to the 
higher expression in leiomyoma cells which are less invasive (Kato et al., 2004). 
Taken together, kindlin-2 has shown variable levels of expression in human cancers 
and the expression level of kindlin-2 may serve as a prognostic marker for tumour 
progression in certain cancers.   
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1.5.1.3 Kindlin-2 and muscle development  
The loss of kindlin-2 in C.elegans resulted in severe muscle detachment which 
highlighted its important role in integrin mediated events. Furthermore, integrins as 
well as ILK play a critical role in cardiac muscle (Hannigan et al., 2007). These key 
observations led to further investigations into the role of UNC-112 vertebrate 
homologue in cardiac development. Kindlin-2 was chosen as the target as it is the 
only member of the kindlin family to be expressed in the cardiac and skeletal muscle 
(Dowling et al., 2008a). Kindlin-2 knockdown has been achieved in zebrafish using 
anti-sense morpholino, which resulted in severe disruption in cardiac structure and 
function (Dowling et al., 2008a). The embryos developed pericardial oedema and 
had significantly slower mean heart rates in comparison to wild type embryos. There 
was disruption to the intercalated discs and the ventricular size, shape and 
contractility was affected (Dowling et al., 2008a). Finally, knockdown of kindlin-2 
caused skeletal myopathy demonstrating an important role for kindlin-2 in skeletal 
myogenesis (Dowling et al., 2008b).  
 
1.5.2 Kindlin-3 
The final member of the kindlin family is kindlin-3, also known as unc-related 
protein 2 or fermitin family homologue 3. Kindlin-3 expression is more restricted 
compared to the other kindlin proteins; it is mostly expressed in haematopoietic 
cells, including leukocytes and erythrocytes, with particularly high levels in platelets 
and megakaryocytes (Siegel et al., 2003; Pasini et al., 2006; Ussar et al., 2006). 
Additionally, kindlin-3 has also recently been found to be expressed in endothelial 
cells (Bialkowska et al., 2010). The importance of kindlin-3 was highlighted in a 
study which produced knockout of kindlin-3 in mice. Mice homozygous for kindlin-
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3 knockout died within a week of birth, and presented with osteopetrosis, severe 
bleeding in gastrointestinal tract, skin, brain and bladder which was determined to be 
due to severe platelet dysfunction (Moser et al., 2008). Loss of kindlin-3 in platelets 
showed a lack of β1 and β3 integrin activation, as well as a failure to form 
lamellipodia and spread (Moser et al., 2008). Overexpression of kindlin-3 in a 
macrophage cell line confirmed the ability of kindlin-3 to cause integrin activation. 
The F-3 PTB domain of kindlin-3 activates integrins by binding to the membrane 
distal NxxY motif of both β1 and β3 integrin cytoplasmic tails (Moser et al., 2008; 
Yates et al., 2012a).  In addition to its role in β1 and β3 integrin activation in 
platelets, kindlin-3 was also shown to be involved in β2 activation in leukocytes. In 
leukocytes, activation of β2 integrins facilitates cell adhesion to endothelial cells, 
allowing transmigration through the blood vessel wall. As with the other integrin 
subunits, kindlin-3 mediates β2 activation through interaction with the distal NxxY 
domain of the cytoplasmic tail (Moser et al., 2009a). 
 
1.5.2.1 Kindlin-3 and LAD-III syndrome 
Leukocyte adhesion deficiency type III (LAD-III) syndrome (OMIM 612840) is a 
rare hereditary human disease (also known as LAD-I variant). It is characterised by a 
failure to activate β1, β2 and β3 integrins in haematopoietic cells resulting in severe 
bleeding due to impaired platelet activation and frequent bacterial and fungal 
infections due to a defect in leukocyte adhesion to endothelial cells (Moser et al., 
2009a). The genetic cause of this disease was discovered to be due to mutations in 
the KIND3 gene (Mory et al., 2008; Kuijpers et al., 2009; Malinin et al., 2009; 
Svensson et al., 2009). Patients with LAD-III syndrome can also exhibit 
osteopetrosis, an increased density and hardening of the bones, which is also seen in 
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kindlin-3 deficient mice (Schmidt et al., 2011). The osteoclasts in these mutant mice 
have defective integrin activation, and they have an inability to spread and organise 
the actin cytoskeleton. In addition, the cells cannot form podosomes and sealing 
zones and are unable to degrade bone matrix. The cells exhibited a loss of integrin 
activation due to kindlin-3 deficiency, highlighting the importance of this process in 
osteoclast mediated bone resorption (Schmidt et al., 2011).    
 
1.5.2.2 Kindlin-3 and erythrocyte function 
Kindlin-3 is also expressed in erythrocytes (Pasini et al., 2006), with a potential role 
in maintaining the membrane skeleton (Kruger et al., 2008). Scanning electron 
microscopy showed that kindlin-3-deficient erythrocytes had highly irregular shapes 
and sizes with membrane invaginations and protuberances (Kruger et al., 2008). The 
use of a quantitative proteomics approach known as SILAC (stable isotope labelling 
by amino acids in cell culture) followed by mass spectrometry analysis revealed 
differences in expression of a number of membrane skeleton proteins. Results 
showed a complete absence of ankyrin-1, band 4.1, adducin-2 and dematin (Kruger 
et al., 2008). These findings showed that kindlin-3 plays a significant role in the 
assembly of membrane skeletal proteins that maintain the structural integrity of 
erythrocytes.    
 
1.6 Cell adhesion and migration 
1.6.1 Integrin-based adhesions  
Integrin-mediated adhesion and migration are essential for a number of important 
biological processes such as immune responses, tissue regeneration and repair, 
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embryonic development, as well as pathological events in cancer and inherited 
immunodeficiency disorders. Integrin-mediated adhesions continually form and turn-
over to function as signalling centres that coordinate a network of signalling 
pathways and provides linkage between the ECM and the actin cytoskeleton 
(Huttenlocher and Horwitz, 2011). There are four subclasses of adhesions that have 
been identified; nascent adhesions, focal complexes, focal adhesions and fibrillar 
adhesions (Geiger and Yamada, 2011; Huttenlocher and Horwitz, 2011; Scales and 
Parsons, 2011). Nascent adhesions and focal complexes are small dot-like structures 
that form at the protrusions of lamellipodia. The nascent adhesions can either 
disassemble or mature into focal complexes which have a longer life and are induced 
by activated Rac (Huttenlocher and Horwitz, 2011; Scales and Parsons, 2011). Focal 
adhesions are much larger in size and also have a slower turnover, with an elongated 
morphology. They are the best characterised and consist of integrin receptors and a 
multiprotein complex of structural and signalling proteins which are linked to the 
actin cytoskeleton (Huttenlocher and Horwitz, 2011). Fibrillar adhesions are stable 
contacts which are also elongated in shape; they are found prominently under the 
central areas of cells and form parallel to bundles of fibronectin (Geiger and 
Yamada, 2011; Scales and Parsons, 2011). 
 
1.6.2 Focal adhesion proteins  
Integrin-based adhesions link the ECM to the cell actin cytoskeleton generating force 
and allowing the cell to respond to its environment. Integrins lack catalytic activity 
and actin binding properties, and hence there is a need for adaptor proteins which 
mediate integrin activation and act as a base for assembly of larger signalling and 
structural scaffolds (Legate and Fassler, 2009). There are 3 main categories of 
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integrin adaptors; first are the adaptor proteins with structural functions, including 
talin and filamin. These proteins connect integrins to the cytoskeleton as they are 
able to bind directly to F-actin. Secondly, there are adaptor proteins with scaffolding 
function that provide binding sites for multiple focal adhesion proteins. Thirdly, 
there are adaptor proteins with enzymatic activity which propagate signal 
transduction pathways and include focal adhesion kinase (FAK), Src and integrin 
linked kinase (ILK) (Legate and Fassler, 2009).      
Talin is one example of a structural protein that is recruited early to adhesion sites, 
and the phosphorylation of tyrosine residues on the NPxY motif of β integrin tail 
regulates its binding which facilitates integrin activation. The FERM domain not 
only binds β integrin tails but also F-actin, PIP2 and FAK. There are additional 
binding sites for β integrin tail and F-actin, and three vinculin binding sites on the 
rod domain of talin. It acts as structural protein, either directly or indirectly, via 
vinculin, connecting integrins to actin (Legate and Fassler, 2009).  
Vinculin and paxillin are examples of scaffolding adaptor proteins. Vinculin is 
activated after binding with talin and helps to increase integrin clustering and focal 
adhesion growth (Humphries et al., 2007). Paxillin also binds to numerous proteins, 
thus providing the ability to control important events such as adhesion turnover and 
cell migration. (Harburger and Calderwood, 2009). Another example of a structural 
adaptor protein is filamin which interacts with β integrin tail and also has an N-
terminal actin binding domain which is involved in actin organisation, thus coupling 
integrins to the actin cytoskeleton directly (Das et al., 2011). Filamin binding to β 
integrin tail was shown to inhibit cell migration and membrane protrusions and is 
now widely accepted as a negative regulator of integrin activation (Calderwood et 
al., 2001; Das et al., 2011; Kim et al., 2011).    
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FAK is an example of an adaptor protein with catalytic function. This protein 
tyrosine kinase is important for adhesion turnover, Rho-family GTPase activation, 
cell migration and cross talk between growth factor signalling and integrins. Integrin 
activation and clustering leads to activation of FAK which can also be enhanced by 
growth factor receptor co-stimulation. When FAK is activated, it autophosphorylates 
and binds Src kinase which in turn phosphorylates other sites on FAK and also FAK-
binding proteins. FAK binds to downstream signalling proteins such as paxillin, 
Grb2 and PI3K. Thus, FAK can mediate multiple signalling events that regulate 
growth, survival and morphogenesis (Schlaepfer et al., 1999; Harburger and 
Calderwood, 2009). In addition to binding to FAK, Src kinase can directly interact 
with the tail of β integrin subunits to propagate kinase activity and is involved in the 
control of cell spreading (Schlaepfer et al., 1999). Another important binding partner 
of β integrin subunits and downstream signalling molecule is ILK. ILK is recruited 
to integrin sites by binding to kindlin-2, as the loss of kindllin-2 results in loss of 
localisation of ILK form focal adhesions (Mackinnon et al., 2002; Montanez et al., 
2008). Furthermore, ILK also forms a complex with PINCH and the actin- and 
paxillin-binding protein PARVIN. In this way, ILK has a key role in integrin 
signalling and actin cytoskeleton reorganisation (Wickstrom et al., 2010). ILK also 
plays a role in crosstalk between integrins and receptor tyrosine kinases; for example 
the association of ILK with Nck-1 protein through PINCH (Hehlgans et al., 2007). 
Nck-2 is involved in binding and recruiting proteins that regulate receptor tyrosine 
kinases, thus allowing crosstalk between integrins and EGFR or PDGFR in 
signalling events implicated in cell survival signalling processes (Ho and Dagnino, 
2012). Furthermore, ILK has also recently been shown to participate in keratinocyte 
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front-rear polarity and migration in response to EGF stimulation and integrin 
activation (Ho and Dagnino, 2012).  
 
1.6.3 Regulation of F-actin in migration  
Actin is the vital component that links protrusion at the leading edge to adhesion 
assembly, maturation and turnover. During migration, actin drives protrusions by 
forming different organisations in lamellipodia and filopodia; the two main types of 
protrusive structures (Stricker et al., 2010). Assembly of functional actin networks 
requires the coordination of different regulators such as filament crosslinkers, 
nucleation and elongation factors, and motor proteins. Actin filaments are polarised 
due to structural polarity with a fast-growing barbed (or plus) ends and slow-
growing pointed (or minus) ends (Le Clainche and Carlier, 2008). Monomeric or 
globular actin (G-actin) with bound ATP polymerises to form F-actin, which may 
hydrolyse its bound ATP to ADP resulting in depolymerisation (Le Clainche and 
Carlier, 2008). Actin filaments are organised into bundles or networks by 
crosslinking proteins resulting in structures like lamellipodia and filopodia. Actin 
filaments can undergo ‘treadmilling’ a process whereby the length remains constant 
as G-actin associates at the plus end and dissociates at the minus end (Le Clainche 
and Carlier, 2008). In lamellipodia, the small GTPases Cdc42 and Rac activate the 
nucleation promoting factors Wiskott–Aldrich syndrome protein (WASP) and 
WASP-family verprolin-homologous protein (WAVE) which in turn activate the 
Arp2/3 complex. The Arp2/3 complex is a nucleation factor that promotes the 
generation of actin filament branches, and results in a broad dendritic-like actin 
network (Pollard and Borisy, 2003; Jaffe and Hall, 2005). In filopodia, Cdc42 
propagates linear actin polymerisation through the diaphanous-related formins and 
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vasodilator-stimulated phosphoprotein (VASP). Organisation of polymerised actin 
into elongated filaments is conducted by fascin (Mattila and Lappalainen, 2008). 
 
1.6.4 Growth factors in adhesion and migration  
Growth factors are proteins that bind to specific growth factor receptors (GFRs) to 
stimulate cellular growth, proliferation and differentiation (Streuli and Akhtar, 
2009). Growth factors are produced by many different cell types. The membrane 
receptors for growth factors are expressed on all cells and most cells have receptors 
for more than one growth factor, thus allowing more synergistic signalling by 
multiple growth factors. In adherent cells, the action of both cell adhesion and GFRs 
are needed for optimal output of synergistic signalling (Streuli and Akhtar, 2009; 
Ivaska and Heino, 2011). Integrins are able to regulate growth factor and GFRs, and 
vice versa, since growth factors can influence the function of integrins by 
modulating expression. For example fibroblast growth factor-2 (FGF-2) can 
upregulate α5β1 expression in endothelial cells, while TGF-β1 is able to increase β1 
and β5 levels and promote the synthesis of αvβ6 in keratinocytes (Streuli and Akhtar, 
2009). Integrins are also able to bind to growth factors directly and cause subsequent 
activation of GFR downstream signalling pathways. For example, αvβ6 can bind to 
the RGD motif on latent transforming growth factor-β (TGF-β) leading to activation 
of the receptor (Munger and Sheppard, 2011). Furthermore, α3β1 and αvβ3 can 
recognise vascular endothelial growth factor-A (VEGF-A) which regulates 
endothelial cell migration, an important process in angiogenesis (Hutchings et al., 
2003).  
The expression, localisation or post-translational modifications of GFRs and levels 
of growth factors can all be regulated by integrins and the receptors also share many 
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downstream signalling molecules. There are several mechanisms by which integrins 
and GFRs cross-talk and are able to coordinate signals (Ivaska and Heino, 2011). 
One mechanism is collaborative activation, which can enable growth factor-
dependent GFR signalling (Ivaska and Heino, 2011). For example, clustering of 
integrins can provide the right environment for GFRs to bind downstream signalling 
proteins after activation through ligand binding (Giancotti and Tarone, 2003). Direct 
activation of GFRs in the absence of growth factors is another mechanism by which 
cross-talk can manifest (Ivaska and Heino, 2011). When cells undego integrin-
dependent adhesion, it can increase the responsiveness of the cell to growth factors 
and loss of adhesions can result in growth arrest and anoikis (Frisch and Francis, 
1994; Danen and Yamada, 2001; Schwartz and Assoian, 2001). An example of 
integrin-mediated activation of GFRs is the ability of integrins to induce EGFR 
phosphorylation in the absence of EGF (Moro et al. 1998). Mechanistically, β1 
integrin has been shown to co-immunoprecipitate with EGFR and the clustering of 
the two receptor types triggers transactivation (Moro et al., 2002; Alam et al., 2007). 
FAK is phosphorylated after integrin ligand binding and then combines with other 
signalling proteins such as Src, p130Cas, Shc and Grb2 which transmit integrin-
triggered signals to the extracellular signal-regulated kinases (ERK)-mitogen-
activated protein (MAP) kinase pathway (Moro et al., 2002). FAK associates with 
activated GFRs through its N-terminal domain and has important functions in 
promoting EGF and platelet-derived growth factor (PDGF)-stimulated cell migration 
(Sieg et al., 2000). Figure 1.5 highlights one of the cross-talk points between 







Figure 1.5: Cross-talk between integrins and growth factor receptors  
Integrins and growth factor receptors (GFRs) are able to cross-talk potentiating 
downstream signalling pathways. One convergence point for the two receptors is 
through FAK, which binds and transmits integrin signals through interactions with 
talin. FAK can also interact with Grb2 which allows it to transmit GFR signals 
downstream (Moro et al., 2002). Growth factor and integrin cross-talk leads to 
amplification of signals leading to changes in proliferation, shape, motility, survival 
and cell cycle. 
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1.7 Hypothesis and aims 
Kindlin-1 plays an important role in integrin activation but its function in the skin is 
still not fully understood. It is unclear how loss of kindlin-1 results in the array of 
phenotypes observed in KS skin and keratinocytes. Therefore, investigations into the 
molecular and cellular pathology of KS keratinocytes will provide insight into the 
function of kindlin-1 in both health and disease and help to elucidate its role in 
integrin-dependent and independent functions. 
 
1.7.1 Hypothesis 
Kindlin-1 associates with specific binding partners, both integrin-dependent and 
independent, resulting in control of keratinocyte cell adhesion and motility. 
 
1.7.2 Aims 
 To characterise kindlin-1 regulated proteins in KS keratinocytes. 
 Identify differentially-expressed proteins in normal human 
keratinocytes (NHK) and Kindler syndrome (KS) cell lysates using 
mass spectrometry.  
 
 Identify novel binding partners of kindlin-1.  
 Use kindlin-1 GST pulldown analysis and mass spectrometry to 
identify new potential binding partners for kindlin-1. Investigate these 
in the context of keratinocyte cell behaviour. 
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 Characterise a novel KS patient mutation of kindlin-1. 
 Analyse a novel small intragenic deletion mutation in kindlin-1 in a 































Materials and Methods 
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2.1 Reagents   
 
Table 2.1 Cell culture Reagents 
 
Reagent  Source  
Bovine Collagen, Type I BD Biosciences 
Calcium Nitrate Sigma Aldrich 
Calyculin A (10 µM final) Calbiochem 
Dymethyl sulphoxide (DMSO) Sigma 
Epidermal Growth Factor (EGF)  Sigma Aldrich  
Fetal Bovine Serum Sera Laboratories International Ltd. 
Fugene HD Promega 
High Glucose Dulbecco’s modified Eagle’s 
media (DMEM) 
Sigma Aldrich 
Leupeptin (25 µM final) Calbiochem  
L-Glutamine PAA 
Lipofectamine Invirogen 
MG132 (20 µM final) Calbiochem 
OptiMEM Gibco 
Penicillin/ Streptomycin Gibco 
Phosphate Buffered Saline (PBS) Lonza 
Polybrene (hexadimethrine bromide) Sigma Aldrich 
Protease inhibitor (PI) cocktail set 1 (stock 
100X, dilute to 1X) 
Containing: 
AEBSF, Hydrochloride - 500 µM 
Aprotinin, Bovine lung, crystalline – 150 nM 
E-64 Protease Inhibitor - 1 µM 
EDTA Disodium – 0.5 mM 
Leupeptin, Hemisulphate – 1 µM   
Calbiochem 














Table 2.2: Molecular biology Reagents  
 
Reagent  Source  
Agarose  Sigma Aldrich 
Ampicillin  Sigma Aldrich  
BL21 (DE3) competent cells Agilent Technologies 
Bovine serum albumin (BSA) New England Biolabs 
Deoxynucleosides (DNTPs) Bioline 
Hyperladder I Biolabs 
Hypperladder V Biolabs 
Kanamycin Sigma Aldrich 
Luria Bertani (LB) agar and broth Sigma Aldrich 
Midiprep kit Qiagen  
Miniprep kit Qiagen 
NEbuffers  New England Biolabs 
One Shot TOP10 chemically competent 
E.Coli 
Invitrogen 
Phusion HF Buffer (5X) Finnzymes 
Phusion Hot Start DNA polymerase Finnzymes 
Phusion buffer (10X) New England Biolabs 
Phusion polymerase New England Biolabs 
QIAquick gel extraction kit Qiagen 
Quickchange Site-directed mutagenesis kit  Stratagene 
Restriction enzymes New England Biolabs 
Safeview  NBS Biologicals  
T4 DNA Ligase and Buffer  New England Biolabs 
















Table 2.3: Biochemical assay reagents  
 
Reagent  Source  
1.5 mm Cassettes Invitrogen 
2-mercaptoethanol Sigma Aldrich 
30% Acrylamide/Bis solution Biorad 
A/G agarose affinity matrix Alpha Diagnostic International 
Ammonium persulphate (APS) Sigma Aldrich 
Bovine Serum Albumin PAA the cell culture company 
Bromophenol blue Sigma Aldrich 
Calyculin A  Sigma Aldrich 
Coomasie blue Fluka Chemika 
ECL Plus western blotting detection system  GE Healthcare 
Fluorsave Mounting media Calbiochem 
Glutathione Sepharose 4 Fast Flow beads Amersham 
Glycine Sigma Aldrich 
Hybond ECL Nitrocellulose membrane  Amersham Biosciences  




Medical X-Ray film Fuji 
Milk Powder MERCK 
Paraformaldehyde (PFA) Sigma Aldrich 
PeqGOLD protein marker V PeqLab 
Pierce BCA protein assay kit Thermo Scientific 
PBS tablets  Oxoid 
Pierce ECL western blotting substrate Thermo Scientific 
Ponceau S solution Sigma Aldrich 
Sodium Chloride  Sigma Aldrich 
Tetramethylethylenediamine (TEMED) Sigma Aldrich 
Tissue-Tek OCT compound VWR international 
Tris-Base  Sigma Aldrich 
Tris-HCL Sigma Aldrich 
Triton X-100 Sigma Aldrich 





Table 2.4: Materials and solutions for biochemical assays 
 
Buffers/Solutions Composition 
5% stacking acrylamide gel 5% 30%-acrylamide mix, 125mM 
Tris-HCl (pH6.8), 0.1% Sodium 
dodecyl sulphate (SDS), 0.1% 
ammonium persulphate (APS), 1% 
TEMED 
8% resolving acrylamide gel 8% 30%-acrylamide mix, 400 mM 
Tris (pH 8.8), 0.1% SDS, 0.1% 
APS, 0.05% TEMED 
12% resolving acrylamide gel 12% 30%-acrylamide mix, 400 mM 
Tris (pH 8.8), 0.1% SDS, 0.1% 
APS, 0.05% TEMED 
Coomassie staining solution 0.025% coomassie brilliant blue 
R250, 40%methanol, 7% acetic acid 
Destaining solution 50% methanol, 10% acetic acid 
Lysis Buffer 50 mM Tris (pH7.2), 500 mM NaCl,  
10mM MgCl, 0.5% sodium 
deoxycholate, 1% Triton X-100, PI 
cocktail, Phosphatase inhibitors: 50 
mM sodium fluoride and 1 µM 
calyculin 
PBS-Tween (1x) 10 tablets of Phosphate buffered 
saline, 0.1% Tween-20 
Running Buffer (10x) 0.25 M Tris base, 1.92 M glycine, 
1% SDS 
SDS Sample Loading Buffer (2x) 60mM Tris-HCl (pH 6.8), 25% 
Glycerol, 2.5% SDS, 0.02% 
Bromophenol blue 
TBS-Tween (10x) 20 mM Tris-base (pH 7.5), 150 mM 
NaCl, 0.1% Tween-20 



















Table 2.5 Antibodies 
Target Dilution  Species Source 
β1 integrin 1/1000 (WB) Rabbit Millipore 
E-cadherin 1/1000 (WB) Mouse Abcam  
EGFR 1/1000 (WB) Rabbit Millipore 
EGFR 1/100 (IF) Rabbit Cell Signalling 
EGFR  1/100 (FC) 1 µg (IP) Mouse Santa Cruz 
ILK  1/1000 (WB) Rabbit OriGene 




Kindlin-2 1/1000 (WB) Mouse OriGene 
Lamp-1  1/100 (IF) Mouse Developmental 
studies 
hybridoma bank  
Talin clone 8D4 1/200 (WB), 1/500 
(IF) 
Mouse Sigma Aldrich 
Talin 1/1000 (WB) Mouse Millipore 
Thrombospondin 1/500 (WB) Mouse Abcam 
Zo-2  1/1000 (WB) Rabbit Santa Cruz 
Anti-Mouse HRP 1/1000 (WB) Goat DAKO 
Anti-Rabbit HRP 1/1000 (WB) Goat DAKO 
Anti-mouse Alexa 
488 












1/500 (IF) Goat Molecular 
Probes 
Phalloidin 633 1/100 (IF)  Invitrogen 
 
Abbreviations: Western blotting (WB), immunoflourescence (IF), flow cytometry 








2.3.1 Molecular biology and cloning 
2.3.1.1 Generation of mutant constructs of kindlin-1 
The following amino acid sequences are of the wild type and mutant constructs of 
kindlin-1. The wild type kindlin-1 amino acid sequence is 677 amino acids 
(GenBank accession number: NP_060141.3). The GST-kindlin-1 construct was 
generously given by Professor David Calderwood, Yale University, USA.    
Wild-type: 
1  MLSSTDFTFA SWELVVRVDH PNEEQQKDVT LRVSGDLHVG GVMLKLVEQI NISQDWSDFA 
61  LWWEQKHCWL LKTHWTLDKY GVQADAKLLF TPQHKMLRLR LPNLKMVRLR VSFSAVVFKA 
121  VSDICKILNI RRSEELSLLK PSGDYFKKKK KKDKNNKEPI IEDILNLESS PTASGSSVSP 
181  GLYSKTMTPI YDPINGTPAS STMTWFSDSP LTEQNCSILA FSQPPQSPEA LADMYQPRSL 
241  VDKAKLNAGW LDSSRSLMEQ GIQEDEQLLL RFKYYSFFDL NPKYDAVRIN QLYEQARWAI 
301  LLEEIDCTEE EMLIFAALQY HISKLSLSAE TQDFAGESEV DEIEAALSNL EVTLEGGKAD 
361  SLLEDITDIP KLADNLKLFR PKKLLPKAFK QYWFIFKDTS IAYFKNKELE QGEPLEKLNL 
421  RGCEVVPDVN VAGRKFGIKL LIPVADGMNE MYLRCDHENQ YAQWMAACML ASKGKTMADS 
481  SYQPEVLNIL SFLRMKNRNS ASQVASSLEN MDMNPECFVS PRCAKRHKSK QLAARILEAH 
541  QNVAQMPLVE AKLRFIQAWQ SLPEFGLTYY LVRFKGSKKD DILGVSYNRL IKIDAATGIP 
601  VTTWRFTNIK QWNVNWETRQ VVIEFDQNVF TAFTCLSADC KIVHEYIGGY IFLSTRSKDQ 
661  NETLDEDLFH KLTGGQD 
 
 
The 9 base pair deletion is an in-frame mutation for which homozygous individuals 
have a Kindler syndrome phenotype indistinguishable from other Kindler syndrome 
patients. The 3 amino acids deleted are from 623 to 625.  
 
F3 9bp deletion: 
1  MLSSTDFTFA SWELVVRVDH PNEEQQKDVT LRVSGDLHVG GVMLKLVEQI NISQDWSDFA 
61  LWWEQKHCWL LKTHWTLDKY GVQADAKLLF TPQHKMLRLR LPNLKMVRLR VSFSAVVFKA 
121  VSDICKILNI RRSEELSLLK PSGDYFKKKK KKDKNNKEPI IEDILNLESS PTASGSSVSP 
181  GLYSKTMTPI YDPINGTPAS STMTWFSDSP LTEQNCSILA FSQPPQSPEA LADMYQPRSL 
241  VDKAKLNAGW LDSSRSLMEQ GIQEDEQLLL RFKYYSFFDL NPKYDAVRIN QLYEQARWAI 
301  LLEEIDCTEE EMLIFAALQY HISKLSLSAE TQDFAGESEV DEIEAALSNL EVTLEGGKAD 
361  SLLEDITDIP KLADNLKLFR PKKLLPKAFK QYWFIFKDTS IAYFKNKELE QGEPLEKLNL 
421  RGCEVVPDVN VAGRKFGIKL LIPVADGMNE MYLRCDHENQ YAQWMAACML ASKGKTMADS 
481  SYQPEVLNIL SFLRMKNRNS ASQVASSLEN MDMNPECFVS PRCAKRHKSK QLAARILEAH 
541  QNVAQMPLVE AKLRFIQAWQ SLPEFGLTYY LVRFKGSKKD DILGVSYNRL IKIDAATGIP 
601  VTTWRFTNIK QWNVNWETRQ VVIEFDQNVF TAFTCLSADC KIVHEYIGGY IFLSTRSKDQ 
661  NETLDEDLFH KLTGGQD 
 




PH+F3 domain deletion: 
1  MLSSTDFTFA SWELVVRVDH PNEEQQKDVT LRVSGDLHVG GVMLKLVEQI NISQDWSDFA 
61  LWWEQKHCWL LKTHWTLDKY GVQADAKLLF TPQHKMLRLR LPNLKMVRLR VSFSAVVFKA 
121  VSDICKILNI RRSEELSLLK PSGDYFKKKK KKDKNNKEPI IEDILNLESS PTASGSSVSP 
181  GLYSKTMTPI YDPINGTPAS STMTWFSDSP LTEQNCSILA FSQPPQSPEA LADMYQPRSL 
241  VDKAKLNAGW LDSSRSLMEQ GIQEDEQLLL RFKYYSFFDL NPKYDAVRIN QLYEQARWAI 
301  LLEEIDCTEE EMLIFAALQY HISKLSLSAE TQDFAGESEV DEIEAALSNL EVTLEGGKAD 
361  SLLEDITDIP KLADNLKLFR PKKLLPKAFK QYWFIFKDTS IAYFKNKELE QGEPLEKLNL 
421  RGCEVVPDVN VAGRKFGIKL LIPVADGMNE MYLRCDHENQ YAQWMAACML ASKGKTMADS 
481  SYQPEVLNIL SFLRMKNRNS ASQVASSLEN MDMNPECFVS PRCAKRHKSK QLAARILEAH 
541  QNVAQMPLVE AKLRFIQAWQ SLPEFGLTYY LVRFKGSKKD DILGVSYNRL IKIDAATGIP 
601  VTTWRFTNIK QWNVNWETRQ VVIEFDQNVF TAFTCLSADC KIVHEYIGGY IFLSTRSKDQ 
661  NETLDEDLFH KLTGGQD 
 
2.3.1.2 Site-directed mutagenesis 
To create the 9 base pair deletion of kindin-1 the quickchange site-directed 
mutagenesis kit was used (Stratagene). The sample reaction was prepared using 5 μl 
of 10X reaction buffer, 1 μl (40 ng) of dsDNA template, 0.5 μl (125 ng) of 
oligonucleotide primer forward, 0.5 μl (125 ng) of oligonucleotide primer reverse, 1 
μl of dNTP mix and double distilled water to a final volume of 50 μl. Then 1 μl of 
PfuTurbo DNA polymerase (2.5 U/μl) was added. Each PCR cycle consisted of an 
initial denaturation (95 °C, 30 seconds) for 1 cycle, denaturation (95 °C, 10 seconds), 
annealing (gradient temperature 55-70 °C), extension (68 °C, 1 min/kb) for 18 
cycles. Following temperature cycling, the reaction was placed on ice for 2 mins to 
cool the reaction to ≤37 °C. 1 μl of the DpnI restriction enzyme (10 U/μl) was added 
directly to the amplification reaction and spun in a microcentrifuge for 1 min. The 
reaction was incubated at 37 °C for 1 hr to digest the parental (i.e., the nonmutated) 
supercoiled double stranded DNA. 1 μl of the solution was then transformed into 
XL1-blue supercompetent cells (Stratagene). 
 
2.3.1.3 Primers for generating mutants 




Kindlin-1 9 bp deletion forward 
5’ AACCCGGCAGGTGGTTGACCAAAACGTCTT 3’ 
 
Kindlin-1 9 bp deletion reverse 
5’ TTGGGCCGTCCACCAACTGGTTTTGCAGTT 3’ 
 
2.3.1.4 Transformation of pGEX GST vectors 
2 µl of DNA was added into 25 µl of BL21 competent cells, left on ice for 30 min 
and heat shocked at 42ºC in a waterbath for 45 seconds and then left in ice for 2 min. 
250 µl SOC media was added and placed in a 37 ºC  shaking incubator for 1 hr. 
Finally the solution was streaked on an agar plate and left in the 37 ºC incubator 
overnight for growth. 
 
2.3.1.5 Bacterial Transformation 
Transformations were performed according to protocols provided by Invitrogen. 
Briefly, One Shot Top10 E.coli were thawed on ice, then 1-5 μl DNA was added to 
each vial (50 μl) of competent cells and were incubated for 30 mins on ice. This was 
followed by incubation at 42 ºC for 45 seconds and then immediate incubation on ice 
for 2 mins. 250 μl S.O.C. media was then added and incubated for 1-2 hrs shaking at 
37 ºC. LB agar plates containing Kanamycin were then spread with the solution. 
Plates were inverted and incubated at 37ºC overnight. 
 
2.3.1.6 Restriction digests 
Restriction digests were performed according to protocols provided by New England 
BioLabs. Briefly, the restriction digest was made up of 2-3 μg DNA, the appropriate 
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NEbuffer (1X) (New England BioLabs), BSA (1X) (New England BioLabs), 1 μl 
restriction enzyme (New England BioLabs) per 1 μl DNA and made up to 50 μl with 
distilled water. For double digest both enzymes were added at the same time, or if 
sequential the second restriction enzyme was added after digest with the first 
restriction enzyme. Loading buffer was added to each digest and they were run on a 
1% agarose gel containing 1:50 (1% stock, 0.02% final) ethidium bromide. 
 
2.3.1.7 Gel extraction 
DNA was extracted using the QIAquick gel extraction kit according to the protocol 
provided by QIAGEN. Briefly, the DNA fragment was removed from the agarose 
gel and 3 volumes of Buffer QG were added to 1 volume of gel. The gel was then 
incubated at 50 ºC for 10 mins until the gel had dissolved and 1 gel volume of 
isopropanol was added to the sample and mixed. The sample was placed in a 
QIAquick spin column and was centrifuged for 1 min. The sample was washed with 
500 μl of Buffer QG and centrifuged for a further 1 min, and also washed with 750 
μl of Buffer PE and centrifuged for a further 1 min. The column was centrifuged for 
a further 1 min and placed in a clean 1.5 ml microcentrifuge tube, 30 μl elution 
buffer was added to the column and left to stand for 1 min. Then the column was 
centrifuged for 1 min to elute the DNA. A nanodrop spectrophotometer was used to 
quantify the concentration and purity of the DNA. 
 
2.3.1.8 Minipreps 
1 ml of bacterial overnight culture was centrifuged at 13,000 rpm for 5 min. The 
supernatant was discarded and the pelleted bacterial cells were resuspended in 250 μl 
of Buffer P1. Before using Buffer P1, LyseBlue reagent was added to Buffer P1 at a 
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ratio of 1 to 1000, RNase was also added and mixed in. 250 μl of Buffer P2 was then 
added and mixed thoroughly by inverting the tube 4–6 times until the solution 
became clear.  The solution turned blue due to the addition of LyseBlue reagent. 350 
μl of Buffer N3 was added and mixed immediately and thoroughly by inverting the 
tube 4–6 times or until the solution became colourless. The solution was centrifuged 
for 10 min at 13,000 rpm (~17,900 x g) in a table-top microcentrifuge at room 
temperature. The supernatant was transferred to the QIAprep spin column and 
centrifuged for 1 min and the flow-through was discarded. To wash the QIAprep 
spin column, 0.75 ml Buffer PE was added and centrifuged for 1 min and the flow-
through was discarded. The QIAprep spin column was centrifuged again for 1 min to 
remove residual wash buffer. To elute DNA, 50 μl of water was added to the centre 
of the QIAprep spin column, and allowed to stand for 1 min at room temperature and 
finally centrifuge for 1 min. The flow-through contained the DNA which was 
measured using a nanodrop spectrophotometer (Labtech international).  
 
2.3.1.9 Midipreps 
25-50 ml of bacterial culture was grown up overnight and pelleted by centrifugation 
at 13000 rpm for 15 min. The pellet was resuspended by pipetting in 2 ml of Buffer 
P1. 2 ml of Buffer P2 was added and gently mixed by inverting and incubated at 
room temperature for 3 min. Due to addition of LyseBlue reagent to Buffer P1, the 
cell suspension turned blue after addition of Buffer P2. Then a further 2 ml of Buffer 
S3 was added to the lysate and mixed immediately by inverting 4–6 times. Addition 
of Buffer S3 caused a fluffy white precipitate to form containing genomic DNA, 
proteins, cell debris, and SDS. The suspension was mixed until all trace of blue was 
gone and the suspension was colourless. The mixture was transferred into the 
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QIAfilter cartridge and incubated at room temperature for 10 min. A plunger was 
inserted into the QIAfilter cartridge and the cell lysate was filtered the into a new 
tube, to which 2 ml of  Buffer BB was added and mixed by inverting 4–6 times. The 
lysate was then transferred to a QIAGEN Plasmid Plus Midi spin column with a tube 
extender attached on the QIAvac 24 Plus. Using vacuum, the solution was drawn 
through the column. DNA bound to the column was washed with 0.75 ml of Buffer 
and again washed with 0.7 ml of Buffer PE. To completely remove the residual wash 
buffer, the column was centrifuged for 1 min at 10,000 x g in a microcentrifuge. The 
column was then placed into a clean 1.5 ml microcentrifuge tube and to elute the 
DNA, 200 μl of water was added to the centre of the column, with 1 min incubation 
at room temperature, and then finally centrifuged for 1 min. 
 
2.3.2 Cell culture  
2.3.2.1 Cell lines and Immortalisation of keratinocytes by human papilloma 
virus (HPV)  
Frozen vials of keratinocytes from two patients with KS harbouring known KIND1 
mutations (c.676insC/c.676insC and p.Glu304X/p.Leu302X) were immortalised by 
Dr Andrew South, University of Dundee, Scotland. Immortalisation of keratinocytes 
was performed by infecting the cells with the human papilloma virus, 208 HPV16 
E6 and E7. The ability of immortalizing human keratinocytes has previously been 
localized to the E6 and E7 region of HPV16 viral DNA (Halbert et al., 1991). The 
immortalised keratinocytes were then grown in serum-free keratinocyte growth 
medium. Their subsequent maintenance and passage were similar to those of primary 
human keratinocytes. Age- and gender-matched NHK were immortalised using an 
identical protocol. All experiments were performed between 15 and 25 passages after 
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immortalisation. All patient cells were obtained under a St Thomas’ Hospital Ethics 
Committee approved project – Molecular basis of inherited skin disease - 
07/H0802/104. Keratinocyte SFM media (Gibco), supplemented with EGF and 
bovine pituitary extract was used to grow and maintain cells. The cells were thawed 
out in this media and transferred to a T25 cm
2
 flask, and placed in a 37 °C incubator 
to allow cells to attach and grow. To passage the cells, they were washed once with 
PBS (without Ca and Mg, APP) and trypsinised (Trypsin in EDTA at 0.05% 
concentration). After detachment the cells were centrifuged for 3 min at 1200 rpm 
and resuspended in 10 ml SFM media which was divided between two flasks. 
 
2.3.2.2 Producing lentiviral particles and infecting cells 
To generate stable cell lines of normal and KS keratinocytes overexpressing wild 
type kindlin-1 or the tryptophan mutant form of kindlin-1, both of these were cloned 
into mCherry lentivector backbones. The original pHR9SIN-SEW lentiviral 
expression vector was a gift from Dr Adrian Thrasher (Institute of Child Health, 
UCL, London), and the mCherry protein tag was subsequently cloned into this 
vector. 
 For each plasmid to be transfected, a flask of T75 cm
2 
of HEK293T was plated. The 
transfection mix was prepared with a total of 5 µg of DNA (2.5 µg target plasmid 
.i.e. WT mCherry-kindlin-1 or mutant mCherry-kindlin-1-W612A, 1.9 µg of 
packaging plasmid Δ8.91 and 0.6 µg of envelope plasmid pMD2.G in 50 µl of OPTI-
MEM. A mastermix of FuGENE transfection reagent in serum-free OPTI-MEM was 
also created. This consisted of 6 µl of FuGENE and 74 µl of OPTI-MEM for every 
reaction. These were left to incubate for 5 min at room temperature. The FuGENE 
mastermix was then added to the DNA transfection mix and incubated for a further 
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20 min at room temperature. The DNA:FuGENE mix was added to the HEK293T 
cells, the media in these cells were changed to OPTI-MEM beforehand to remove the 
presence of antibiotics. The cells were incubated for overnight at 37 ºC. The media 
was then changed to remove the transfection reagent and replaced with DMEM plus 
10% FBS and penicillin/streptomycin and again left to incubate for 24 hrs at 37 ºC. 
At this point the virus was harvested by removing the media, which contained the 
virus particles and centrifuging at 1200 rpm for 3 min as well as filtering through a 
0.45 µm filter to remove cells. The cells were replaced with fresh media and the 
virus was collected again after 24 hrs. The virus was used immediately for infecting 
cells or was stored at -80 ºC.  
For infection of the target cells, normal and KS keratinocytes were plated on 6 well 
plates and grown to 70% confluency. The media was replaced but with the addition 
of polybrene at a concentration of 8 µg/ml to increase efficiency of viral infection. 1 
ml of lentiviral particle solution was added to the cells and left to incubate at 37 ºC. 
The media was changed after 24 hrs to remove the virus and cells were grown and 
passaged. A fluorescence microscope was used to check expression of mCherry 
tagged protein in the keratinocytes. To obtain a pure population of stably expressing 
mCherry tagged kindlin-1 proteins, the cells were put through fluorescence activated 
cell sorting (FACS). The cells were trypsinised and centrifuged at 1200 rpm for 3 
min. They were then resuspended in 1 ml of SFM media with 4% FBS. Only cells 
that were mCherry-positive were collected and plated on T25 cm
2
 flasks and used for 






2.3.3 Protein production, purification and biochemical analysis 
2.3.3.1 GST-kindlin protein purification 
DNA encoding GST-kindlin-1 proteins were transformed into BL21 cells for optimal 
expression/purification. Colonies were added to 30 ml LB with Ampicillin at a 
concentration of 100 µg/ml and left to grow overnight in a shaking incubator at 37 
°C, 250 rpm. Cultures were seeded evenly into 6 x 1 litre flasks (800 ml LB) 
containing ampicillin (100 µg/ml) and left to grow at 37°C until optical density 
(OD
600
) reached approximately 0.4 and then for a further 30 min at 16 °C. IPTG 
(1:1000) was added to the bacterial culture which was left in the shaking incubator 
overnight at 16 °C, 225 rpm. Bacteria were pelleted and resuspended in 25 ml per 
litre of lysis Buffer: 50 mM phosphate, 300 mM NaCl, 5 mM imidazole, pH 8.0.  
This was then transferred to 50 ml Falcon tube and placed at -80 °C overnight to 
freeze. The cells were thawed at room temperature in a water bath with mixing. 500 
µl of lysozyme (20 mg/ml of water) was added and rocked for 15 min at room 
temperature, and left to stand at room temperature for 15 min. Cells were sonicated 
on ice (20 pulses of 10 seconds (200 seconds total) at power 10 with 10 seconds of 
cooling in between). After sonication, 50 µl of DNaseI per litre centrifuge tubes was 
added and placed in a rocker for 15 min. The cell debris was pelleted by 
centrifugation. 0.5 ml of Glutathione sepharose beads was added to 5 ml of lysis 
buffer (for washing) and spun at 1000 rpm for 5 min at room temperature and 
aspirated. The pre-cleared lysate was poured into 50 ml Falcon tubes containing 
beads and was allowed to mix overnight at 4 ºC. Finally the beads were washed with 





2.3.3.2 GST pulldowns 
Keratinocytes were washed twice with ice-cold PBS. Cold lysis buffer containing 
protease inhibitor, sodium fluoride and calyculin was added. The keratinocytes were 
scraped into lysis buffer (50 mM Tris (pH7.2), 500 mM NaCl, 10 mM MgCl, 0.5% 
sodium deoxycholate, 0.5% Triton X-100, PI cocktail, phosphatase inhibitors: 50 
mM sodium fluoride and 1 µM okadaic acid), 500 µl for ~80% confluent T75 cm
2
 of 
cells) and transferred into 1.5 ml tubes. This was left on a rotator at 4 ºC for 30 mins 
to ensure complete lysis and then centrifuged at 13,000 rpm for 1 min at 4 ºC to 
pellet insoluble material. 20 µl of the sample of cell lysate was removed before 
adding lysate to beads to allow analysis of total protein on the same gel as the 
pulldown samples. The cleared lysates were transferred into tubes with 50 µl GST-
tagged protein and placed on a rotator at 4 ºC for 60 mins. The beads were washed 4 
times with ice-cold lysis buffer. After the final wash, the wash buffer was removed 
and SDS sample buffer was added. The sample was boiled for 10 mins and run on a 
10% acrylamide gel. 
 
2.3.3.3 SDS PAGE analysis 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) separates 
protein based on molecular weights. SDS loading buffer was added to the samples 
which denatured the protein from its tertiary structure to the basic amino acid 
primary structure. The SDS also induced a negative charge to proteins so that when 
an electrical charge was applied the protein would migrate towards the cathode pole. 
Gels of 8% or 12 % were made in 1.5 mm cassettes with stacking gel on top and 
resolving gel beneath. Along with the samples, a marker was run which includes 
molecular weight standards of known sizes. The gel was run for 1.5 hrs at 100 V.  
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2.3.3.4 Silver staining 
The polyacrylamide gels were silver-stained using the plusone silver staining kit (GE 
Healthcare) to provide higher sensitivity for band detection. The gel was first left in 
fixing solution 40 % ethanol for 30 min (Ethanol 100 ml, glacial acetic acid 25 ml, 
water to 250 ml) and then left in sensitising solution for 30 min (ethanol 75 ml, 
sodium thiosulphate (5 % w/v) 10 ml, sodium acetate 17 g). The gel was washed 
with water 3 times for 5 min and silver solution was added (silver nitrate solution 
(2.5 % w/v) 25 ml, water to 250 ml). After 20 min, the gel was washed 2 times for 1 
min and then developing solution was added (sodium carbonate 6.25 g, water to 250 
ml, 0.2 ml formaldehyde 37 % w/v), the gel was transferred to stopping solution 
when bands reached the desired intensity (EDTA-Na2∙2H2O 3.65 g, water to 250 ml). 
After washing for a further 3 times for 5 min the gel was left in preserving solution 
(ethanol 75 ml, glycerol 11.5 ml, water to 250 ml) for 30 min, twice. 
 
2.3.3.5 Western Blotting 
Samples for western blotting were prepared from cell lysates and/or pulldown 
experiments. The protein samples were loaded onto a Tris-Glycine polyacrylamide 
gel alongside a protein ladder and run for 1.5 hours at 100 V. The proteins were 
transferred onto nitrocellulose membranes (Amersham Biosciences) for 1 hr at 100 
V using a transfer kit (Biorad). The membranes were blocked using % Milk/PBS or 
3% BSA/TBS for 1 hr at room temperature. The membranes were then probed with 
the primary antibody overnight at 4 ºC or for 3 hrs at room temperature. The 
membranes were then washed 3 times for 10 mins each with PBS-Tween (0.1% 
Tween in PBS) prior to incubation with horseradish peroxidase-conjugated 
secondary antibodies for 1 hr at room temperature. Membranes were then washed a 
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further 3 times and proteins were detected by ECL chemiluminescence kit (Thermo 
Scientific), exposed on Medical X-ray film (Fuji) and developed using a Xograph 
compact X4 developer (Imaging Systems). For reprobing, blots were stripped with 
Re-blot strong (10X) (Chemicon) diluted to 1X in distilled water for 10 mins at room 
temperature, and then treated as before. 
 
2.3.3.6 Immunoprecipitation (IP) 
Cells were cultured until 80% confluent in T75 cm
2
 tissue culture flasks and lysed in 
500 μl IP buffer on ice. A/G agarose affinity matrix suspension was washed 3 times 
with PBS prior to use. Lysates were pre-cleared with 100 μl washed A/G agarose 
affinity matrix suspension rotating at 4 ºC for 30 mins, and 50 μl lysate was kept (1:1 
IP buffer: sample buffer) prior to pre-clearing at -20 ºC for an input sample. Pre-
cleared lysates were centrifuged and the supernatants were collected. Each IP 
experiment had a duplicate of primary antibody and control IgG. Antibody or control 
IgG was incubated with 200 μl pre-cleared lysate tumbling at 4 ºC overnight. Then 
50 μl of washed A/G agarose affinity matrix suspension was added to the antibody 
lysate mix for 2 hrs tumbling at 4 ºC. Alternatively, antibody was pre-incubated with 
beads overnight tumbling at 4 ºC. Then, excess antibody was removed by washing 3 
times with PBS, and pre-cleared lysate was added to each antibody A/G agarose 
affinity matrix suspension mix for 2 hrs tumbling at 4 ºC. After antibody, lysate and 
A/G agarose affinity matrix suspension incubation, the mixtures were centrifuged 
and 25 μl supernatant (1:1 supernatant: sample buffer) was kept for an unbound 
sample and was stored at -20 ºC. The rest of the supernatant was removed and the 
A/G agarose affinity matrix suspension was washed three times for 10 mins in IP 
buffer. Samples were either used immediately or stored at -20ºC (1:1 IP: reducing 
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sample buffer). Lysates were boiled at 95 ºC and centrifuged to clear cell debris 
before use. 40 μl of each sample was loaded in each well of 8% SDS-PAGE gels in 
1.5 mm cassettes and subjected to SDS-PAGE, and then the Western blotting 
protocol was followed. Each IP was performed at least 3 times. 
 
2.3.3.7 Mass spectrometry   
The bands cut out from pulldown analysis gels were sent off for mass spectrometry 
analysis to Aberdeen Proteomics (University of Aberdeen, School Medical Sciences, 
Lab 1.35, IMS Building, Foresterhill, Aberdeen). The samples were first digested 
with trypsin to obtain smaller samples which were then ionised. The ions were 
accelerated and deflected by a magnetic field. The analyser region of the mass 
spectrometer separated the ions according to their mass (m) to charge (z) ratios 
(m/z). The separated ions were then detected and the signal was recorded. The mass 
to charge ratio was recorded along with the relative abundance to be presented on a 
m/z spectrum. The experiment was performed in a vacuum to allow the ions to move 
freely without colliding into air molecules. Data were analysed using MASCOT 
search software and databases to determine the identity of the bands. 
 
2.3.4 Flow cytometry (FC) 
Confluent T25 cm
2
 flask of cells were scraped in 5 ml of PBS and centrifuged at 
1200 rpm for 3 mins followed by fixation in 500 μl 4% PFA/PBS for 30 mins on ice. 
Cells were then washed 3 times in 500 μl of PBS and blocked in 100 μl 5% 
BSA/PBS for 30 mins on ice. Cells were then incubated with primary antibody in 
100 μl 5% BSA/PBS for 2 hrs at 4 ºC. Samples were divided to include a secondary 
only negative control, which was not incubated with any primary antibodies. The 
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samples were washed 3 times in 500 μl PBS and incubated with secondary antibody 
in 100 μl 5% BSA/PBS for 30 min. They were then washed a further 3 times in 500 
μl PBS and finally re-suspended in 500 μl of PBS. Cells were analysed on a BD 
FACSCalibur flow cytometer (BD Biosciences) with CellQuest Pro software. Gates 
were set to exclude outlying cells and then histograms were plotted to show cell 
count against intensity of staining for FITC. For FITC intensity, the mean value for 
cells only incubated with secondary antibody was deducted from the mean values for 
the other samples to compensate for non-specific intensity values. Gates were set to 
count positive FITC cells, giving a measure of the amount of positive FITC cells for 
each cell type. Each experiment was repeated at least 3 times and the corrected mean 
values were averaged and plotted as histograms using Excel. 
 
2.3.5 Microscopy 
2.3.5.1 Immunofluorescence  
The cells were plated onto coverslips on 4 well plates. Coverslips were coated with 
human plasma fibronectin (1/10) (Millipore) for a minimum of 30 mins and then 
washed once with PBS. The cells were plated in SFM media and allowed to grow 
overnight at 37 °C. At this point, cells were fixed using 4% para-formaldehyde 
(PFA/PBS) for 10 mins, washed twice with PBS and then permeabilised with 0.2% 
Triton-X/PBS for 10 mins. Coverslips were again washed with PBS and blocked 
with 1% BSA/PBS for 20 mins. The selected primary and secondary antibodies were 
diluted in 3% BSA/PBS for 3 hrs and then 2 hrs at room temperature successively. 
Secondary antibodies (Alexa Fluor 488 anti-mouse, Alexa Flour 568 anti-rabbit and 
Alexa Fluor 633 phalloidin; Invitrogen). Coverslips were washed with PBS and 
distilled water and finally mounted on slides using mounting media (FluorSave 
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reagent, Calbiochem). Images of fixed cells were acquired on a Zeiss LSM 510 
confocal microscope (Carl Zeiss Inc., Oberkochen, Germany).  
 
2.3.5.2 Immunohistochemistry 
5 μm thick frozen skin sections were cut from skin biopsies obtained from control 
and patients with KS in whom loss-of-function KIND1 mutations had been 
determined. Skin biopsy samples were previously embedded vertically in Tissue-Tek 
OCT Compound (VWR International, Lutterworth, Leicestershire, UK) and frozen in 
liquid nitrogen-cooled isopentane. The blocks were then stored at -80 °C for later 
use. Prior to cryosectioning, the tissue blocks were equilibrated to -20 °C in the 
cryostat. The skin sections were air-dried for at least 1 hr. The sections were fixed 
with 4% PFA for 10 min and permeabilised with 0.2% Triton-X for 5 min. Each 
section was then blocked for 1 hr at 37ºC using 10% FBS in PBS and then washed in 
PBS. The sections were then incubated with the relevant primary antibody diluted in 
3% BSA/PBS solution overnight at 37 °C. The sections were then washed three 
times with PBS before being incubated with secondary antibody and DAPI diluted in 
3% BSA/PBS solution for 1 hr at 37ºC. Following a further PBS wash, the sections 
were mounted by adding a drop of mounting media and placing a coverslip on top. 
Stained sections were viewed under a Zeiss LSM 510 confocal microscope (Carl 
Zeiss Inc.) 
 
2.3.5.3 Random migration assay  
For the random migration assay, NHK, KS, WT kindlin-1 and mutant kindlin-1-
W612A overexpressing KS cells were seeded on 12 well plates. The cells were 
starved overnight by replacing the media with optimem. The cells were stimulated 
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with EGF at a concentration of 100 ng/ml. The cells were imaged with time-lapse 
microscopy before and after stimulation. Live cell imaging was performed on Zeiss 
Axiovert 100 microscope using an automated scanning stage. Images were acquired 
by phase contrast imaging using a 10x N-Achroplan Phase contrast objective 
(numerical aperture 0.25). Cell images were collected using a Sensicam (PCO Cook) 
charge coupled device (CCD) camera, taking a frame every 10 mins for 16 hrs using 
AQM acquisition software (Andor Bioimaging, Belfast, U.K.). Subsequently, all the 
acquired time-lapse sequences were converted to movie files (.AVI) using ImageJ 
and cells from the time-lapse sequence were tracked using IQ Tracking Software 
(Andor Bioimaging). At least 60 cells were tracked for each sample. Tracking 
resulted in the generation of a sequence of position coordinates relating to each cell 
in each frame. Motion analysis was then performed on these sequences using 
Wolfram Mathematica 6.  
 
2.3.5.4 Confocal microscopy 
Images of fixed cells were acquired on a Zeiss LSM 510 confocal microscope (Carl 
Zeiss Inc.) or Nikon A1R confocal microscope (Nikon Instruments UK). Excitation 
wavelengths of 488 nm (Argon laser), 543 nm (HeNe1 laser) and 633 nm (HeNe2 
laser) were used. Images were taken using a 63x oil Plan Fluor immersion objective 
(numerical aperture 1.4). Images were exported from Database Files.mdb to TIFF 







2.3.5.5 Image analysis  
For colocalisation analysis the confocal images were processed with the ImageJ 
plugin:http://imagejdocu.tudor.lu/doku.php?id=plugin:analysis:jacop_2.0:just_anoth
er_colocalization_plugin:start    
For analysis of surface levels vs. total levels of EGFR or kindlin proteins, images 
were manually thresholded in ImageJ and intensity values were calculated per cell 
area (corrected for total μm) and normalised to the control cells in that sample set. 
 
2.3.5.6 Statistical analysis 
All statistical tests were performed using Students T-tests (Excel) except for the 
random migration data which was analysed using ANOVA (SPSS). Significance was 
taken as p<0.05 and significance values were assigned in specific 




































Kindlin-1 is predominantly expressed in epithelial tissue in the skin and the intestine. 
In the skin it is found to be highly expressed in keratinocytes of the epidermis 
(Siegel et al., 2003). Keratinocytes containing mutations in the KIND1 gene have 
been previously reported to show various abnormal phenotypes which indicate the 
importance of kindlin-1 regulation of normal function in these cells. The array of 
defects include reduced cell adhesion, spreading, migration and proliferation, as well 
as abnormal cell shape, loss of polarisation and multiple leading edges (Herz et al., 
2006; Has et al., 2008). Directed migration of cells is required for normal 
development, and also in regenerative processes, such as wound healing. A main 
feature of migrating cells is the lamellipodium which consists of polarised network 
of actin filaments that form the protruding front of a motile cell. Migration is 
dependent on integrin-mediated adhesion and changes to the cytoskeleton and is 
controlled by Rho GTPases (Ridley, 2001). Kindlin-1 can bind and activate integrins 
in cooperation with talin, thus kindlin-1 deficient keratinocytes are not able to carry 
out these important integrin dependent processes. Kindlin-1 deficient cells have 
reduced active Rho GTPases and their downstream effectors (Has et al., 2009), 
showing that there is disruption in the propagation of the downstream signalling of 
integrin that controls cell migration and polarisation. Integrins are heterodimeric 
transmembrane receptors, their primary function is mediating cell-cell and cell-
matrix interactions and internal linkage to the cytoskeleton and cell signal 
transduction (Hynes, 2002). Integrins mediate signalling from the extracellular space 
into the cell via adaptor molecules such as FAK, ILK and particularly interesting 
new cysteine-histidine rich protein (PINCH) (Harburger and Calderwood, 2009). 
Activated pathways signal a variety of processes including survival, apoptosis, 
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proliferation, cell-cycle progression, cell shape, polarity, adhesion, migration and 
differentiation (Hynes, 2002). Integrins bind to cell surface and ECM components 
such as fibronectin, vitronectin, collagen, and laminin and cell associated ligands 
such as ICAMs and VCAMs (Harburger and Calderwood, 2009). Integrin ligands 
also include matrix metalloproteinase (MMP) and thrombospondin (TSP) (Bein and 
Simons, 2000; Chandrasekaran et al., 2000).  
TSPs are matricellular glycoprotein that mediates cell-matrix interaction. There are 
five members in the TSP family, which are subdivided into two groups. TSP-1 and 
TSP-2 are homotrimers, while TSP-3, TSP-4 and TSP-5 are homopentamers and 
lack the type 1 or TSP repeats responsible for the important functions of TSP-1 and 
TSP-2. TSP-1 and TSP-2 are the best studied although they differ significantly in 
their expression pattern (Adams and Lawler, 2004). In normal human skin, TSP-1 is 
expressed by basal epidermal keratinocytes and is deposited in the dermal-epidermal 
basement membrane. It helps to form a protective barrier against ingrowth of blood 
vessels into the dermis (Yano et al., 2005). TSP-1 is involved in various biological 
processes, including cell proliferation, migration and differentiation of a number of 
cell types (Adams and Lawler, 2004). TSP-1 has multiple domains which facilitate 
its activities including the amino-terminal heparin-binding domain, the procollagen 
domain, the properdin-like type I repeats, and the globular carboxy-terminal domain. 
The protein also contains type II repeats with epidermal growth factor-like homology 
and type III repeats that contain an RGD sequence (Adams and Lawler, 2004). The 
different domains enable it to interact with cell-surface receptors, ECM, growth 
factors and proteases which allow it to positively and negatively modulate cell 
adhesion, growth and motility (Chen et al., 2000). One of the major functions of 
TSP-1 is its role in angiogenesis. Angiogenesis is the physiological process 
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involving growth of new blood vessels and this is vital during normal growth and 
development as well as in wound healing and tumour development. TSP-1 also acts 
to prevent angiogenesis by inhibiting endothelial cell migration. This is mediated via 
an interaction of the type 1 repeats of TSP-1 with β1 integrin in a PI3K dependent 
manner (Short et al., 2005). Studies have shown that downregulation of TSP-1 
results in a switch to an angiogenic phenotype. One factor that can modulate an 
angiogenic switch is UV radiation, as TSP-1 is downregulated in UVB radiated skin 
(Howell et al., 2004). Further studies have confirmed that UV exposure reduces 
TSP-1 expression in human skin and keratinocytes and that this is mediated by 
activation of the PI3K-Akt pathway (Yano et al., 2005; Kim et al., 2006). KS 
patients also display sensitivity to UV and accelerated skin ageing, both of which 
have been linked to TSP-1 expression previously. However, any link between 
kindlin-1 expression and TSP-1 has not been previously explored. Indeed, the role of 
kindlin-1 in integrin-mediated processes provides insight into some of the 
phenotypes of KS such as epithelial fragility; however, there is still a need for further 
investigations into the pathogenic mechanisms underlying the other clinical features 
noted in KS patients. The aim of this chapter was to screen for novel targets 
downstream of kindlin-1 using mass spectrometry. This analysis revealed a number 
of interesting new kindlin-1 dependent proteins, including TSP-1, which may be 









3.2.1 Characterisation of normal and KS keratinocytes 
To characterise the morphology of the three cell lines used in the project, the NHK 
and the two KS keratinocyte cell lines were plated on coverslips and phase contrast 
images were acquired to show the overall shape and morphology of the cells (Figure 
3.1 (a)). Images demonstrated that NHK show differences in morphology compared 
to that seen in KS patient cells. Control NHK appeared to be rounded in shape, while 
KS(1) keratinocytes were more elongated and KS(2) keratinocytes were extremely 
rounded up.  This could be as a result of inefficient speading of the cells which has 
previously shown by other studies (Kloeker et al., 2004; Herz et al., 2006). To 
analyse the levels of KIND1 mRNA in the NHK and KS cells, cells were subjected 
to semi-quantitative reverse transcriptase PCR. This technique assesses relative 
levels of mRNA by generating cDNA from the mRNA and then amplifying genes of 
interest using specific primers. Kindlin-1 levels were assessed and GAPDH was used 
a control to ensure equal loading between samples (Figure 3.1 (b)). Data 
demonstrated a marked reduction of mRNA levels in both KS keratinocytes.  
In addition, Immunofluorescence staining of the three cell lines with an anti-kindlin-
1 antibody was performed to analyse localisation of the protein. In NHK, kindlin-1 
was found at the periphery of the cells but was also present in the cytoplasm (Figure 
3.2 (a)). By comparison, KS keratinocytes showed a distinct lack of kindlin-1 
staining at the cell periphery but there was still signal present in the cytoplasm 
(Figure 3.2 (a)). Immunohistochemistry was also performed on normal human skin 
(NHS) and KS patient skin (Figure 3.2 (b)). In NHS, kindlin-1 is predominantly 
expressed in the basal keratinocyte layer close to the dermal-epidermal junction. 
However, in KS skin there was a marked absence of kindlin-1 expression. Moreover, 
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in KS skin there was a striking loss of rete ridges giving rise to a flat appearance to 
the dermal-epidermal junction, as well as an atrophic epidermis, and overlying 
hyperkeratosis. A secondary only control shows some non specific staining on 

















Figure 3.1: Characterisation of NHK and KS keratinocytes.  
Characterisation of NHK and KS patient keratinocytes. a) Phase contrast images of 
the three cell lines; normal human keratinocytes (NHK), KS keratinocytes (KS(1) 
and KS(2)). Scale bar = 50 μm. b) Semi-quantitative RT-PCR of KIND1 mRNA 








Figure 3.2: Localisation of kindlin-1.  
Characterisation of kindlin-1 in NHK and KS patient keratinocytes and skin. a) 
Confocal images of the localisation of kindlin-1 in NHK and KS keratinocytes. 
Endogenous kindlin-1 is shown in green and F-actin in red (Phalloidin 633)  Kindlin-
1 and phalloidin channels have been zoomed in from the original image as 
highlighted by the white boxes. Red arrow indicates localisation of kindlin-1 at the 
cell periphery. Scale bar = 10 μm. b) Confocal images of the localisation of kindlin-1 
in normal human (NHS) and KS patient skin (KS) with secondary only conrol. 
Dashed line indicates dermal-epidermal junction (DEJ). Scale bar = 50 μm. 
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3.2.2 Mass spectrometry analysis of proteins expressed in KS cells 
To determine whether there were any other differences in protein expression 
between NHK and KS keratinocytes, the cells were grown to confluency and lysed. 
The lysates were run on a SDS-PAGE gel and stained with silver staining solutions. 
This allowed higher sensitivity of the detection of protein bands and allowed the 
band profiles of the lysates to be compared and assessed for any differences. The 
bands that were consistently seen to be downregulated or upregulated in at least three 
different experiments were cut out and subjected to mass spectrometry analysis (by 
Aberdeen Proteomics, University of Aberdeen). Examples of some of the bands that 




















Figure 3.3: Different protein banding patterns seen in NHK and KS lysates.  
SDS-PAGE analysis of NHK and KS(1) lysates. a) Silver stained 12% acrylamide 
gel comparing lysates from NHK and KS lysates. Red boxes highlight examples of 
differentially expressed bands that were cut out for mass spectrometry analysis. The 
band was cut only from the NHK lysate sample and not from KS. b) Table of results 
from mass spectrometry analysis of proteins downregulated in KS keratinocytes, also 










The proteins that were identified in the bands were sequenced and the results of the 
mass spectrometry analysis from multiple samples are listed in Figure 3.3 (b). 
Immunoblotting was then used to validate the results from the mass spectrometry 
data. Keratin 14, mDia1, plectin, ROCK 1, filamin A, ZO-2, E-cadherin, EGFR and 
TSP-1 were assessed using immunoblotting followed by quantification with 
densitometry analysis from at least 3 independent experiments as shown in Figure 
3.4 (a) and (b). The total protein levels of keratin 14, mDia1, plectin, ROCK1, 
filamin A and ZO-2 were not significantly different between NHK vs. KS 
keratinocytes. However, E-cadherin, EGFR and TSP-1 levels were significantly 


















Figure 3.4: KS keratinocytes have lower levels of EGFR, TSP-1 and E-
Cadherin.     
Validation of mass spectrometry results using western blotting to compare total 
protein levels in NHK and two KS cell lines. a) example blots of western blots of the 
proteins keratin 14, mDia1, plectin, ROCK 1, filamin A, ZO-2, E-cadherin, EGFR 
and TSP-1 with GAPDH (loading control). b) Graphs show densitometry analysis of 
the corresponding proteins in NHK vs. KS keratinocytes. Error bars are S.E.M., n=3, 
* = P<0.05, * * = P<0.001, * * * = P<0.0001.    
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3.2.3 Kindlin-1 regulates the expression of TSP-1 in human keratinocytes 
To validate and further investigate the downregulation of TSP-1, levels of TSP-1 
mRNA and total protein were analysed using semi-quantitative RT-PCR and western 
blotting respectively (Figure 3.5 (a,b)). Results demonstrated no change in mRNA 
levels of TSP-1, but a significant reduction in the total TSP-1 protein levels in KS 
cells. To analyse the localisation of TSP-1 in skin, immunohistochemistry was 
performed on normal human skin and KS skin by staining fixed 5 μm frozen sections 
with an antibody against TSP-1 and DAPI. Confocal images demonstrated TSP-1 
was highly localised to the dermal-epidermal junction (shown by white arrows) 
(Figure 3.5 (d)) in normal human skin. In contrast, TSP-1 staining appeared to be 
more disrupted in skin from KS patients compared to the normal skin although 
localisation was still most prominent at the dermal-epidermal junctions (Figure 3.5 
(d)). To determine whether reduced TSP-1 levels seen in KS cells was due to 
increased TSP-1 in the insoluble fraction, cells were fractionated after lysing and 
split into soluble fraction (the supernatant) and the insoluble fraction (pellet). The 
fractions were analysed with western blotting and probed for TSP-1(Figure 3.5 (e)). 
As seen in previous soluble lysate analysis, TSP-1 levels were very low in the 
soluble fractions of KS keratinocytes but there was no corresponding increase in 











Figure 3.5: Characterisation of TSP-1 in keratinocytes and skin.  
Characterisation of the gene and protein level and localisation of TSP-1 in NHK vs 
KS. a) Semi-quantitative RT PCR of TSP-1 mRNA levels in NHK and KS 
keratinocytes. b) Western blot example of TSP-1 total level in NHK vs. KS 
keratinocytes. c) Graphs show densitometry analysis of the protein. Error bars are 
S.E.M., n=3, * * *  = P<0.0001. d) Confocal images of the localisation of TSP-1 
(green) and DAPI (blue) in normal human skin (NHS) and KS patient skin. Arrows 
indicate localisation of TSP-1. Scale bar = 10 μm. e) Western blot of TSP-1 levels in 




3.2.4 TSP-1 is incorrectly deposited by KS cells 
The localisation of TSP-1 in NHK and KS keratinocytes was determined by 
immunofluorescence microscopy. The cells were fixed and stained with antibodies 
against TSP-1 as well as α6-integrin, the latter being used as a marker of 
hemidesmosome adhesion complexes (Figure 3.6). TSP-1 was localised to the cell 
membrane and co-localised with α6-integrin staining in NHK. The protein was also 
secreted from NHK, which was seen as a layer of TSP-1 deposited around the cells 
in a rosette-like structure (Figure 3.6). Cells that were fixed in mid-migration also 
appeared to leave a trail of TSP-1 behind in the migration track. By contrast, KS 
keratinocytes showed much lower levels of TSP-1 deposited in the immediate 
surrounding area and no trail of TSP-1 was evident. However, TSP-1 could still be 
detected at the membrane of the KS cells. The difference in TSP-1 secretion was not 
quantified, however approximately 80% of KS keratinocytes analysed showed 
abnormal secretion and deposition of TSP-1. To investigate whether TSP-1 re-
expression could rescue deposition and localisation in KS cells, KS keratinocytes 
were transfected with a cDNA construct encoding human TSP-1, fixed and stained 
with anti-TSP-1 antibodies (Figure 3.7). Transfected cells showed overexpression of 
TSP-1, but this TSP-1 still did not localise in a similar pattern to that seen in NHK 
keratinocytes and as seen befor around 80% percent of the cells were not secreting or 





Figure 3.6: TSP-1 is retained at the membrane in KS keratinocytes.     
Confocal images of fixed NHK or KS keratinocytes. TSP-1 is shown in green and α6 
integrin in red. TSP-1 and α6 integrin channels have been zoomed in from the 
original image as highlighted by the white boxes. The red outline highlights the 
periphery of the cells. TSP-1 is secreted and deposited around the cells and the 
staining gives a rosette-like appearance. In KS keratinocytes there appears to be less 
secreted TSP-1 around the cells, with approximately 80% of cells analysed 








Figure 3.7: TSP-1 overexpression in KS keratinocytes does not restore normal 
TSP-1 deposition patterns. Confocal images of fixed NHK and KS keratinocytes 
overexpressing TSP-1. TSP-1 is shown in green and F-actin in red (Phalloidin 633). 
TSP-1 and phalloidin channels have been zoomed in from the original image as 
highlighted by the white boxes. The red outline highlights the periphery of the cells. 
The TSP-1 expressing KS keratinocytes were unable to secrete and deposit the 






3.2.5 Re-expression of kindlin-1 in KS keratinocytes rescues expression levels of 
TSP-1.      
To confirm the role of kindin-1 in regulation of TSP-1 regulation, KS cell lines 
stably re-expressing kindlin-1 were generated. Wild type (WT) kindlin-1 and the 
non-integrin binding mutant Kindlin-1-W612A with an N-terminal mCherry tag 
(Figure 3.8 (a)) were cloned into lentiviral vector backbone to allow stable infection 
and re-expression in KS keratinocytes. FACS was used to sort the cells to achieve a 
pure population of mCherry positive cells. The level of TSP-1 in the KS 
keratinocytes expressing WT kindlin-1 or kindlin-1-W612A was determined using 
western blot analysis followed by densitometry analysis as shown in Figure 3.8 (b, 
c). KS keratinocytes expressing WT kindlin-1 showed a partial rescue of TSP-1 
levels, although this was not significant. However, in the KS keratinocytes 
expressing kindlin-1-W612A there was a complete absence of TSP-1. The kindlin-1-
mCherry expressing cells were further analysed using immunofluorescence after 
fixing and staining with TSP-1. The KS keratinocytes expressing WT kindlin-1 
appeared to show rescue of TSP-1 deposition as more TSP-1 was secreted from the 
cells and was left as a track around the cells as they moved, this was seen in 
approximately 50-60% of the cells although quantification wss not performed 
(Figure 3.9). This rescue of TSP-1 localisation was not seen in the KS keratinocytes 
expressing kindlin-1-W612A as they did not exhibit normal TSP-1 deposition 










Figure 3.8: Kindlin-1 WT but not W612A mutant expression can partially 
rescue TSP-1 levels.  
Genration of kindlin-1 rescue cell lines. a) Schematic of mCherry tagged kindlin-1 
construct. Arrow indicates the location of the mutation W612A. b)Western blot 
analysis of TSP-1 total protein levels in NHK or KS keratinocytes stably expressing 
mCherry alone, mCherry WT kindlin-1 or mCherry tagged W612A kindlin-1 
mutant. c) Graph shows densitometry analysis of TSP-1 protein levels. Error bars are 













Figure 3.9: Deposition of TSP-1 is rescued by WT kindlin-1 but not by W612A 
mutant of kindlin-1. 
Confocal images of fixed KS keratinocytes expressing mCherry, mcherry-WT 
kindlin-1 or mCherry kindlin-1-W612A. TSP-1 is shown in green, mCherry alone, 
WT kindlin-1 or kindlin-1-W612A in red and F-actin in blue (Phalloidin 633). TSP-
1, mCherry and phalloidin channels have been zoomed in from the original image as 
highlighted by the white boxes. The red outline highlights the periphery of the cells. 
Approximately 50-60% of WT kindlin-1 expressing cells showed a rescue of the 
phenotype comparable to NHK, while kindlin-W612A expressing cells did not show 








In this chapter I characterised the cell lines to be used in the project. Two KS patient 
cell lines with known mutations in kindlin-1 were chosen. KS(1) and KS(2) 
keratinocytes harbouring the following mutations, compound heterozygous 
p.E304X/p.L302X and homozygous c.676insC respectively. These mutations have 
been identified and characterised in previous studies (Ashton et al., 2004). The use 
of two patient cell lines allowed comprehensive analysis of changes in protein 
expression relative to NHK cell line which was used as the control. The aberrant 
morphology of KS keratinocytes have previously been characterised by other groups, 
which have described the cells as having proliferation, adhesion, and migration 
defects (Herz et al., 2006; Has et al., 2009). The ability to bind and activate β1 
integrin (Harburger et al., 2009) allows kindlin-1 to participate in important integrin-
mediated processes such as cell adhesion to underlying matrix, migration, cell 
polarisation. Hence kindlin-1 is important in controlling polarity, adhesion and 
maintenance of the cytoskeletal architecture in normal keratinocytes, and loss of 
kindlin-1 results in a range of associated defects. 
Analysis of NHK and KS keratinocyte lysate using mass spectrometry identified a 
number of differentially-expressed proteins. The following proteins showed reduced 
expression in KS keratinocyts: Keratin 14, mDia1, plectin, ROCK2, filamin A, ZO-
2, E-cadherin, EGFR and TSP-1. However, immunoblotting showed no comparative 
differences in these proteins with the exception of E-Cadherin, EGFR and TSP-1 
indicating that the other findings were false positives, possibly due to the target 
bands being not well-resolved enough on SDS-PAGE gels and thus containing 
multiple proteins. Interestingly, the proteins that were validated to change expression 
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level are all associated with control of cell-cell or cell-matrix adhesion in skin 
biology. 
 E-Cadherin is an important cell-cell adhesion protein that has been implicated in 
cancer progression and metastasis due to loss of function or reduced expression 
(Gumbiner, 2005). Changes in E-Cadherin could possibly be related to the increased 
susceptibility of squamous cell carcinoma that is a clinical feature in KS patients. 
Due to time constraints I did not further investigate the link between kindlin-1 and E-
Cadherin. However, this will be an important topic to analyse in future studies.   
TSP-1 was another protein found to be significantly reduced in KS keratinocytes. 
TSP-1 is a matricellular protein that mediates cell-cell and cell-matrix interactions. It 
is also a potent inhibitor of angiogenesis and is also found to be reduced in 
photoageing skin (Yano et al., 2005; Kim et al., 2006). This may explain some of the 
telangiectasiae and atrophy that is evident in the skin of many KS patients. 
Immunofluorescence of NHK and KS keratinocytes with TSP-1 showed that TSP-1 
was secreted and deposited around the cells, whereas in KS cells (KS(1) and KS(2)) 
TSP-1 is retained at the cell membrane. This suggests that there is a disruption in the 
secretory mechanism of the KS cells. Overexpressing TSP-1 in KS cells was unable 
to rescue normal deposition implying a defect in the regulation of TSP-1.  
Expression of wild type kindlin-1 was able to partially rescue expression levels in 
KS keratinocytes, as well as rescuing normal deposition of TSP-1. However, this 
was not seen when the W612A non-β1 binding mutant of kindlin-1 was re-expressed 
in KS cells. In fact, TSP-1 was completely absent from these cells and expression 
seemed to be repressed. The ability of wild type but not the W612A kindlin-1 to 
rescue TSP-1 levels and secretion confirms that kindlin-1 is involved in TSP-1 
regulation and further suggests that this regulation depends on integrin binding to 
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kindlin-1. It is possible that TSP-1 deposition requires fully active 1 integrins, and 
kindlin-1 is required for this step. Alternatively (or additionally), kindlin-1:integrin 
binding may control a signalling pathway that promotes TSP-1 protein production 
and secretion. These would be interesting hypotheses to test in future studies. 
Taken together, these results have identified a number of novel targets that are 
differentially expressed in KS keratinocytes. Results also show that kindlin-1 is 
important for the expression and secretion of TSP-1. The role of kindlin-1 in 










































Integrin receptors independently propagate signals in cells, however they are also 
able to coordinate with other transmembrane receptors such as receptor tyrosine 
kinases (RTK). The crosstalk between these two receptor types is vital for normal 
development, tissue homeostasis, cell proliferation, survival and migration (Alexi et 
al., 2011). The co-operation can occur at the level of integrin-dependent activation of 
RTK, recruitment of transducing proteins to membrane cytoskeletal complexes and 
increased nuclear localisation of transcriptional regulators (Eliceiri, 2001). RTK 
activate a multitude of signalling pathways including PI3K and MAPK which are 
important for cell proliferation and survival (Bazley and Gullick, 2005).  There are 
different mechanisms of crosstalk between integrins and RTK. Growth factors that 
bind and activate RTK can alter integrin localisation and activation thereby 
regulating integrin mediated events such as cell adhesion, spreading and migration 
(Cabodi et al., 2004). Conversely, integrin signals are needed for enhanced 
activation of RTK. In epithelial cells, β1 integrin has been shown to activate EGFR 
and is also required for full activation in response to EGF leading to transcriptional 
changes (Cabodi et al., 2004). Adhesion of epithelial cells to ECM is sufficient to 
stimulate EGFR and activate the Akt and Erk pathways which lead to upregulation 
of cyclin D1 for cell cycle progression (Bill et al., 2004). EGFR belongs to the 
family of ErbB RTK, which consists of four members.  EGFR (ErbB1) exists on the 
cell surface and is activated by binding of its specific ligands, including epidermal 
growth factor (EGF), transforming growth factor α (TGFα) and heparin binding EGF 
(HB-EGF) (Bazley and Gullick, 2005). EGFR is the main member of the ErbB 
family that is expressed in keratinocytes in skin. Upon activation by its growth factor 
ligands, EGFR undergoes transition from an inactive monomeric form to an active 
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homodimer. In addition to forming homodimers after ligand binding, EGFR may 
also form heterodimers with another member of the ErbB receptor family (Bazley 
and Gullick, 2005). There is also evidence to suggest that clusters of activated 
EGFRs form, although it remains unclear whether this clustering is important for 
activation itself or occurs subsequent to activation of individual dimers. EGFR 
dimerisation stimulates its intrinsic intracellular protein-tyrosine kinase activity and 
this causes autophosphorylation of several tyrosine residues in the C-terminal 
domain of EGFR. Autophosphorylation elicits downstream signalling that involve 
other proteins that associate with the phosphorylated tyrosines through their own 
phosphotyrosine-binding SH2 domains. These downstream signalling proteins 
initiate several signal transduction cascades, principally the MAPK, Akt and JNK 
pathways and these pathways modulate phenotypes such as cell migration, adhesion, 
and proliferation (Bazley and Gullick, 2005). Inactivation of EGFR is achieved 
through dephosphorylation by phosphotyrosine phosphatases or receptor 
downregulation. Downregulation of EGFR occurs when ligands bind to the receptor 
leading to its internalisation and subsequent degradation. Unbound EGFR is recycled 
back to the cell surface, while the ligand bound receptors are degraded in the 
lysosome by proteases (Authier et al., 1999). EGFR has also been shown to be 
degraded through another pathway. Ubiquitination of EGFR is mediated by the c-
Cbl protein, which possesses a SH3 domain that interacts with phosphorylated 
tyrosine on the EGFR cytoplasmic domain (Joazeiro et al., 1999). This propagates a 
signal for degradation by the 26S proteasome (Ettenberg et al., 2001). Reports 
suggest that integrins may have a role in regulating EGFR recycling, for example 
chemically inhibiting β3 integrin increases the recycling of EGFR and α5β1 where 
both can form a complex and be endocytosed together (Caswell et al., 2008). The 
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aim of this chapter was to further characterise the kindlin-1-dependent regulation of 
EGFR levels identified in the previous results chapter, and to determine how kindlin-
1 may act co-operatively with EGFR to maintain normal keratinocyte signalling 
























 4.2 Results 
4.2.1 EGFR is downregulated in KS keratiniocytes 
Mass spectrometry analysis initially showed a reduction in protein levels of EGFR in 
KS keratinocytes. However, semi-quantitative RT-PCR detected no change in the 
mRNA level of EGFR as demonstrated in Figure 4.1 (a). To confirm changes in total 
protein level immunoblotting was performed (Figure 4.1 (b), which showed a 
significant reduction in levels of EGFR in both KS cell lines. Furthermore, FACS 
analysis revealed a significant reduction in cell surface levels of EGFR also in both 
KS cell lines (Figure 4.1 (c)). Localisation of EGFR was analysed by imuunostaining 
normal human skin (NHS) and KS skin with an anti-EGFR antibody, followed by 
confocal analysis. KS skin showed an almost complete absence of EGFR in the basal 
keratinocytes, but not in NHS.    
To analyse the localisation of EGFR in KS keratinocytes, the cells were fixed and 
stained with an anti-EGFR antibody alongside F-actin staining. Confocal images 
were taken of NHK and KS keratinocytes for comparison (Figure 4.2). In NHK, 
EGFR localised partially at the membrane and also at some perinuclear vesicular 
structures as has been reported previously in other cells types. By contrast, EGFR 
staining in KS keratinocytes was very low at the membrane and increased within 











Figure 4.1: EGFR levels are reduced in KS cells 
Characterisation of protein and mRNA levels of EGFR in NHK vs. KS keratinocytes  
a) Semi-quantitative RT-PCR of EGFR mRNA levels in NHK and KS keratinocytes. 
b) Western blot example of EGFR total level in NHK vs. KS keratinocytes. Graph 
shows densitometry analysis of the protein Error bars are S.E.M., n=3, * * = 
P<0.001. C) Quantification of surface levels of EGFR in NHK and KS keratinocytes 
by FACS analysis. Error bars are S.E.M., n=3, * = P<0.05, * * * = P<0.0001. d) 
Confocal images of EGFR (green) and DAPI (blue) in normal human skin (NHS) 





Figure 4.2: In KS keratinocytes EGFR localises more to the nuclear periphery 
than at the membrane. 
Confocal images of fixed NHK and KS keratinocytes. Endogenous EGFR is shown  
in green and F-actin in red (Phallodin 633). EGFR and phalloidin channels have been 









4.2.2 KS keratinocytes show altered response to EGF 
To examine the effects of EGF stimulation on EGFR localisation, cells were starved 
overnight in OPTI-MEM (that contains no growth factors) and then stimulated with 
EGF (100 ng/ml). Cells were fixed at 0 min, 15 min or 60 min after EGF treatment 
and stained with anti-EGFR antibody followed by analysis by confocal microscopy 
(Figure 4.3). At 0 min EGF treatment (i.e. starved cells), NHK cells showed EGFR 
localisation at both the plasma membrane and cytoplasm, and after 15 min of EGF 
stimulation there was lower EGFR at the membrane and more in discrete punctate 
vesicles within the cytoplasm, some of which were immediately beneath the plasma 
membrane. After 60 min, EGFR was almost completely absent from the plasma 
membrane but showed more punctate localisation in the cytoplasm in vesicles, 
mainly around the perinuclear region. Moreover, staining for F-actin demonstrated a 
clear increase in peripheral protrusions in NHK after EGF treatment, and polarisation 
of the cell at 60 minutes. In KS keratinocytes there were no obvious changes in 
EGFR localisation in response to EGF stimulation. In starved cells there was high 
perinuclear staining of EGFR that did not change following 15 minutes or 60 






Figure 4.3: EGFR is internalised after EGF treatment in NHK.  
Confocal images of NHK or KS(1) keratinocytes treated with EGF (100 ng/ml) for 
15 or 60 mins and stained for EGFR, shown in green and F-actin in red (Phalloidin 









To further investigate the regulation of EGFR in response to EGF stimulation in 
NHK and KS cells, the total and plasma membrane associated levels of EGFR was 
measured by intensity analysis of confocal images before and after EGF stimulation. 
Example confocal images of the cells used to quantify total and surface EGFR before 
and after stimulation are shown in Figure 4.4 (a). Laser levels and detector settings 
were maintained at identical levels for all images acquired to permit direct 
comparison. The total level of EGFR did not change in response to EGF stimulation 
in either NHK or KS keratinocytes as demonstrated by total EGFR intensity 
quantification in Figure 4.4 (b). However, as seen by western blotting, there was 
almost half the level of EGFR in KS vs. NHK keratinocytes. The surface level of 
EGFR significantly decreased in NHK after 60 minutes EGF stimulation. However, 
surface levels of EGFR in KS keratinocytes were reduced to a significantly lower 








Figure 4.4: EGFR surface levels and intensity reduced in KS cells.  
a) Example confocal images of EGFR staining in cells treated with EGF over time. 
Quantification of b) total and c) surface EGFR levels in cells at time 0 or 60 mins 
post-EGF by intensity analysis (graphs). n= >15 cells for each pooled from two 









Given the striking changes in EGFR levels and response of KS cells to EGF, I next 
analysed whether EGFR signalling may be defective in KS cells. EGFR is known to 
undergo multiple tyrosine phosphorylation events at the cytoplasmic domain in 
response to EGF stimulation. To analyse this, EGFR was immunoprecipitated from 
NHK and KS lysates before and after EGF stimulation (10 min at 100 ng/ml) 
followed by western blotting and probing with anti-phophotyrosine antibody (Figure 
4.5 (a)). Data showed that EGFR was being phosphorylated at tyrosine residues in 
response to EGF in both NHK and KS cells. However, KS cells showed a possible 
decrease in levels of phospho-EGFR corresponding to the lower level of EGFR that 
is immunoprecipitated in these cells.  
To further analyse whether EGFR downstream signalling after EGF stimulation was 
also occurring in KS cells, immunoblotting was used to compare lysates from 
starved NHK and KS cells and those treated with EGF (10 min at 100 ng/ml). Two 
key proteins in the different signalling pathways of EGFR was analysed, including 
Akt and phospho-Akt or Erk1/2 and phospho-Erk1/2. This revealed no significant 
changes in total Akt, phospho-Akt or total Erk1/2. However, strikingly, KS cells 
showed no increase in phospho-Erk1/2 after stimulation with EGF whereas a robust 











Figure 4.5: EGFR signalling is defective in KS keratinocytes. 
a) Immunoprecipitation of EGFR from lysates from NHK and KS keratinocytes -
/+EGF (100ng/ml, 10mins) and probed for phosphotyrosine (top panel; PY), EGFR 
or HSC70 (input only). b) Western blots of lysates from NHK and KS -/+ EGF (100 
ng/ml, 10 mins) probed for phospho or total Akt and Erk1/2. GAPDH was used as a 
loading control.  
119 
 
To investigate the functional response of KS keratinocytes to EGF stimulation, phase 
contrast time lapse microscopy was employed to observe any changes in behaviour. 
NHK and KS keratinocytes were imaged lived before and after treatment with EGF 
as illustrated by the still images taken from time-lapse movies (Figure 4.6 (a)). As 
EGF is known to induce cell rounding followed by re-spreading in keratinocytes, the 
cell area was measured and quantified as a percentage relative to time 0 min in both 
cells lines (Figure 4.6 (b)). Both NHK and KS keratinocytes immediately contracted 
after EGF stimulation and at 4 min the percentage cell area was less than half that 
seen before stimulation. From this time point the cells began to re-spread again and 
by 10 mins post-EGF the NHK cells had reached 80% of initial cell area size. 
However, the KS keratinocytes demonstrated delayed re-spreading and only reached 







Figure 4.6: KS Keratinocytes show delayed re-spreading after EGF stimulation.  
a) Still images of NHK or KS keratinocytes taken from time-lapse movies in cells 
pre and post EGF (100ng/ml). b) Graph shows quantification of spread cell area 







To further analyse the differential response of NHK and KS cells to EGF, time-lapse 
confocal microscopy was employed to study EGFR-GFP localisation in NHK and 
KS keratinocytes before and after EGF treatment over time. Still images from 
example movies are shown in Figure 4.7 from time points 0, 3, 7 and 11 mins post-
EGF.  In starved cells, GFP-EGFR appeared to localise predominantly at the plasma 
membrane and in some vesicles in NHK cells, as seen in staining for endogenous 
EGFR. KS cells, however, showed higher levels of EGFR-GFP localised within 
cytoplasmic vesicles. After stimulation with EGF, GFP-EGFR in NHK began to 
move into the cell as it was internalised from the plasma membrane, as seen by an 
increased level of punctate GFP-EGFR localisation in the centre of the cell. This 
internalisation was very rapid and was observed by 3 mins post-EGF and 
progressively increased over the 11 mins time range. By comparison GFP-EGFR 
localisation in KS keratinocytes did not significantly change following EGF 
treatment as the receptor was mainly localised within the cell in vesicles rather than 
the plasma membrane throughout the imaging time. However, by 7 mins there 
appeared to be a slight increase in levels of GFP-EGFR within perinuclear 





Figure 4.7: Live imaging of EGFR in KS keratinocytes shows slow response to 
EGF 
Still images taken from time-lapse confocal movies of NHK or KS cells expressing 










EGF is known to promote migration in human keratinocytes. To analyse whether the 
differences seen in the functional response of NHK and KS keratinocytes to EGF 
also lead to altered migration, cells were subjected to phase contrast time-lapse 
microscopy before and after treatment with EGF. Cells were tracked in movies and 
the migration speed and persistence was measured and plotted in the graphs shown 
in Figure 4.8 (a). Data demonstrated a significant increase in migration speed in KS 
cells compared to NHK in the absence of EGF. NHK responded to EGF stimulation 
by showing an increase in migration speed and persistence. However, there were no 
significant changes in speed or persistence by KS keratinocytes after EGF 
stimulation, suggesting a defect in the response and signalling mechanism in these 



















Figure 4.8: KS keratinocytes migration speed and persistence does not alter 
after EGF stimualation.  
a) Representative tracks of NHK or KS keratinocytes undergoing migration before or 
after EGF stimulation (100ng/ml). Graphs of quantification from >60 cells of b) 







4.2.3 Kindlin-1 regulates EGFR degradation  
As the reduced protein level of EGFR could not be explained by downregulation at 
the gene level, it was suspected that EGFR was being degraded in the KS cells. It has 
been reported that the proteasome plays a role in the degradation of ubiquitinated 
EGFR and use of a proteasomal inhibitor, such as MG132, can prevent the 
degradation of EGFR and result in its accumulation (Ettenberg et al., 2002; Longva 
et al., 2002). Thus, NHK and KS keratinocytes were treated with the proteasomal 
inhibitor MG132 to determine whether this could rescue levels of EGFR in KS 
keratinocytes and confirm that EGFR was being rapidly degraded in these cells. 
Figure 4.9 (a) shows a representative western blot of EGFR levels in NHK and KS 
keratinocytes before and after treatment with MG132. From this data it is clear that 
EGFR is not being rescued from degradation in either of the KS cell lines using 
MG132. A further mechanism known to regulate EGFR degradation is the lysosomal 
pathway (Authier et al., 1999). Degradation of a protein via the lysosome can be 
inhibited by the compound leupeptin. Treatment of KS keratinocytes with leupeptin 
was able to fully rescue levels of EGFR in one of the KS cell line and only partially 
in the other (Figure 4.9 (b)). 
To determine whether EGFR was also seen in the lysosomal compartment in KS 
cells, cells were fixed and stained for the lysosomal marker LAMP-1 and EGFR and 
analysed by confocal microscopy. Images were subjected to Pearson’s correlation 
colocalisation analysis to determine whether more EGFR resided in this 
compartment in KS cells. Analysis revealed that there was increased colocalisation 
of EGFR with the lysosomal marker LAMP-1.  Pearsons’s colocalisation co-efficient 
showed that colocalisation between EGFR and LAMP-1 was twice as high in KS 
compared to NHK (NHK 0.29+/-0.04 vs KS 0.64+/-0.08). Example confocal images 
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Figure 4.9: EGFR is being degraded via the lysosomal pathway in KS 
keratinocytes.  
a) Western blot of EGFR total protein levels in NHK and KS keratinocytes before 
and after treatment with the proteasomal inhibitor MG132. HSC70 used as a loading 
control. b) Western blot of EGFR total protein levels in NHK and KS keratinocytes 












Figure 4.10: Increased colocalisation of EGFR with the lysosomal marker 
LAMP1 in KS keratinocytes. 
Representative confocal images of NHK or KS keratinocytes stained for EGFR, 
shown in green and LAMP-1 in red. Scale bar = 10 μm. Images were analysed for 
colocalisation using Pearson’s correlation co-efficient analysis (% colocalisation 












4.2.4 Rescue of EGFR levels and response to EGF in KS cells 
In order to confirm that the loss of EGFR in KS cells was directly due to kindlin-1 
expression, WT kindlin-1 and kindlin-1-W612A non β1-integrin binding mutant 
were re-expressed in KS keratinocytes to see if they could rescue levels of EGFR. 
Kindlin-1 was tagged with mCherry to enable localisation to be assessed.  mCherry 
alone controls were generated to ensure that any changes in protein levels were not 
due to overexpression of the mCherry protein. Stable cell lines were generated using 
lentiviral vectors expressing WT kindlin-1 or kindlin-1-W612A mutant. Cells were 
lysed and used for immunoblotting (Figure 4.11 (a)). Levels of EGFR were 
significantly restored in both KS keratinocytes expressing the WT kindlin-1 and 
kindlin-1-W612A mutant suggesting that the loss of EGFR was due to the loss of 
kindlin-1 expression in these cells. However, the EGFR levels in the W612A re-
expressing cells remained significantly lower than in WT cells (Figure 4.11 (b)). 
To determine whether expression of kindlin-1 in KS keratinocytes leads to changes 
in EGFR localisation, fixed cells were stained for EGFR and analysed by confocal 
microscopy.  In Figure 4.12 KS keratinocytes expressing mCherry alone control 
vector show mainly perinuclear localisation of EGFR, as seen before. The wild type 
and kindlin-1-W612A expressing cells showed EGFR localised to the plasma 
membrane and reduced levels of perinuclear staining. Thus, the expression of 










Figure 4.11: EGFR levels are rescued by expressing kindlin-1 in KS 
keratinocytes. 
a) Lysates of KS cells stably expressing mCherry-WT kindlin-1 or mCherry-kindlin-
1-W612A mutant and probed for EGFR. b) Graph shows densitometry analysis of 






Figure 4.12: EGFR localisation is rescued by kindlin-1 re-expression in KS 
keratinocytes.     
Confocal images of fixed KS keratinocytes expressing mCherry, mcherry-kindlin-1 
and mCherry-W612A kindlin-1. EGFR is shown in green, mCherry in red and F-
actin in blue (Phalloiden 633). EGFR, mCherry and phalloidin channels have been 











The ability of WT kindlin-1 and kindlin-1-W612A to rescue keratinocyte phenotypes 
was further examined. Cells were fixed and stained for EGFR and total protein 
intensity and the surface levels of EGFR were analysed as before using confocal 
microscopy. These measurements were made in cells before and after treatment with 
EGF. The intensity of EGFR was quantified from immunofluorescence staining of 
EGFR in cells expressing WT kindlin-1 or kindlin-1-W612A and expressed as a 
percentage of EGFR levels in NHK control. Representative confocal images are 
presented in Figure 4.13 (a). The data shows that total and surface levels of EGFR 
were rescued in KS keratinocytes expressing either WT kindlin-1 or kindlin-1-
W612A mutant. The total level of EGFR in these kindin-1 expressing cells did not 
change after stimulation with EGF which is consistent with that seen in NHK control 
cells (Figure 4.13 (b)). The surface level of EGFR decreased in response to EGF 
stimulation in a similar way to that seen in NHK control cells (Figure 4.13 (b)). In 
cells expressing wild type kindlin-1 the percentage of surface level after EGF 
stimulation was reduced by more than half (61%), whereas in kindlin-1-W612A 
mutant expressing cells the surface EGFR levels following EGF was significantly 
lower than WT kindlin-1 expressing cells (38%) indicating kindlin-1-integrin 








Figure 4.13: Kindlin-1 is able to rescue EGFR surface levels and intensity.  
a) Example confocal images of KS cells stably expressing Kindlin-1-mCherry or 
Kindlin-1W612A-mCherry treated with EGF, fixed and stained for EGFR. Graphs 
show quantification of EGFR b) total intensity or c) surface levels analysed from 
>20 images per condition. Error bars are S.E.M., * = P< 0.01 KS (expressing WT 
kindlin-1) vs no EGF, * = P< 0.05 KS (expressing kindlin-1-W612A) vs no EGF and 








To help determine whether loss of directed migration in response to EGF is kindlin-1 
dependent, the migration speed and persistence of KS keratinocytes expressing either 
WT kindlin-1 or kindlin-1-W612A was analysed, as seen in Figure 4.8. Figure 4.14 
(a) illustrates examples of the migration tracks of the cells that were analysed. Both 
migration speed and persistence in kindlin-1 rescued cells were reduced to the same 
levels as NHK control cells and there was a significant increase in both parameters in 
response to EGF. The quantification for this data can be seen in Figure 4.14 (b, c). 
However, cells expressing kindlin-1-W612A did not show restoration of migration 













Figure 4.14: Kindlin-1 expression in KS keratinocytes can rescue migration 
speed and persistence in response to EGF stimualtion.  
a) Representative tracks of NHK, KS, KS(1)+K1 (expressing WT kindlin-1) or 
KS(1)+W612A (expressing kindlin-1-W612A) keratinocytes undergoing migration 
before or after EGF stimulation (100ng/ml). Graphs of quantification from >60 cells 
of a) migration speed or b) persistence. Error bars are S.E.M., * * = P< 0.001.   
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I next aimed to examine whether kindlin-1 may regulate EGFR through formation of 
a complex. Colocalisation studies of EGFR and kindlin-1 were performed in the 
presence and absence of EGF to examine whether these proteins show colocalisation 
and if there is any changes to this localisation in response to EGF stimulation. 
Representative confocal images are presented in Figure 4.15 (a) from which 
Pearson’s colocalisation coefficient analysis was conducted as before. Analysis 
revealed in Figure 4.15 (b) indicates that EGFR shows some degree of colocalisation 
with both with the WT kindlin-1 and the kindlin-1-W612A mutant. After 15 min of 
EGF stimulation this colocalisation increased significantly. Following further 60 min 
stimulation, the level of colocalisation was reduced with the WT kindlin-1 but 
significantly less in the kindlin-1-W612A mutant. This suggests that there is a 
potential complex formed between EGFR and kindlin-1 and that the interaction may 
be increased during EGF-dependent cellular responses. Furthermore, the dissociation 






Figure 4.15: Kindlin-1 colocalises with EGFR and colocalisation increases after 
EGF stimulation.  
a) Representative confocal images of KS cells stably expressing mCherry-WT 
kindlin-1 (KS(1)+K1) or mCherry- kindlin-1-W612A (KS(1)+W612A) (red) with or 
without EGF treatment, fixed and stained for EGFR shown in green and F-actin in 
blue (Phalloidin 633). Images were analysed for colocalisation using Pearson’s 
correlation co-efficient analysis. Scale bar = 10 μm. b) % colocalisation shown in 
graph, Error bars are S.E.M., *  = P< 0.05, * *  = P< 0.005, * * * = P< 0.0001.  
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4.2.5 Kindlin-1 interacts with EGFR 
From the data collected so far it appeared that EGFR may potentially be an 
interacting partner of kindlin-1. To explore this hypothesis, GST pulldown 
experiments were carried out using GST tagged kindlin-1. A GST tagged 9 bp 
deletion mutant of kindlin-1 was also used for this experiment, as this mutant 
represents a unique mutation in a KS patient which is located within the F3 
subdomian of kindlin-1 and is predicted to be important in integrin binding.  
Pulldowns were performed with lysates from NHK control cells followed by 
immunoblotting. Data showed that EGFR is able to form a complex with kindlin-1 
and there was no difference in the levels of interaction between WT kindlin-1 and 
kindlin-1 9 bp deletion mutant (Figure 4.16 (a)). The interaction was quantified 
relative to GST alone control as demonstrated in Figure 4.16 (b).  
To validate the interaction between kindlin-1 and EGFR, and determine whether the 
interaction was direct, fluorescence resonance energy transfer (FRET) was analysed 
between EGFR-GFP and kindlin1-mCherry using fluorescence lifetime imaging 
microscopy (FLIM). FRET is the transfer of energy between two fluorophores in 
close proximity (less than 10 nm), in this case GFP-EGFR and mCherry-WT kindlin-
1 or mCherry-kindlin-1-W612A mutant. The efficiency of FRET was measured 
using FLIM which determines the change in the fluorescence lifetime of the donor 
molecule (GFP); if two proteins are interacting, the lifetime will decrease. The 
example images from the FRET analysis in Figure 4.17 (a) shows the GFP channel 
(the donor) of EGFR, the mCherry channel (acceptor) of kindlin-1 and also the 
lifetime map of GFP lifetime represented as a pseudocolour scale. The red colour in 
the map indicated when FRET was occurring (low lifetime) and blue areas indicated 
no FRET (higher lifetimes). The FRET efficiency was calculated in multiple cells, 
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pooled and plotted as a percentage as depicted in Figure 4.17 (b) under conditions of 
0 min, 10 min and 60 min EGF stimulation. The FRET analysis confirmed that 
EGFR is able to interact with kindlin-1. At 0 min there was higher FRET efficiency 
with the kindlin-1-W612A than the wild type kindlin-1. After 10 min of EGF 
stimulation the FRET efficiency more than doubles for both wild type (4% to 9.3%) 
and W612A kindlin-1 (7.1% to 14.9%) implying an increased level of interaction 
between EGFR and kindlin-1. Following 60 min of EGF stimulation the FRET 
efficiency decreased to 5.8% for the WT kindlin-1 and a smaller reduction to 12.1% 
for knidlin-1-W612A mutant. The data suggest that there is preferential binding of 
EGFR to kindlin-1-W612A mutant and that optimal binding occurs after 10 min 
EGF stimulation.     
    
 
















Figure 4.16: Kindlin-1 interacts with EGFR  
a) Western blot of pulldown with GST alone, GST-WT kindlin-1- and GST-kindlin-
1 9 bp deletion mutant from NHK lysate and probed with anti-EGFR antibody. 
Coomassie stained gels shows GST-tagged protein used for pulldown assay. b) 
Graph shows quantification of interaction of EGFR with GST-WT kindlin-1 or GST-




Figure 4.17: FRET analysis validates interaction between kindlin-1 and EGFR. 
FRET/FLIM analysis of interactions between EGFR-GFP and WT Kindlin-1-
mCherry or W612A kindlin-1-mCherry expressed in KS cells. a) Example images of 
GFP intensity channel, widefield image of mCherry acceptor and lifetime map of 
GFP lifetime shown as pseudocolour scale. Red area show low lifetime (FRET), blue 
is higher lifetimes (no FRET). Scale bar = 10 µm. b) Graph shows cumulative FRET 
efficiency data from >15 cells per treatment. Error bars are S.E.M., * = P< 0.05, * * 
= P< 0.005, * * * = P< 0.0001. FRET/FLIM experiment and analysis was done by 




The aim of this chapter was to analyse the role of kindlin-1 in the regulation of the 
receptor tyrosine kinase EGFR, as this protein was found to be reduced in KS 
keratinocytes through mass spectrometry analysis (Chapter 3). This was then further 
confirmed by western blotting and FACS analysis, which showed reduction in total 
and surface levels of EGFR, although there was no overall reduction at gene level. 
This indicates that protein is being produced normally in the cells but is subsequently 
degraded. Analysis of EGFR in normal and KS skin showed that EGFR was 
markedly reduced in the basal keratinocytes, the non differentiated cells, of KS skin, 
while all the differentiated cells above the basal layer have normal levels of EGFR. 
This suggests that basal cells routinely have EGFR, however this level is 
significantly reduced as a consequence of loss of kindlin-1. There are a few 
possibilities for why this occurs one explanation is that there are compensatory 
mechanisms in the differentiated cells. Cells undergoing differentiation go through 
transcriptional changes, for example in the skin integrins are downregulated and 
keratins are upregulated as the cells move suprabasally (Eckert and Rorke, 1989; 
Jones and Watt, 1993). Therefore, it is possible that proteins newly expressed in the 
differentiated cells compensate for the loss of kindlin-1. Another possibility of the 
difference of EGFR expression in different epidermal layers is that kindlin-1, which 
has been shown to be expressed higher in basal layers (Lai-Cheong et al., 2009a), is 
more important in these cells for regulating EGFR than in the upper layers. A change 
in EGFR localisation was also observed in KS cells, with the receptor being more 
highly localised to lysosomal compartments suggesting that EGFR is less efficiently 
recruited to, or maintained at, the plasma membrane to carry out its normal ligand-
binding function.  
143 
 
Further characterisation of EGFR signalling responses and the effects of EGFR 
downregulation in KS keratinocytes revealed functional roles for these changes. 
NHK cells treated with EGF (the main ligand of EGFR1 in keratinocytes) led to 
increased internalisation of EGFR, as detected by a significant reduction in surface 
levels. However, in KS keratinocytes the response was not as great as that seen in 
NHK. Immunoprecipitation assay showed that EGFR was still being phosphorylated, 
although at a reduced level due to total reduced levels of EGFR. This suggests that 
kindlin-1 is not involved in ligand binding or autophosphorylation of EGFR, the first 
steps that occur during signalling. However, there were clear defects in activation of 
downstream intracellular signalling, specifically in the MAPK pathway in KS cells 
following EGF stimulation. This reduced intracellular signalling may be explained 
by the reduction in EGFR levels in KS cells. Alternatively, it is possible that kindlin-
1 is required for initiation of specific signalling steps downstream of EGFR 
activation. Erk1/2 activation and phosphorylation require recruitment of a host of 
adaptor proteins and kinases to the EGFR including Grb2, Sos, and the GTPases Ras 
and Raf. Grb2 and Sos bind directly to the EGFR cytoplasmic domain following 
tyrosine phosphorylation. Given that loss of kindlin-1 does not inhibit the EGF-
induced tyrosine phosphorylation of EGFR, it would seem unlikely that this step in 
the cascade would be inhibited in KS cells. However, this would be important to 
determine in future studies. 
Functional studies were performed to analyse the behaviour of KS keratinocytes to 
EGF stimulation. Live imaging showed that after treatment with EGF, NHK cells 
rapidly contracted, showing large retraction fibres at the plasma membrane and then 
the cells rapidly start to spread out again after 10 minutes. KS keratinocytes, 
however, displayed a reduction in this initial contraction and there was an additional 
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delay in re-spreading after treatment. These data are consistent with previous reports 
demonstrating spreading defects in KS keratinocytes following re-plating on integrin 
ligands (Has et al., 2008). Furthermore, there was altered response in migration 
speed and persistence of KS keratinocytes. Firstly, KS cells showed significantly 
higher migration speeds than NHK, and NHK showed a significant increase in speed 
and persistence after EGF stimulation that was not seen in KS keratinocytes. The 
increased migration speed and persistence before EGF treatment in KS keratinocytes 
was not expected, as previous studies showed that KS keratinocytes display a 
reduced migration speed (Herz et al., 2006). An explanation for this inconsistency 
maybe due to the fact that the data in this thesis was collected by monitoring random 
migration, whereas other reports have analysed cell migration with in vitro wound 
closure or ‘scratch’ assays. Thus KS keratinocytes show delayed ability to close an 
in vitro scratch wound but as single cells, migrate faster. The biggest difference 
between these two assays lies in the fact that scratch wound assays rely on the use of 
cells as a monolayer, that have formed close cell-cell adhesive contacts, whereas 
single cells are analysed in random migration assays. Epithelial cell movement as a 
monolayer into scratch wounds requires collective communication and migration 
between cells. KS cells are known to have defective cell-cell adhesion both in vivo 
and in vitro, and indeed data from this thesis have shown that these cells exhibit 
reduced E-cadherin levels. This may explain the reason for the reduced migration 
into wounds, but not as single cells. Indeed as kindlin-1 is known to activate 
integrins, it seems plausible that the reduced integrin activation in KS cells could 
result in lower adhesion and thus faster motility. The expression of WT kindlin-1 in 
KS keratinocytes was able to rescue normal migration speed and persistence and 
response to EGF in these cells, whereas kindlin-1-W612A was unable to do this. 
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This also strongly supports kindlin-1:integrin binding as being a critical complex in 
the control of keratinocyte migration.  
The reduction of total EGFR levels was not due to downregulation at gene level but 
is predicted to be due to increased degradation via the lysosomal compartment in KS 
keratinocytes.  This was validated by showing EGFR levels could be rescued by the 
lysosomal inhibitor leupeptin and also supported by immunofluorescence studies 
showing increased localisation of EGFR with LAMP-1 in KS keratinocytes. The 
data here therefore suggest that kindlin-1 is involved in the recycling of EGFR, and 
that kindlin-1 potentially acts to retain EGFR at the membrane, or increase EGFR 
traffic back to the plasma membrane from recycling endosomes. Stable expression of 
WT kindlin-1 and kindlin-1-W612A in the KS keratinocytes was able to 
significantly rescue total levels of EGFR and its localisation in the cells, 
demonstrating a direct link between kindlin-1 and EGFR. Furthermore, surface 
levels of EGFR and internalisation were also rescued by wild type and W612A 
kindlin-1 expression. These data also suggest that kindlin-1 regulation of EGFR is 
not dependent upon kindlin-1-integrin binding. Interestingly, the kindlin-1-W612A 
non-integrin binding mutant actually led to enhanced retention of kindlin-1 at the 
plasma membrane following EGF stimulation. This suggests that kindlin-1 that is 
constitutively non-integrin associated may be more effective at associating with 
EGFR at the membrane, and potentially cycling of kindlin-1 between integrin and 
non-integrin compartments plays a key role in allowing kindlin-1 to play a role in 
EGF signalling. As confocal analysis here demonstrates that kindlin-1 is rapidly lost 
from adhesions following EGF treatment, and instead localises in membrane ruffles, 
this would suggest that EGF itself may induce kindlin-1 to cease its localisation with 
integrins. This may potentially free kindlin-1 up to associate with other binding 
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partners such as EGFR. Further analysis of the relationship between kindlin-1 and 
EGFR show that EGFR colocalises with WT kindlin-1 but at an increased level with 
kindlin-1-W612A. Most interestingly the level of colocalisation of kindlin-1-W612A 
does not reduce to levels similar to WT kindlin-1 further suggesting a preferential 
association function of the non-integrin binding mutant.  
The colocalisation and binding studies between kindlin-1 and EGFR infer that they 
may possibly be interaction partners. Also the presence of a NPXY motif in the 
cytoplasmic domain of EGFR similar to the kindlin-1 binding motif found in β 
integrin cytoplasmic domains would seem a likely candidate for the binding site for 
kindlin-1. GST pulldown assays with purified kindlin-1 implicated EGFR as a 
potential interaction partner for kindlin-1, although purified EGFR would need to be 
used to comfirm the interaction is direct biochemically. This assay also showed that 
binding was not altered with a 9 bp deletion mutant of kindlin-1 within a domain 
adjacent to the integrin binding site in the F3 subdomain. To validate these findings 
and confirm the interaction, FRET/FLIM analysis was also used. The FRET 
efficiency, which was an indicator of interaction between two proteins, verified 
EGFR and kindlin-1 as binding partners in intact keratinocytes. Moreover, it showed 
preferential binding of EGFR to kindlin-1-W612A, as hypothesised from the EGFR 
surface levels analysis following EGF treatment. The interaction seems to be optimal 
after 15 min of EGF stimulation during which EGFR is internalised into the cells, 
thus binding occurs mostly in the cytoplasm as opposed to the membrane. This 
further supports the idea of a non-integrin binding pool of kindlin-1 directly 
associating with EGFR to retain the receptor at the membrane; this may in turn 
promote more efficient EGFR signalling. 
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In this present study, important observations are made about the function of kindlin-
1. The ability of kindlin-1 to rescue EGFR from degradation in KS keratinocytes 
implied that it has a function in EGFR recycling. Kindlin-1 interaction with EGFR 
may facilitate localisation of EGFR back to the membrane and further degradation 
via the lysosomal pathway. These effects are enhanced with the use of kindlin-1-
W612A supporting the proposal that this function is clearly independent to integrin 
signalling. These data provide insight into a novel role for kindlin-1 in regulating a 
growth factor receptor, and provide a potentially exciting new mode of cross-talk 


























Chapter 5:  
Characterisation of a novel KS mutation in kindlin-1 















Previous studies have shown that all of the kindlin protein family members are able 
to interact with β1 and β3 integrin subunits and that kindlin-3 additionally binds to 
the β2 integrin subunit (Kloeker et al., 2004; Shi et al., 2007; Moser et al., 2009a). 
Integrins are heterodimeric integral membrane receptors consisting of α and β 
subunits. Integrin activation and subsequent downstream signalling has been 
proposed to occur via two distinct mechanisms. Firstly, “outside-in” signalling 
whereby the ligands that bind to the extracellular domain of integrin cause a 
conformational change that leads to subsequent changes within the cell. Secondly 
“inside-out” signalling has been proposed as a mechanism by which binding of 
intracellular adaptor proteins to the β integrin cytoplasmic tail can lead to subsequent 
changes in the conformation and affinity of the integrin receptor for its ligands 
(Harburger and Calderwood, 2009). Kindlin-1 has been proposed to act in concert 
with talin to regulate integrin activation by changing it affinity to ligand binding 
(Moser et al., 2009b). Talin consists of a N-terminal globular head domain and a C-
terminal rod domain. The head domain comprises the FERM domain, homologous to 
that found in kindlins (Calderwood, 2004). The F3-PTB like domain of talin required 
for integrin binding is autoinhibited by the rod domain, and upon calpain cleavage or 
binding to phosphatidylinositol 4, 5-bisphosphate (PIP2), F3-PTB is exposed to 
interact with β integrin subunit tail and induce activation (Martel et al., 2001; Yan et 
al., 2001). The attachment of talin is proposed to lead to the separation of α and β 
subunits cytoplasmic domains resulting in activation. Similarly, kindlins also bind to 
the β integrin cytoplasmic tail but at the membrane distal NxxY motif leading to an 
as yet unknown conformational change in the receptor (Kloeker et al., 2004). The F3 
subdomains of talin and kindlin-1 are key to binding the cytoplasmic tail of β 
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integrin (Calderwood et al., 2002; Shi et al., 2007) and it is hypothesised that 
kindlin-1 is recruited to the β integrin tail by its PH domain which may bind to a 
phosphoinositide, another possibility is recruitment through phosphorylation (Moser 
et al., 2009b). Forty six different mutations in the KIND1 gene have been identified 
in KS patients to date (Has et al., 2011a). A number of these result in mutated or 
truncated protein being produced that has a clear effect on kindlin-1 function, but the 
specific domains within kindlin-1 that contribute to this function remain unexplored. 
Moreover, it is currently unclear how talin and kindlin-1 cooperate to activate 
integrin, but there are three possibilities which have been suggested. First, talin and 
kindlin-1 bind successively to one β integrin cytoplasmic tail and cause change in 
ligand binding affinity. Secondly, both proteins may bind at the same time and 
provide the same effects. Thirdly, talin and kindlin-1 may bind to different β integrin 
tails resulting in the clustering of integrins and cross-talk between the two proteins 
(Moser et al., 2009b).  Talin and kindlin have not yet been shown to interact with 
each other, but studies show that they both interact with the β integrin tail at the 
same time (Bledzka et al., 2012). Further investigation is needed to fully explain 
how the mechanism of integrin activation is achieved.  
Kindlin-1 is also able to form a complex with migfilin, a LIM-containing focal 
adhesion protein (Lai-Cheong et al., 2008). Migfilin can bind to filamin which in 
turn binds to actin, therefore providing an indirect interaction between kindlin-1 and 
the actin cytoskeleton (Lai-Cheong et al., 2008; Malinin et al., 2010). Migfilin is 
proposed to be a promoter of integrin activation as it binds to the same region in 
filamin where integrin β cytoplasmic tails bind (Ithychanda et al., 2009) and has 
been shown to rescue activation of integrin that was inhibited by filamin (Das et al., 
2011). Another binding partner of kindlin-1 is kindlin-2, although the functional 
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relevance of this interaction has yet to be elucidated (Lai-Cheong et al., 2008). FAK 
and α-actinin have also been shown to interact with kindlin-1, although in depth 
analysis has not been done to further explore the link between these proteins (Has et 
al., 2009). These interactions might be involved in the mechanisms by which 
kindlin-1 conveys outside-in signals and links integrins to the actin cytoskeleton.  
 ILK has been shown to interact with kindlins, but so far evidence is exclusive to the 
kindlin-2 family member (Mackinnon et al., 2002; Tu et al., 2003). ILK is an 
adaptor protein that also interacts with β integrins after its activation where it serves 
to interact and recruits other proteins to focal adhesions. This includes kindlin-2, 
PINCH and the F-actin binding proteins parvin and paxillin. In this way ILK links 
integrins with the cytoskeleton and growth factor signalling pathways (Wu and 
Dedhar, 2001). ILK may potentially be a binding partner of kindlin-1 as both 
kindlin-1 and kindlin-2 appear to share many of the same binding partners.  
The information about the various binding partners of kindlin-1 provides some 
insight into its function and to some extent explains the phenotypes observed in KS 
patients. However, there is a need to investigate other potential interaction partners 
of kindlin-1 that will help to fully understand the biological role of kindlin-1. The 
aim of this chapter was to analyse potential new binding partners for kindlin-1 with a 
view to shedding more light on how kindlin-1 may control keratinocyte function 
through integrin dependent and independent events. One novel mutation in kindlin-1 
within the F3 subdomain, identified in a KS patient, was also employed to help 







5.2.1 GST pulldown assay and mass spectrometry analysis to identify potential 
kindlin-1 interaction partners 
To investigate one of the initial aims to elucidate novel binding partners of kindlin-1, 
GST pulldown assays were performed. This required the production of GST tagged 
WT kindlin-1 and the 9 bp deletion mutant (a novel mutation identified in a single 
KS patient) purified protein produced in E-coli. The purified proteins were run on a 
SDS PAGE gel and stained with coomassie to validate the size, integrity and 
estimate concentration. The purified protein bands can be seen in the example gel in 
Figure 5.1 (a). The proteins were then used as bait in GST pulldown assays, whereby 
the proteins were incubated with lysates from NHK or KS keratinocytes. The 
resulting bound fractions of proteins bound to kindlin-1 were run on a SDS-PAGE 
gel, silver-stained, and the band profiles between samples compared. The red boxes 
in figure 5.1 (b) highlight the bands selected for mass spectrometry analysis as these 
were differentially associated with wild-type versus mutant kindlin-1. The mass 
spectrometry data revealed a number of interesting target proteins and potential 
interacting partners including kindlin-2, ILK, peptide sequences within the talin 






Figure 5.1: GST pulldown assay followed by mass spectrometry reveals 
potential interacting partners of kindlin-1 
a) 10% coomassie stained acrylamide gel of purified GST tagged WT kindlin-1 and 
kindlin-1 9 bp deletion mutant b) A silver-stained 12% acrylamide gel showing 
samples from a pulldown assay using GST–kindlin-1 or GST kindlin-1 9 bp 
pulldown with NHK and KS keratinocyte lysates. GST alone was used as a negative 
control. Red boxes highlight protein bands that were analysed with mass 
spectrometry. c) Table of protein targets identified from the gel bands by mass 
spectrometry analysis that are potential binding partners of kindlin-1.  
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5.2.2 Validation of potential interaction partners  
In order to validate the results obtained from the mass spectrometry data, the GST 
pulldowns were repeated but this time used for immunblotting analysis and probed 
for the specific target proteins (Figure 5.2 (a)). Quantification of the interaction of 
the target protein with kindlin-1 relative to GST alone from multiple experiments is 
displayed in Figure 5.2 (b). Previous studies have already shown that kindlin-1 is 
able to bind to bind to kindlin-2 (Lai-Cheong et al., 2008) and these pulldown 
experiments further confirm an interaction between kindlin-1 and kindlin-2 although 
there were no differences in binding between WT and the 9 bp mutant kindlin-1. 
There was also an interaction seen between kindlin-1 and ILK, in contrast to other 
reports that had previously only shown an interaction between kindlin-2 and ILK. 
There was also no change in interaction between ILK and the WT kindlin-1 or the 
kindlin-1 9 bp mutant. The pulldown experiments also verified an interaction with 
talin. The anti-talin antibody used here recognises the head domain of talin, and thus 
the interaction can be detected as being specific to the head domain either alone or 
present as part of the full length talin. In addition, there was a significant reduction 
of the head domain of talin binding to the kindlin-1 9 bp mutant compared to WT 
kindlin-1. Talin has not been previously reported to bind to kindlins so I chose to 






Figure 5.2: GST pulldown followed by immunoblotting validates mass 
spectrometry results 
a) GST pulldown with WT kindlin-1 and kindlin-1 9 bp deletion mutant, analysed 
using western blotting and probed for kindlin-2, ILK and talin. GST alone was used 
as a negative control. b) Quantification of GST pulldown assays, with binding 








5.2.3 Talin is a potential novel binding partner of kindlin-1     
Further analysis was required to validate talin as a potential binding partner of 
kindlin-1 and more specifically to confirm that the binding is specific to the talin 
head domain. HEK 293T cells overexpressing RFP-talin head (N-terminus FERM 
domain, residues 1-433) were used to carry out GST pulldown assay with WT 
kindlin-1 and kindlin-1 9 bp mutant proteins.  The western blot analysis displayed in 
Figure 5.3 clearly shows an interaction between the talin head domain-RFP and 
kindlin-1. It also shows that the kindlin-1 9 bp mutant results in a lower level of 
interaction as seen before.  
In addition to the pulldown experiments, an immunoprecipitation assay was 
performed to analyse the interaction between kindlin-1 and talin in keratinocytes. An 
anti-GFP antibody was used to precipitate out kindlin-1-mCherry expressed in KS 
cells and its complex of binding partners and resultant complexes were subsequently 
probed for talin. There was no available anti-mCherry antibody but since it shows a 
high homology with GFP, the anti-GFP antibody was used to detect the mCherry 
protein. mCherry alone expressing cells were used as a control for non-specific 
binding. The immunoprecipitation assay shows further confirmation that the talin 












Figure 5.3: Kindlin-1 interacts specifically with the head domain of talin. 
Western blot of GST pulldown with GST-WT kindlin-1 or GST-kindlin-1 9 bp and 





Figure 5.4: Immunoprecipitation of kindlin-1 with talin further validates 
complex formation. 
Western blot of immunoprecipitation assay of kindlin-1 from NHK lysates stably 
expressing mCherry-kindlin-1 and probed for talin. Rabbit IgG fraction and lysates 










5.2.3 Talin levels are increased in KS keratinocytes 
Given the identification of this novel interaction, lysates from KS keratinocytes were 
analysed to determine whether loss of kindlin-1 resulted in any changes in total 
levels of talin. Firstly, the expression of the TLN1 gene was evaluated using semi-
quantitative PCR.  Analysis revealed increased expression of TLN1 mRNA in 
keratinocytes from KS patients compared to controls (Figure 5.5 (a)). Analysis of 
total protein levels of talin by immunoblotting also demonstrated an increase in 
expression level of both full length and head domain in KS keratinocytes (Figure 5.5 
(b)). Quantification of full length talin (~270 kDa) demonstrated a significant 
increase in this molecular weight species of ~100% in both KS keratinocyte cell 
lines (Figure 5.5 (c)).     
The localisation of talin was subsequently analysed by immunostaining and confocal 
microscopy in NHK and KS cells. Example images are shown in Figure 5.6. Talin 
localised mainly at focal adhesions at the periphery of the NHK cells but was also 
present in the cytoplasm. This was also seen in KS keratinocytes as there was no 







Figure 5.5: Talin expression is increased in KS keratinocytes. 
Characterisation of the gene and protein level of talin NHK vs. KS keratinocytes. a) 
semi-quantitative RT-PCR of TLN1 mRNA levels in NHK and KS keratinocytes. b) 
Western blot example of full-length talin total protein level in NHK vs. KS 
keratinocytes. c) Graphs show densitometry analysis of talin levels. Error bars are 





Figure 5.6: Talin localisation does not change in KS keratinocytes.     
Confocal images of fixed NHK or KS keratinocytes. Endogenous talin is shown in 
green and F-actin in red (Phalloidin 633). Talin and phalloidin channels have been 









5.2.4 Talin levels in KS keratinocytes are rescued by re-expression of kindlin-1  
The generation of KS cells re-expressing mCherry-kindlin-1 (see Chapter 4) allowed 
for further investigation into the link between talin levels and kindlin-1. KS 
keratinocytes stably expressing either WT kindlin-1 or kindlin-1-W612A (the non-
integrin binding mutant) were analysed for talin levels. Figure 5.7 (a) is an example 
western blot showing talin levels in NHK and KS keratinocytes alongside KS cells 
expressing WT kindlin-1 or kindlin-1-W612A. Data demonstrates a significant 
reduction of talin levels, (Figure 5.7 (b)) suggesting both WT kindlin-1 and kindlin-
1-W612A are able to regulate levels of talin. 
Furthermore, analysis of KS keratinocytes by confocal microscopy demonstrated that 
mCherry-WT kindlin-1 colocalised with talin at focal adhesions. However, mCherry-
kindlin-1-W612A was not localised at focal adhesions as has been shown previously 






Figure 5.7: Expression of WT kindlin-1 or Kindlin-1-W612A restores talin 
levels in KS keratinocytes.  
a) Western blot analysis of full-length talin total protein levels in NHK or KS 
keratinocytes stably expressing mCherry alone, mCherry-WT kindlin-1 or mCherry-
kindlin-1-W612A mutant. b) Graphs show densitometry analysis of talin levels from 





Figure 5.8: Talin localisation rescued by kindlin-1 expression in KS 
keratinocytes.     
Confocal images of fixed KS keratinocytes expressing mCherry alone, mCherry-WT 
kindlin-1 or mCherry-kindlin-1-W612A. Endogenous talin is shown in green, 
mCherry in red and F-actin in blue (Phalloidin 633). Talin, mCherry and phalloidin 
channels have been zoomed in from the original image as highlighted by the white 











In this chapter I have addressed one of the major aims of my thesis: to identify novel 
binding partners of kindlin-1. Very few binding partners have been reported for 
kindlin-1 and more information is needed about how this protein is regulated and 
how it can control integrin-dependent and potentially independent functions.  
The GST pulldown technique was employed as it is a useful starting tool for 
identifying potential protein-protein interactions. GST pulldowns were used as a 
screening method to identify new interacting proteins for kindlin-1, as well as those 
proteins that associate differentially with a mutant kindlin-1 identified in a KS 
patient. Purified GST-tagged WT kindlin-1 and kindlin-1 9 bp mutant were used to 
precipitate the complex of proteins bound to kindlin-1 from NHK or KS lysates. The 
aim was to compare band profiles from WT kindlin-1 and the kindlin-1 9 bp mutant 
protein pulldowns to identify changes in interactions due to the mutation and 
potentially provide further insight into kindlin-1 function. Mass spectrometry was 
used to analyse the protein bands that showed differential binding. The resultant 
peptide coverage of the identified bands revealed a number of interesting target 
proteins; kindlin-2, ILK, Ste-20 like kinase, tubulin (alpha and beta) and talin 
(FERM domain). Kindlin-2 has previously been characterised as a binding partner of 
kindlin-1 (Lai-Cheong et al., 2008) and this study has further validated this 
interaction. The functional consequence of this interaction is still unclear, but 
potentially may provide a mechanism by which kindlin family members are able to 
regulate one another. Other FERM domain proteins are known to undergo self-
association (such as talin and ezrin) and potentially dimerisation, and this is thought 
to restrict access for regulatory and signalling binding partners. In the case of ezrin, 
this autoinihbition is released through control of a c-terminal phosphorylation site 
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(T567, through protein kinase C; (Wald et al., 2008)). Whilst the phosphorylation 
status, and self-association of kindlin proteins in intact cells remains unknown, this 
mechanism of regulation would be important to study in future to understand how 
kindlin proteins may co-operate with one another to control cellular function.  
ILK has not previously been shown to interact with kindlin-1 but is a known binding 
partner of kindlin-2 (Montanez et al., 2008). This study described ILK as an 
interacting partner of kindlin-2 and that ILK recruitment to focal adhesions depends 
on binding to kindlin-2. Furthermore, ILK has been shown to act as a molecular 
switch in conjunction with migfilin as a regulator of integrin activation (Ithychanda 
et al., 2009; Das et al., 2011). GST pulldown analysis in this thesis has established 
that ILK is also able to interact with kindlin-1, and it is possible that this interaction 
may have similar function to the interaction between ILK and kindlin-2 in 
recruitment of ILK to focal adhesions.  Given that keratinocytes express both 
kindlin-1 and -2 it would seem unlikely that ILK is no longer targeted to focal 
adhesion in KS cells, as kindlin-2 should be sufficient to localise ILK. However, it 
would be important to analyse the localisation and dynamics of ILK in KS cells in 
more detail in future to determine whether kindlin-1 plays a specific role in this 
context, and one that kindlin-2 cannot compensate for. Interestingly, a recent study 
has highlighted a role for ILK in controlling keratinocyte responses to EGF (Ho and 
Dagnino, 2012). This study demonstrated that ILK and β1 integrins are required for 
keratinocytes to establish front-rear polarity in response to EGF in a rac-dependent 
manner, and that this in turn dictates epithelial cell migration. Given the findings in 
Chapter 4 of this thesis, demonstrating a potential interaction between EGFR and 
kindlin-1, this presents an interesting possibility that kindlin-ILK-EGFR complexes 
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may be required for efficient keratinocyte responses to EGF. This will be an 
important hypothesis to test in future studies. 
Another potential novel binding partner for kindlin-1 identified in this study was 
talin. This protein was a particularly interesting target as it is a very well 
characterised focal adhesion protein that contains a N-terminal FERM domain 
(similar to kindlins), and along with kindlins is also known to play a key role in 
activation of integrins through inside-out signalling. Further analysis with GST- 
pulldown  and immunoprecipitation assays showed that interaction was specific to 
the head domain of talin and this interaction was considerably effected with the 
kindlin- 1 9 bp mutant. These experiments do not, however, confirm that the 
complex between kindlin and talin is direct and not mediated through an additional 
third binding partner. In order to analyse this, GST kindlin-1 pulldowns would need 
to be repeated using recombinant purified fragments of talin. An obvious potential 
intermediate binding partner would be β1 integrin, as both proteins are known to 
associate with the cytoplasmic domain of this receptor. However, 
immunoprecipitating either talin or kindlins with integrins is very difficult in the 
absence of chemical cross-linkers as the binding is very sensitive to detergent 
extraction. Integrins would therefore seem to be an unlikely potential molecular 
bridge to explain the interaction data in this thesis. It is also not clear from the 
pulldown data presented here whether the complex depends upon the ability of 
kindlin-1 to bind integrins. The binding site on the integrin cytoplasmic domain for 
talin and kindlins are distinct so it is possible that the two molecules can occupy the 
same integrin tail, and potentially bind to one another at the same time. However, 
another possibility is the interaction between kindlin-1 and talin provides a 
mechanism to recruit or remove these proteins to and from the plasma membrane.  It 
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will be important to test direct interactions and potential mediators of this complex 
formation in future studies.  
Further investigation into the levels of talin in KS keratinocytes showed that mRNA 
and total protein levels were significantly upregulated in these cells. This was also 
supported by immunofluorescence analysis, which showed increased intensity of 
talin staining in KS cells.  Expression of both WT kindlin-1 and kindlin-1-W612A in 
KS cells was able to significantly reduce talin levels back to those seen in NHK. 
These data raise the possibility that talin is being upregulated by KS cells to 
compensate for the lack of kindlin-1. This would be particularly important in the 
context of integrin activation. However, increased talin levels cannot make up for the 
loss of kindlin-1 as integrin activation in KS cells is significantly lower than that in 
NHK (Lai-Cheong et al., 2009a). This further supports the concept that both talin 
and kindlins are required for co-operative induction of maximum integrin activity. 
Moreover, re-expression of kindlin-1-W612A resulted in rescue of normal talin 
levels, suggesting that kindlin-1 has an important role outside of the association with 
integrins in controlling talin levels. Indeed, kindlin-1 may play a more direct role in 
the regulation of talin transcription, potentially through regulating specific 
transcription factors. Given the fact that the GST pulldown data in this thesis also 
suggests talin and kindlins form a complex, this association may also act to regulate 
levels of talin via a negative feedback mechanism. The discovery of this interaction 
adds a new dynamic to integrin activation and regulation and the roles that talin and 









Chapter 6: General discussion and 








6.1 Kindlin-1 regulates protein levels 
6.1.1 Proteomic analysis of KS keratinocytes    
The data in this thesis have identified a number of proteins that showed reduced 
expression in patient-derived KS keratinocytes. The differential expression of these 
proteins, which include E-cadherin, TSP-1 and EGFR, were initially detected using 
silver staining of whole cell lysates, followed by mass spectrometry and 
subsequently validated by western blotting. Mass spectrometry is a powerful 
analytical technique that is based on the detection of the molecular mass of a 
molecule. The method works by generating charged particles by ionising the 
chemical compound and then measuring the mass to charge ratio. This information 
then permits the mass of particles to be calculated and subsequently the elemental 
composition of a molecule can be determined. Many studies utilise this technique to 
identify differentially regulated proteins, novel interaction partners, and downstream 
molecules of a particular pathway. An example of this includes a study which used a 
co-immunoprecipitation assay followed my mass spectrometry to identify interaction 
partners for the N-terminal region of periplakin (a cytoskeletal linker protein), with 
identification of plectin as a target protein (Boczonadi et al., 2007). Another example 
is the use of 2D gel electrophoresis followed by mass spectrometry to reveal proteins 
that play a role in keratinocyte transformation and contribute towards tumourigenesis 
(Akgül et al., 2009). These examples highlight the value and effectiveness of this 
technique. Mass spectrometry proved to be a highly useful tool for analysing isolated 
protein bands in my study, however, there were some limitations associated with it. 
The technique is a very sensitive one and it detected a number of non-specific 
proteins in each sample, largely due to the fact that it is difficult to fully resolve the 
bands excised from the SDS-PAGE gels to isolate single proteins. However, despite 
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this limitation a number of proteins identified were subsequently shown to be 
significantly reduced in the KS keratinocytes. Those proteins that were reduced in 
KS keratinocytes, namely TSP-1 and EGFR, were not downregulated at the gene 
level, as confirmed by semi-quantitative RT-PCR. This highlights the strength and 
importance of the application of proteomics methods as these targets would not have 
been detected if only a transcriptomic or gene chip approach had been taken. Gene 
chip analysis (or microarrays) is a useful tool to determine the gene expression 
profiles between different samples; it provides important information about genes as 
well as pathways that are involved in biological processes. For example, the use of 
microarray allowed the detection of kindlin-1 as a TGF-β inducible gene (Kloeker et 
al., 2004). Another example of the use of this technique was in determining the 
effects of mutant keratin 5 and 14 in EB simplex. This allowed analysis of the 
changes in expression of other genes to explain some of the underlying mechanisms 
and other aspects of the EB simplex associated pathology (Liovic et al., 2009). They 
detected a downregulation of various genes that encode components of the cell 
junction, which they proposed to indirectly contribute to the blistering and skin 
fragility in the EB simplex patients (Liovic et al., 2009). However, a drawback of the 
microarray analysis technique is that strong gene expression resulting in abundant 
mRNA does not necessarily result in abundant protein expression or activation. 
Thus, key information about the functional molecules may be missed, which can be 






6.1.2 Kindlin regulation of protein levels is integrin-dependent and independent  
Both TSP-1 and EGFR were significantly reduced in two KS keratinocyte cells lines 
in comparison to NHK cells. Furthermore, the localisation of these proteins were 
also disrupted in skin and cells from KS patients. TSP-1 was retained at the 
membrane of the KS keratinocyte cells and was not secreted from the cells or 
deposited in the same pattern as with NHK cells. Re-expressing TSP-1 into KS 
keratinocytes was unable to rescue the localisation and secretion pattern in these 
cells indicating that the defect lies not only in the regulation of TSP-1 but perhaps 
also in its secretory mechanism. However, the introduction of WT kindlin-1 was able 
to partially rescue TSP-1 levels as well as its deposition and secretion from the cells, 
thereby providing a link between kindlin-1 and TSP-1 regulation. Interestingly, 
expression of the kindlin-1-W612A non-β1 integrin binding mutant was unable to 
rescue TSP-1 expression and deposition in KS keratinocytes, highlighting the 
importance of integrin-kindlin binding and potentially implicating integrin activation 
in the process of TSP-1 regulation and function. It would be important to test this 
relationship by directly activating integrins in KS keratinocytes to test whether this 
can upregulate TSP-1 expression levels and also its deposition. This could be done 
by adding exogenous Manganese (Mn), which is able to activate integrins 
independently of inside-out signalling through the metal-ion binding site within the 
extracellular domain of the receptor. Alternatively, mutations could be introduced 
into the β1 integrin subunit which can cause constitutively active or inactive 
integrins. It would also be interesting to determine whether conditional loss of 1 
integrins in keratinocytes, or mutation of the cytoplasmic domain responsible for 
binding to kindlin-1, results in a similar loss of TSP-1 levels. Previous studies have 
shown that β1 integrin may regulate TSP-1 expression. For example, the 
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downregulation of 1 integrin in prostate cancers resulted in a downregulation of 
TSP-1 (Goel et al., 2009), indicating that 1 integrin downstream effectors may 
contribute to the TSP-1 pathway. However, the mechanism and the particular 
signalling molecules involved need further investigation.   
Despite the greatly reduced TSP-1 protein levels in KS keratinocytes, TSP-1 mRNA 
levels were normal compared to NHK controls. This finding raises the possibility 
that TSP-1 may be degraded in these cells, potentially due to lack of proper secretion 
and incorporation into the ECM. Further investigation of this possible degradation 
would require use of proteasomal or lysosomal inhibitors to assess their ability to 
rescue TSP-1 levels. Any rescue observed would strongly suggest that TSP-1 
secretion and degradation is regulated through kindlin-1-mediated integrin 
activation. The fact that kindlin-1 regulation of TSP-1 appears to be entirely integrin-
dependent raises the possibility of a new mechanism through which β1 integrin 
activation might act to stabilise TSP-1 and thereby protein levels in the skin.  
Surface levels of EGFR were also found to be significantly reduced in KS 
keratinocytes and in the basal cells of KS patient skin. More detailed analysis in cells 
revealed increased EGFR localisation at the perinuclear region. In addition, KS 
keratinocytes showed altered responses to EGF stimulation, as EGFR was not 
internalised and the localisation did not change as expected with prolonged 
stimulation with EGF, and as seen in NHK cells. Moreover, analysis of downstream 
signalling molecules of the EGFR transduction pathway showed that ERK 
phosphorylation was greatly reduced suggesting defective EGFR signalling or 
activation. There is a possible link between the observed TSP-1 reduction and 
defects in EGFR signalling in KS patients. Expression of TSP-1 is upregulated in 
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response to various growth factors including PDGF, EGF, TGF-α, TGF-β and bFGF 
(Majack et al., 1985; Nickoloff et al., 1988; Penttinen et al., 1988; Donoviel et al., 
1990). Studies have shown that TGF-β1 can upregulate levels of TSP-1 through the 
p38 MAP kinase pathway (Okamoto et al., 2002). Moreover, both EGF and TGF-α 
were also shown to enhance TSP-1 expression in human keratinocytes. TGF-α, but 
not EGF, altered expression by changing mRNA stability (Nickoloff et al., 1988). 
This study suggested that multiple growth factors and ECM components can interact 
to regulate keratinocyte behaviour in the skin, as the EGF-stimulated keratinocyte 
proliferation was associated with the induction of TSP-1 biosynthesis (Nickoloff et 
al., 1988). Therefore, a loss of EGFR signalling, as observed in KS keratinocytes, 
may contribute to the loss of expression of TSP-1. EGFR appears to be regulated by 
an altogether different mechanism to that of TSP-1. Both the WT kindlin-1 and 
kindlin-1 W612A non-β1 integrin binding mutant were able to rescue EGFR total 
and surface levels and also its response to EGF stimulation. These data suggest that 
kindlin-1 is able to regulate EGFR in a totally integrin independent manner.  
The role of kindlin-1 in E-cadherin regulation was not investigated further in this 
thesis due to time constraints. However, the potential regulation of E-cadherin by 
kindlin-1 does offer a potentially interesting new insight into explaining some of the 
phenotypes seen in KS keratinocytes. E-cadherin is a protein found in adherens 
junctions that mediates cell-cell adhesion in a calcium-dependent manner. E-
cadherin, in particular, plays a critical role in maintaining epithelial cell and tissue 
structure (Roy and Berx, 2008). As detected by mass spectrometry followed by 
western blotting (Results Chapter 1 of this thesis), E-cadherin was significantly 
reduced in both of the KS keratinocyte cell lines. It is possible that the epithelial 
integrity in KS patients is compromised due to a loss of E-cadherin and consequent 
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disruption in cell-cell junctions. Previous in vitro studies have demonstrated that E-
cadherin is involved in controlling cell migration and cell shape (Roy and Berx, 
2008). Thus, the loss of E-cadherin may also be a contributing factor in the changes 
noted in migration and cell shape in KS keratinocytes (Herz et al., 2006; Has et al., 
2009). Data in this thesis have also shown defects in cell-cell adhesion in KS 
keratinocytes that may be explained by the aberrant cell adhesions as well as the 
reduced migration seen in wound closure assays performed with these cells. 
Furthermore, there is evidence of cross-talk between cadherins and integrins 
especially in the processes of cell adhesion, motility and contractility. Cross-talk can 
occur through different ways, for example, the adhesion of the cell to specific ECM 
protein or to neighbouring cells can result in a change of expression and levels of 
particular proteins involved in regulating adhesion (Weber et al., 2011). In addition 
to this, integrins and cadherins also have convergence points downstream of their 
signalling pathways, which may include non-receptor tyrosine kinases, adaptors and 
scaffolding proteins and small GTPases (Weber et al., 2011). There is also some 
evidence to suggest that GFRs such as insulin-like GF-1 receptor (IGF1R) can 
facilitate lateral associations of integrins and cadherins thereby mediating a point of 
interaction between the two receptors (Canonici et al., 2008). This finding raises the 
possibility of a defective link between integrins, EGFR and E-cadherins leading to 
the defects seen in KS keratinocytes. A previous study has also shown a reduction in 
E-cadherin levels in KS keratinocytes, which along with other phenotypes displayed 
that correlated with an epithelial-to-mesenchymal transition (EMT) (Qu et al., 2012). 
Kindlin-1 has not been reported to be found in cell-cell junctions although its family 
member kindlin-2 does localise to cell-cell junctions and may be involved in the 
formation of these junctions (Ussar et al., 2006; He et al., 2011). It is plausible that 
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kindlin-1 may transiently localise to cell-cell junctions during certain conditions, but 
further analysis of this is required. It is also possible that kindlin-1 may regulate E-
cadherin through other proteins, perhaps via kindlin-2 which is a binding partner of 
kindlin-1 (Lai-Cheong et al., 2008). 
 
6.2 Kindlin regulation of growth factor receptor trafficking   
6.2.1 Lysosomal sorting of EGFR  
The data in chapter 4 focused primarily on the regulation of EGFR by kindlin-1 as it 
was shown that EGFR was significantly downregulated at the protein level in KS 
keratinocytes. It appeared that EGFR was being increasingly degraded in KS 
keratinocytes via the lysosomal pathway, as inhibition with leupeptin, but not 
MG132, resulted in increased levels in KS cells. The lysosomal pathway is a well-
established mechanism in which proteins are routed and packaged for intracellular 
degradation. After GFRs are internalised by clathrin-mediated endocytosis, they 
proceed along the endocytic pathway resulting in downregulation of the receptor 
(Sorkin and Goh, 2008; Platta and Stenmark, 2011). The endocytic pathway includes 
the early endosome, late endosome and the terminal lysosome that uses hydrolytic 
enzymes to digest macromolecules. Those receptors that are not activated are 
recycled back to the cell surface and are not further targeted for degradation (Platta 
and Stenmark, 2011). The internalisation of EGFR can be accelerated by acute 
stimulation with its growth factor ligand EGF, and the adaptor protein Grb2 has also 
shown to be important for this process (Jiang et al., 2003). Furthermore, EGFR can 
be targeted for degradation by Cbl proteins which signal the receptor for 
ubiquitination (Ettenberg et al., 2001). In the case of KS keratinocytes, the addition 
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of lysosomal inhibitors was shown to rescue the total level of EGFR confirming that 
it was indeed being degraded in these cells. Given the known synergy between 
integrins and GFRs, the initial hypothesis was that reduced kindlin-1-mediated 
integrin activation in KS keratinocytes was responsible for the downregulation of 
EGFR. However, experiments showed that kindlin-1-W612A was able to rescue 
EGFR levels and cellular responses to EGF stimulation as well as WT kindlin-1. 
There was also increased retention of EGFR in kindlin-1-W612A expressing cells, 
suggesting that EGFR regulation was not integrin-dependent. Moreover, EGFR 
showed preferential binding to kindlin-1 W612A as opposed to WT kindlin-1, as 
demonstrated by FLIM analysis, further pointing towards an alternative integrin-
independent function of kindlin-1. Taken together, the data suggest that kindlin-1, by 
binding to EGFR, may retain the receptor to the membrane and prevent its 
internalisation or that kindlin-1 may act as a signal to prevent EGFR sorting to the 
degradative pathway. Furthermore, EGF treatment leads to a change in the 
localisation of kindlin-1 from adhesion sites and an increase in binding to EGFR is 
also seen after prolonged stimulation. Thus, it appears that kindlin-1 may have a 
function separate from its role in integrin activation that is involved in the recycling 
of EGFR and the prevention of its degradation. The mechanism through which this 
occurs will be an important future area to study and may provide novel insight into 
cross-talk mechanisms between the two receptor pathways. 
 
6.2.2 Kindlin-1 dependent EGFR recycling  
EGFR contains a NPxY motif in the cytoplasmic domain that mediates the 
interaction with downstream signalling molecules such as Shc (van der Geer et al., 
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1995). This may also be a potential binding site for kindlin-1 as the latter has already 
been shown to bind to similar motifs in the cytoplasmic tails of β integrins 
(Harburger et al., 2009). This NPxY motif is also found in other GFRs such as nerve 
GFR (NGFR) and IGF-IR as well as in transferrin (TFR) and low-density lipoprotein 
(LDL) receptors (Hsu et al., 1994; van der Geer et al., 1995). In IGF-IR and 
transferrin receptors, NPxY has been shown to be an important recognition element 
for internalisation of the receptor, and mutations introduced in the motif showed that 
it was also crucial for receptor autophosphorylation and kinase activity (Hsu et al., 
1994). Furthermore, the NPxY motif in the LDL receptor was demonstrated to be a 
binding site for sorting nexin 17 (SNX17). SNX17 has been suggested to play a role 
in LDL receptor trafficking by sorting the receptor away from the degradative 
pathway and towards the recycling pathway as it is required for normal endosomal 
localisation of the receptor (Burden et al., 2004). Interestingly, SNX17 has recently 
been shown to bind to β1 integrin cytoplasmic tail on the NxxY motif after being 
recruited to early endosomes to aid its recycling back to the cell surface (Bottcher et 
al., 2012). Members of the SNX family appear to have differing roles in endosomal 
trafficking of proteins, for example, they have been identified as mediating EGFR 
lysosomal degradation, but also show opposing roles in that they can assist recycling 
of receptors such as transferrin back to the membrane (Kurten et al., 1996). The 
SNX family, including SNX17, all consist of a phox (PX) domain which facilitates 
interactions with phosphoinositides, such as those on the endosomal membrane, 
thereby allowing recruitment to these compartments (Carlton et al., 2005). In 
addition, SNX17 also posseses a FERM domain similar to that of kindlin and talin in 
which the PTB like-F3 subdomain has been demonstrated to form interactions with 
the NxxY motif found on the LDL receptor (Burden et al., 2004). Thus, kindlin-1 
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appears to possess some features in common with SNX17, and through its FERM 
domain, it too is able to interact with the same motifs on integrin receptors and, as 
data from this thesis has shown, potentially on EGFR.  
Kindlin-1 also has a PH domain, which raises the possibility that this part of the 
protein is involved in recruitment to the early endosomal membrane, as occurs with 
the PX domain in SNX17. The PH domain of kindlin-1 is able to interact with 
phosphatidylinositol 3,4,5-triphosphate (PIP3), which is found in lipid bilayers of the 
plasma membrane as well as in the endosomal membrane (Siegel et al., 2003; Yates 
et al., 2012b). PIP3 functions to promote recruitment and binding of proteins with a 
PH (or PX) domain. Thus, it is possible that the PH domain drives the recruitment of 
kindlin-1 to the cell surface and also possibly to the early endosome. Indeed the PH 
domain has been shown to be important for kindlin-dependent integrin activation as 
deletion of this domain results in impairment but not total inhibition of integrin 
activation (Yates et al., 2012b). Studies have also shown that kindlin-2 binds to PIP3 
and localises to PIP3-enriched membranes, so it is likely that its family member 
kindlin-1 also functions in this way (Liu et al., 2011). PIP3 is generated by 
phosphoinositide-3-kinase (PI3K), which converts phosphatidylinositol 4,5-
biphosphate (PIP2) to PIP3. PI3K is activated through EGF stimulation as EGFR can 
recruit PI3 via adaptor proteins, thus promoting the formation of PIP3 (Bazley and 
Gullick, 2005). It is feasible, therefore, that kindlin-1 activity is regulated by EGF-
mediated PI3K activity and local PIP3 production. Other domains in kindlin-1 also 
have functional importance. Notably, kindlin-1 has a region homologous to talin 
within its N-terminus region, known as F0, as well as an insert in its F1 subdomain 
that has previously not been observed (Goult et al., 2009). The kindlin-1 F0 domain 
has been shown to adopt a ubiquitin-like fold (Goult et al., 2009) and it has been 
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suggested that the N-terminal region in kindlins is the site for mediating interaction 
with ILK and migfilin (Larjava et al., 2008). The insert in the F1 subdomain has 
been shown to consist of a polylysine motif that allows kindlin to bind to negatively-
charged lipid head groups, thereby providing another means by which kindlins can 
be recruited to the membrane. This domain is also important for targeting to focal 
adhesions and integrin activation (Bouaouina et al., 2012). 
Kindlin-1 may potentially be a downstream signalling molecule of EGF stimulation, 
as EGFR activation after ligand binding may induce binding of kindlin-1 to its 
cytoplasmic tail and cause kindlin-1 phosphorylation. Kindlin-1 has previously been 
shown to be phosphorylated and so it may possibly be a target of intracellular kinase 
signalling (Herz et al., 2006). EGFR is known to have intrinsic kinase activity, thus 
presenting a means by which kindlin-1 is phosphorylated. This process may act as a 
signal for the recycling of EGFR and prevent further targeting for degradation, 
although it could also serve to recruit kindlin-1 to sites of EGFR localisation at the 





Figure 6.1: Proposed model for recycling of EGFR regulated by kindlin-1 
A model showing the recycling pathway of EGFR after stimulation with its ligand 
EGF. Kindlin-1 may be recruited and bind to EGFR after its activation and is sorted 
into the early endosome. However the presence of kindlin-1 may prevent further 
targeting and degradation to the lysosome, and therefore it is recycled back to the 
cell surface.    
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6.3 Kindlin-1 and talin interaction 
6.3.1 Kindlin-1 mediates talin-dependent activation of integrins  
The discovery in this thesis that kindlin-1 is able to interact with talin is a novel 
finding and raises many new questions regarding potential co-operation between 
these two integrin activation molecules. Experiments here have demonstrated that 
kindlin-1 binds specifically to the head (FERM) domain of talin and that this 
interaction is disrupted when a 9bp KS-patient derived mutation is deleted within the 
kindlin-1 F3 subdomain. Studies have shown that the talin head domain is key for 
the activation of integrins as this domain activates when expressed alone (Ma et al., 
2008; Montanez et al., 2008; Harburger et al., 2009). However, the same studies 
have also shown that kindlins are required for the enhancement and full activation of 
integrins (Ma et al., 2008; Montanez et al., 2008; Harburger et al., 2009). Thus, it 
appears that talin may be the primary mediator of integrin activation while kindlins 
primarily assist in this process. The role kindlin-1 plays in binding to talin may 
possibly be to promote recruitment of talin to the integrin sites or to enable it to 
localise in a correct position for binding to the NPxY motif on β integrin cytoplasmic 
tails. Another possibility is that kindlin-1 helps to stabilise talin and prevent its 
degradation and cleavage via calpain or trypsin by occluding sites of cleavage. The 
expression levels of talin are upregulated in KS keratinocytes possibly due to 
compensation effects, and re-expression of both WT kindlin-1 and kindlin-1-W612A 
was able to significantly reverse the increased protein level of talin. This suggests 
that kindlin-dependent regulation of talin is independent of kindlin-1 binding to 
integrins. One potential model might be that kindlin-1-talin binding occurs when 
kindlin-1 is not bound to β integrin cytoplasmic tail, enhancing the concept that 
kindlin-1 acts to promote talin-mediated integrin activation. The kindlin-1 9 bp 
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deletion represents a homozygous germline mutation found in a patient with KS who 
displayed the full clinicopathological features of this syndrome. This genotype-
phenotype correlation suggests that the deletion of the three amino acids encoded by 
this 9bp deletion is enough to cause significant disruption to the protein, resulting in 
defective function. The three amino acids in question are isoleucine, glutamic acid 
and phenylalanine, and are located within the F3 subdomain of the kindlin-1 FERM 
domain. The biophysical structure of full-length kindlin-1 has yet to be deciphered, 
although the crystal structure of other FERM domain containing proteins, including 
talin, have been resolved. The structure of the F3 subdomain of talin interacting with 
the β integrin cytoplasmic domain has been crystallised, confirming binding to the 
NPxY motif which previously was only shown biochemically (Anthis et al., 2009). 
The three amino acids identified as absent in the KS patient and studied in this thesis 
have not previously been implicated in interaction with integrins. However, the fact 
that the loss of these residues results in disruption to kindlin-1 function indicates the 
importance of these specific amino acids. When kindlin-1 is aligned with the protein 
sequence of talin, similar conserved amino acids are located in a loop after the β 
strand that is known to be involved in binding to the integrin cytoplasmic tail (Anthis 
et al., 2009). This location raises the possibility that disruption of the loop, by 
deletion of these amino acids, could cause changes to the structure or folding of the 
protein, thus affecting the integrin-binding capability of the protein. 
 
6.3.2 Interactions between FERM domain-containing proteins 
Other FERM domain-containing proteins have previously been shown to be able to 
bind to each other. For example, kindlin-1 and kindlin-2 bind to each other and are 
184 
 
also able to form dimers: the interaction between these two family members has been 
demonstrated in this thesis and in a previous report, although the functional 
relevance of this interaction is still unclear (Lai-Cheong et al., 2008). Furthermore, 
talin has been shown to form interactions with FAK, another FERM domain 
containing protein. This interaction is mediated through the F3 subdomain of talin 
and the specific binding site may overlap with that of β integrin (Lawson et al., 
2012). Thus, it is possible that the F3 subdomain of talin is also involved in kindlin-1 
interaction, as this site is not exclusive for β integrin binding. In addition, talin is 
also able to form homodimers through its C-terminus rod domain which helps to 
facilitate actin binding (Gingras et al., 2008). Many FERM-domain containing 
proteins, such as ezrin, radixin, moesin (ERM) and FAK, are regulated by 
autoinhibition, whereby the F2 and F3 subdomains bind to the C-terminus regions of 
these proteins (Smith et al., 2003; Frame et al., 2010). In these cases, autoinhibition 
maintains the protein in a dormant state and can be activated by phosphorylation, as 
in the case of ezrin or by the binding of other protein or lipids to the FERM domain, 
such as with FAK (Smith et al., 2003; Frame et al., 2010). It is possible that a similar 
mechanism occurs with kindlin-1 and talin, whereby the autoinhibited talin is 
released for activation by kindlin-1 binding to the talin FERM domain. It is also 
possible that kindlin-1 offers this function for other FERM domain containing 
proteins. Kindlin-1 expression is restricted to mostly epithelial cells of the skin and 
gastro-intestinal tract, while its family member kindlin-2 is ubiquitously expressed, 
and kindlin-3 is found mostly in haematopoeitic cells. Both of these other kindlins 
have also shown their important contribution to integrin activation in cooperation 
with talin, and their deficiency results in severe defects. Both kindlin-2 and -3 also 
share a similar domain organisation, as well as binding partners, with kindlin-1, and 
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so it is highly possible that they also carry out similar functions by interacting with 
talin and facilitating its activity.    
 
6.3.3 EGF mediated regulation of kindlin-1-talin binding 
In addition to the role of talin-kindlin binding in integrin activation, there may also 
be a further link with EGFR and its interaction with talin. Data in this thesis show 
that EGF stimulation increases the binding of kindlin-1 with EGFR, suggesting a 
similar mechanism may occur with talin. Nevertheless, it seems unlikely that 
kindlin-1 forms a complex with talin and EGFR at the same time, especially if the 
purpose of kindlin-1-talin interaction is to stabilise talin or co-ordinate its correct 
position for integrin activation. It is more likely that kindlin-1 carries out separate 
and independent functions with EGFR and talin. This mode of action is supported by 
the finding that the kindlin-1-W612A non β1 integrin binding mutant preferentially 
binds to EGFR, showing that when kindlin-1 is not engaged with integrin activation, 
it instead acts to regulate EGFR activity. How this switch in function between 
receptor types occurs will be an important area for future studies. Of note, kindlin-1 
has previously been demonstrated to be a phosphoprotein (Herz et al., 2006), 
although the exact residues or the particular kinase responsible for this activity are 
not known. It is possible that EGFR or downstream signals may regulate the 
phosphorylation status of kindlin-1 and this in turn may dictate the binding partners 
through conformational changes or alterations in membrane phospholipid binding. 
The ability of growth factors to control integrin activity has been previously 
demonstrated and ocuurs either through direct activation or the convergence of 
signals between GFR and integrins (Ivaska and Heino, 2011). Thus, EGF signalling 
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may be a driving force that regulates integrin and therefore focal adhesion activity, 
which can influence cell migration and adhesion through the formation of 
interactions between kindlin-1 and integrin, talin or EGFR. EGF is known to be an 
important regulating factor in establishing correct cell-cell and cell-substratum 
contacts in keratinocytes. EGF may control focal adhesions through driving kindlin-
1 binding to integrin, talin and EGFR. There is also a possibility that EGF may 
regulate adherens junctions through kindlin-1 mediated regulation of E-cadherin. 
Furthermore, there is evidence to suggest that EGF can control hemidesmosome 
disassembly through phosphorylation of β4 integrin subunit which leads to increased 
keratinocyte migration (Rabinovitz et al., 2004). Their findings therefore underscore 
the role of EGF in regulating the activity of several molecules involved in cell-cell 
and cell-substratum biology.  
 
6.4 Conclusions                                              
The present study has identified several findings that enhance the general 
understanding of the biological functions of kindlin-1. The results demonstrate that 
kindlin-1 is involved in the regulation of TSP-1 expression and deposition. Kindlin-1 
is also important for the trafficking and recycling of EGFR. In addition, kindlin-1 
was shown to be a novel interaction partner of talin, thereby providing new 
information on how these two proteins may be involved in integrin activation. 
Collectively, these data have improved the understanding of KS at the molecular and 
cellular level and the increased knowledge of kindlin-1 and its functional role in 
novel pathways that subsequently may provide a wider scope for therapeutic 
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targeting in KS or other aspects of skin biology, perhaps related to cell adhesion, 
skin ageing and carcinogenesis. 
 
6.5 Future directions 
The findings in the project have led to the discovery of novel pathways in which 
kindlin-1 plays a key role. The ability of kindlin-1 to regulate TSP-1 expression and 
deposition indicates that it may be involved in varying cellular processes, including 
angiogenesis. Notably, one of the key clinical features of KS is the presence of small 
dilated blood vessels, known as telangiectasiae. The aetiology of these aberrant 
blood vessels is not known but it is plausible that the alterations in TSP-1 in KS may 
be a contributing factor. However, more information is required regarding the 
downregulation of TSP-1 and whether it is being increasingly degraded in KS 
keratinocytes. It is clear that kindlin-1 is essential for this pathway as reintroduction 
of TSP-1 failed to recover normal deposition of this protein. Integrin activation was 
also shown to be important for this process, as kindlin-1-W612A non β1 integrin 
binding mutant failed to rescue TSP-1 levels and normal deposition, while WT 
kindlin-1 was able to do this. To increase understanding about this pathway further 
analysis is required, especially of the secretory pathway of TSP-1 in conjunction 
with integrin activation. Antibodies that recognise active β1 integrin could be used 
alongside TSP-1 staining to look at the localisation of these proteins and whether 
there are any differences between control and KS keratinocytes in fixed cells. It 
would also be interesting to use live cell imaging using tagged proteins of kindlin-1 
or β1 integrin and TSP-1 to analyse their dynamics in normal and KS patient cells. 
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The present study has also shown that kindlin-1 regulates the recycling of EGFR by 
preventing its degradation, potentially through binding with its cytoplasmic tail. As 
with TSP-1, kindlin-1 re-expression was sufficient to rescue protein levels and also 
response to EGF stimulation, although in this case the process was shown to be 
entirely integrin independent. There are, however, issues that remain unresolved and 
questions that need to be answered for a clearer conclusion to be made. One of these 
questions is the mechanism by which kindlin-1 is recruited to the membrane and 
subsequently how it binds with the EGFR cytoplasmic tail. It is possible that kindlin-
1 is recruited to the membrane in an EGF dependent manner and this may be tested 
by the use of an EGFR tyrosine kinase inhibitor such as AG1478 followed by 
analysis of kindlin-1 localisation after treatment with EGF. EGF stimulation may 
actually lead to kindlin-1 phosphorylation, and the examination of the changes in the 
phosphorylated portion of kindlin-1 by using western blotting or 
immunoprecipitation after treatment of cells with EGF could provide answers. 
Moreover, treatment with PI3K inhibitors, such as LY294002, may provide more 
insight into whether EGF induced changes in Akt signalling or PIP3 production 
leads to kindlin-1 recruitment to the membrane.    
The work in this thesis has provided another clue as to the dynamics of integrin 
activation by kindlin-1 and talin. There is evidence to show that kindlin-1 is able to 
form an interaction with talin independently of integrin, although the full 
significance of this is still unclear. Further investigations will be required to 
determine the specific subdomains and sequences in talin needed for binding to 
kindlin-1. This could be facilitated by introducing mutations followed by GST 
pulldown or immunoprecipitation assays. Alternatively, direct binding assays using 
WT or mutated purified proteins and surface plasmon resonance analysis could be 
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performed. However, such an approach may not provide the necessary conformation 
of each protein that controls binding, and therefore a combination of in vitro and in 
cell analysis should be considered. It would also be interesting to investigate whether 
kindlin-2 and -3 are able to bind to talin, work that could be achieved using similar 
approaches taken in this study. Expression of the kindlin-1 9 bp deletion mutant in 
KS keratinocytes may provide further information about the functional effects on 
integrin activation, by analysing the level of active integrins with 
immunofluorescence or FACS. Changes in localisation and dynamic behaviour of 
talin and the kindlin-1 9 bp deletion mutant could also be determined in these cells 
with the use of live cell imaging.    
Another important question that remains to be determined is whether KS or KS-like 
conditions could arise as a result of mutations in other genes. EB is known to be 
caused by mutations in at least 11 different genes that code for structural/signalling 
components of the hemidesmosome-anchoring filament complex (Shinkuma et al., 
2011). Thus far, mutations in KIND1 represents the only genetic disorder related to 
skin blistering that is found in focal contacts.  It is therefore possible that there could 
be genetic heterogeneity within the spectrum of KS phenotypes observed and that 
this could reflect inherent mutations in genes that code for other different 
components of the focal adhesion complex or indeed some of those proteins 
identified in this study (e.g. talin). Another aspect to be considered is the role that 
kindlin-1 may have on other diseases or pathologies. For example, kindlin-1 may 
make an important contribution to wound healing. Several studies have shown that 
kindlin-1 deficient cells show a delay in wound healing in vitro (Herz et al., 2006; 
Has et al., 2009). In support of this role, this thesis has shown the importance of 
kindlin-1 in EGFR regulation and potentially also E-cadherin regulation, both of 
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which are key proteins involved in single and collective cell migration as well as cell 
proliferation. Angiogenesis is a process characterised by an increase in angiogenic 
factors, such as VEGF, and a decrease in anti-angiogenic factors, like TSP-1. The 
imbalance of TSP-1 levels in cells harbouring kindlin-1 mutations or overexpression 
may also lead to an increase in angiogenesis, like that seen in primary tumour 
growth. Thus, it is also possible that deregulation of TSP-1 due to loss of kindlin-1 
may have a role in cancer formation. Indeed, patients with KS have been found to 
have a significantly increased life-time risk of developing malignancies such as 
cutaneous squamous cell carcinomas (Lai-Cheong et al., 2009b). Kindlin-1 has also 
been shown to be upregulated in many cancers and this raises the possibility of a 
further link with EGFR, also known to be upregulated or mutated in many cancers 
(Weinstein et al., 2003; Bazley and Gullick, 2005). It is possible that dysregulation 
of kindlin-1 leads to an upregulation of EGFR contributing to a metastatic 
phenotype. Thus, a better understanding of the functional roles of kindlin-1, as well 
as other proteins/genes implicated in direct or indirect pathways, may generate 
fundamental new data on various pathological and physiological processes. The 
present study has greatly improved the general understanding of kindlin-1 function 
and has shown that its re-introduction into cells can in some measures rescue the 
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